CN104736131A - 包含双峰乳液的化妆品组合物 - Google Patents
包含双峰乳液的化妆品组合物 Download PDFInfo
- Publication number
- CN104736131A CN104736131A CN201380055413.3A CN201380055413A CN104736131A CN 104736131 A CN104736131 A CN 104736131A CN 201380055413 A CN201380055413 A CN 201380055413A CN 104736131 A CN104736131 A CN 104736131A
- Authority
- CN
- China
- Prior art keywords
- emulsion
- cosmetic composition
- decentralized photo
- mixture
- organosilicon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 293
- 239000000839 emulsion Substances 0.000 title claims abstract description 244
- 239000002537 cosmetic Substances 0.000 title claims abstract description 94
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 131
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 62
- 239000004094 surface-active agent Substances 0.000 claims abstract description 38
- 230000002209 hydrophobic effect Effects 0.000 claims abstract description 10
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- -1 chelating agen Substances 0.000 claims description 192
- 239000003921 oil Substances 0.000 claims description 91
- 239000012071 phase Substances 0.000 claims description 78
- 230000002902 bimodal effect Effects 0.000 claims description 57
- 229910052710 silicon Inorganic materials 0.000 claims description 45
- 239000010703 silicon Substances 0.000 claims description 45
- 238000000034 method Methods 0.000 claims description 44
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 40
- 239000003795 chemical substances by application Substances 0.000 claims description 40
- 239000001993 wax Substances 0.000 claims description 27
- 239000002453 shampoo Substances 0.000 claims description 23
- 241001597008 Nomeidae Species 0.000 claims description 22
- 238000002156 mixing Methods 0.000 claims description 21
- 229920000832 Cutin Polymers 0.000 claims description 17
- 239000000835 fiber Substances 0.000 claims description 17
- 230000000474 nursing effect Effects 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 15
- 230000003750 conditioning effect Effects 0.000 claims description 13
- 230000036541 health Effects 0.000 claims description 12
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 239000000284 extract Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 9
- 239000008346 aqueous phase Substances 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 8
- 150000001768 cations Chemical class 0.000 claims description 7
- 150000002191 fatty alcohols Chemical class 0.000 claims description 7
- 210000004905 finger nail Anatomy 0.000 claims description 7
- 239000000049 pigment Substances 0.000 claims description 7
- 230000000475 sunscreen effect Effects 0.000 claims description 7
- 239000000516 sunscreening agent Substances 0.000 claims description 7
- 210000004906 toe nail Anatomy 0.000 claims description 7
- 235000001014 amino acid Nutrition 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 230000003115 biocidal effect Effects 0.000 claims description 6
- 229920013750 conditioning polymer Polymers 0.000 claims description 6
- 235000018102 proteins Nutrition 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 210000002374 sebum Anatomy 0.000 claims description 6
- 239000000758 substrate Substances 0.000 claims description 6
- 208000001840 Dandruff Diseases 0.000 claims description 5
- 230000002421 anti-septic effect Effects 0.000 claims description 5
- 125000002091 cationic group Chemical group 0.000 claims description 5
- 230000003571 opsonizing effect Effects 0.000 claims description 5
- 239000002250 absorbent Substances 0.000 claims description 4
- 230000002745 absorbent Effects 0.000 claims description 4
- 230000001166 anti-perspirative effect Effects 0.000 claims description 4
- 239000003213 antiperspirant Substances 0.000 claims description 4
- 239000003139 biocide Substances 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 239000000118 hair dye Substances 0.000 claims description 4
- 235000013599 spices Nutrition 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 239000006096 absorbing agent Substances 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 239000003638 chemical reducing agent Substances 0.000 claims description 3
- 239000003086 colorant Substances 0.000 claims description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 239000004530 micro-emulsion Substances 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 230000001590 oxidative effect Effects 0.000 claims description 3
- 239000000419 plant extract Substances 0.000 claims description 3
- 239000003380 propellant Substances 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 229940106189 ceramide Drugs 0.000 claims description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 2
- 239000000375 suspending agent Substances 0.000 claims description 2
- 239000011149 active material Substances 0.000 claims 1
- 239000010408 film Substances 0.000 claims 1
- 239000004519 grease Substances 0.000 claims 1
- 238000000926 separation method Methods 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
- 239000008406 cosmetic ingredient Substances 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 description 73
- 239000004205 dimethyl polysiloxane Substances 0.000 description 56
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 56
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 56
- 239000002245 particle Substances 0.000 description 34
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 33
- 241001080929 Zeugopterus punctatus Species 0.000 description 28
- 150000002148 esters Chemical class 0.000 description 27
- 229920001577 copolymer Polymers 0.000 description 26
- 239000011347 resin Substances 0.000 description 25
- 229920005989 resin Polymers 0.000 description 25
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 229910052799 carbon Inorganic materials 0.000 description 20
- 239000003054 catalyst Substances 0.000 description 20
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 20
- 239000002253 acid Substances 0.000 description 19
- 125000000217 alkyl group Chemical group 0.000 description 19
- 229940008099 dimethicone Drugs 0.000 description 18
- 239000002585 base Substances 0.000 description 17
- 210000000582 semen Anatomy 0.000 description 17
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 17
- 210000003491 skin Anatomy 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- 229920000642 polymer Polymers 0.000 description 16
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 15
- 150000001875 compounds Chemical class 0.000 description 15
- 238000009826 distribution Methods 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- 238000013019 agitation Methods 0.000 description 11
- 229920006037 cross link polymer Polymers 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000012153 distilled water Substances 0.000 description 11
- 230000001804 emulsifying effect Effects 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 229920001558 organosilicon polymer Polymers 0.000 description 11
- 230000008859 change Effects 0.000 description 10
- 238000006459 hydrosilylation reaction Methods 0.000 description 10
- 229920002554 vinyl polymer Polymers 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 150000001721 carbon Chemical group 0.000 description 9
- 229930195733 hydrocarbon Natural products 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 229910052697 platinum Inorganic materials 0.000 description 9
- 229920001223 polyethylene glycol Polymers 0.000 description 9
- 239000004215 Carbon black (E152) Substances 0.000 description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 8
- 239000003085 diluting agent Substances 0.000 description 8
- 229920001971 elastomer Polymers 0.000 description 8
- 239000000806 elastomer Substances 0.000 description 8
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 8
- 239000007764 o/w emulsion Substances 0.000 description 8
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 8
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 7
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 7
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 239000011668 ascorbic acid Substances 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 7
- 238000007046 ethoxylation reaction Methods 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 150000002430 hydrocarbons Chemical class 0.000 description 7
- 125000001183 hydrocarbyl group Chemical group 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 239000000377 silicon dioxide Substances 0.000 description 7
- 239000000600 sorbitol Substances 0.000 description 7
- PMNLUUOXGOOLSP-UHFFFAOYSA-N 2-mercaptopropanoic acid Chemical compound CC(S)C(O)=O PMNLUUOXGOOLSP-UHFFFAOYSA-N 0.000 description 6
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 6
- 235000013162 Cocos nucifera Nutrition 0.000 description 6
- 244000060011 Cocos nucifera Species 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 6
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical group OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- 235000008673 Persea americana Nutrition 0.000 description 6
- 244000025272 Persea americana Species 0.000 description 6
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 6
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 6
- 244000269722 Thea sinensis Species 0.000 description 6
- 229960005070 ascorbic acid Drugs 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 238000005660 chlorination reaction Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 229920000570 polyether Polymers 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000011734 sodium Substances 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 235000015424 sodium Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 6
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 229920002884 Laureth 4 Polymers 0.000 description 5
- 229920001213 Polysorbate 20 Chemical group 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- 229910004283 SiO 4 Inorganic materials 0.000 description 5
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical class OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 5
- RKFMOTBTFHXWCM-UHFFFAOYSA-M [AlH2]O Chemical compound [AlH2]O RKFMOTBTFHXWCM-UHFFFAOYSA-M 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 5
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 5
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- BANXPJUEBPWEOT-UHFFFAOYSA-N isohexadecane Natural products CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 5
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Chemical group 0.000 description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
- 229940068977 polysorbate 20 Drugs 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 238000010008 shearing Methods 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 150000005846 sugar alcohols Polymers 0.000 description 5
- 125000002769 thiazolinyl group Chemical group 0.000 description 5
- 235000010384 tocopherol Nutrition 0.000 description 5
- 229930003799 tocopherol Natural products 0.000 description 5
- 229960001295 tocopherol Drugs 0.000 description 5
- 239000011732 tocopherol Substances 0.000 description 5
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 4
- ZCTQGTTXIYCGGC-UHFFFAOYSA-N Benzyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OCC1=CC=CC=C1 ZCTQGTTXIYCGGC-UHFFFAOYSA-N 0.000 description 4
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 4
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 4
- 229910019142 PO4 Inorganic materials 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 102000035195 Peptidases Human genes 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 239000004721 Polyphenylene oxide Substances 0.000 description 4
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 4
- 229920002472 Starch Polymers 0.000 description 4
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 4
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 239000000058 anti acne agent Substances 0.000 description 4
- 229940124340 antiacne agent Drugs 0.000 description 4
- 239000011324 bead Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 239000000412 dendrimer Substances 0.000 description 4
- 229920000736 dendritic polymer Polymers 0.000 description 4
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 4
- 210000003811 finger Anatomy 0.000 description 4
- 239000006260 foam Substances 0.000 description 4
- 210000004247 hand Anatomy 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 4
- 235000019388 lanolin Nutrition 0.000 description 4
- 229940039717 lanolin Drugs 0.000 description 4
- 229940100556 laureth-23 Drugs 0.000 description 4
- 229940061515 laureth-4 Drugs 0.000 description 4
- IIYFAKIEWZDVMP-UHFFFAOYSA-N linear paraffin C13 Natural products CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 229920000620 organic polymer Polymers 0.000 description 4
- 150000003961 organosilicon compounds Chemical class 0.000 description 4
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 235000010265 sodium sulphite Nutrition 0.000 description 4
- 239000008107 starch Substances 0.000 description 4
- 235000019698 starch Nutrition 0.000 description 4
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 238000004381 surface treatment Methods 0.000 description 4
- 235000020679 tap water Nutrition 0.000 description 4
- 239000004408 titanium dioxide Substances 0.000 description 4
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 3
- WZCQRUWWHSTZEM-UHFFFAOYSA-N 1,3-phenylenediamine Chemical compound NC1=CC=CC(N)=C1 WZCQRUWWHSTZEM-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 3
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 3
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 3
- 239000005995 Aluminium silicate Substances 0.000 description 3
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 3
- 241000195940 Bryophyta Species 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 3
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 3
- 239000004593 Epoxy Substances 0.000 description 3
- 108700032487 GAP-43-3 Proteins 0.000 description 3
- 229920002907 Guar gum Polymers 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 235000006468 Thea sinensis Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 3
- 235000012211 aluminium silicate Nutrition 0.000 description 3
- 125000003368 amide group Chemical group 0.000 description 3
- 239000003945 anionic surfactant Substances 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 3
- 229940049706 benzodiazepine Drugs 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 229940025250 camphora Drugs 0.000 description 3
- 239000010238 camphora Substances 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N caprylic alcohol Natural products CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 239000003093 cationic surfactant Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 210000005224 forefinger Anatomy 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 3
- 125000005456 glyceride group Chemical group 0.000 description 3
- 239000000665 guar gum Substances 0.000 description 3
- 235000010417 guar gum Nutrition 0.000 description 3
- 229960002154 guar gum Drugs 0.000 description 3
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 3
- 229960001340 histamine Drugs 0.000 description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 229940031674 laureth-7 Drugs 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 235000011929 mousse Nutrition 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 3
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 3
- 150000002894 organic compounds Chemical class 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- 229940059574 pentaerithrityl Drugs 0.000 description 3
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 3
- 229960003742 phenol Drugs 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229940057874 phenyl trimethicone Drugs 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 3
- 125000001453 quaternary ammonium group Chemical class 0.000 description 3
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 235000012222 talc Nutrition 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 239000008399 tap water Substances 0.000 description 3
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- QIJRTFXNRTXDIP-UHFFFAOYSA-N (1-carboxy-2-sulfanylethyl)azanium;chloride;hydrate Chemical compound O.Cl.SCC(N)C(O)=O QIJRTFXNRTXDIP-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 description 2
- OIQXFRANQVWXJF-QBFSEMIESA-N (2z)-2-benzylidene-4,7,7-trimethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C2CCC1(C)C(=O)\C2=C/C1=CC=CC=C1 OIQXFRANQVWXJF-QBFSEMIESA-N 0.000 description 2
- UFPKLWVNKAMAPE-UHFFFAOYSA-N (4-aminophenyl)azanium;hydrogen sulfate Chemical compound OS(O)(=O)=O.NC1=CC=C(N)C=C1 UFPKLWVNKAMAPE-UHFFFAOYSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 2
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 2
- SQZCAOHYQSOZCE-UHFFFAOYSA-N 1-(diaminomethylidene)-2-(2-methylphenyl)guanidine Chemical compound CC1=CC=CC=C1N=C(N)N=C(N)N SQZCAOHYQSOZCE-UHFFFAOYSA-N 0.000 description 2
- QUMXDOLUJCHOAY-UHFFFAOYSA-N 1-Phenylethyl acetate Chemical compound CC(=O)OC(C)C1=CC=CC=C1 QUMXDOLUJCHOAY-UHFFFAOYSA-N 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 2
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N 1-nonene Chemical compound CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- NQDZCRSUOVPTII-UHFFFAOYSA-N 10-methylundecan-1-ol Chemical compound CC(C)CCCCCCCCCO NQDZCRSUOVPTII-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-AAKVHIHISA-N 2,3-bis[[(z)-12-hydroxyoctadec-9-enoyl]oxy]propyl (z)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCC(O)C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CC(O)CCCCCC)COC(=O)CCCCCCC\C=C/CC(O)CCCCCC ZEMPKEQAKRGZGQ-AAKVHIHISA-N 0.000 description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
- QTDIEDOANJISNP-UHFFFAOYSA-N 2-dodecoxyethyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOCCOS(O)(=O)=O QTDIEDOANJISNP-UHFFFAOYSA-N 0.000 description 2
- WSSJONWNBBTCMG-UHFFFAOYSA-N 2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C1=CC=CC=C1O WSSJONWNBBTCMG-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- SGVYKUFIHHTIFL-UHFFFAOYSA-N 2-methylnonane Chemical compound CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- ZTGKHKPZSMMHNM-UHFFFAOYSA-N 3-(2-phenylethenyl)benzene-1,2-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC(C=CC=2C=CC=CC=2)=C1S(O)(=O)=O ZTGKHKPZSMMHNM-UHFFFAOYSA-N 0.000 description 2
- CWLKGDAVCFYWJK-UHFFFAOYSA-N 3-aminophenol Chemical compound NC1=CC=CC(O)=C1 CWLKGDAVCFYWJK-UHFFFAOYSA-N 0.000 description 2
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical class OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- IUNVCWLKOOCPIT-UHFFFAOYSA-N 6-methylheptylsulfanyl 2-hydroxyacetate Chemical group CC(C)CCCCCSOC(=O)CO IUNVCWLKOOCPIT-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- 235000007173 Abies balsamea Nutrition 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 108010065511 Amylases Proteins 0.000 description 2
- 102000013142 Amylases Human genes 0.000 description 2
- 239000004857 Balsam Substances 0.000 description 2
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- 241000206575 Chondrus crispus Species 0.000 description 2
- 244000241257 Cucumis melo Species 0.000 description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 101100381997 Danio rerio tbc1d32 gene Proteins 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 229940097420 Diuretic Drugs 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 241000402754 Erythranthe moschata Species 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- FMRHJJZUHUTGKE-UHFFFAOYSA-N Ethylhexyl salicylate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1O FMRHJJZUHUTGKE-UHFFFAOYSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 229920000926 Galactomannan Polymers 0.000 description 2
- 206010017886 Gastroduodenal ulcer Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical group Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- 244000018716 Impatiens biflora Species 0.000 description 2
- 241000334154 Isatis tinctoria Species 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 101100381999 Mus musculus Tbc1d32 gene Proteins 0.000 description 2
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 2
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 2
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 229920000153 Povidone-iodine Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- 235000011572 Pyrus ussuriensis Nutrition 0.000 description 2
- 244000173166 Pyrus ussuriensis Species 0.000 description 2
- 235000004433 Simmondsia californica Nutrition 0.000 description 2
- 244000044822 Simmondsia californica Species 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 235000009392 Vitis Nutrition 0.000 description 2
- 241000219095 Vitis Species 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 2
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 2
- XOSMYOZCNUFSJU-UHFFFAOYSA-N [O].C[SiH](C=CCCCC)C Chemical compound [O].C[SiH](C=CCCCC)C XOSMYOZCNUFSJU-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- DHKHKXVYLBGOIT-UHFFFAOYSA-N acetaldehyde Diethyl Acetal Natural products CCOC(C)OCC DHKHKXVYLBGOIT-UHFFFAOYSA-N 0.000 description 2
- 150000001241 acetals Chemical class 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 125000002723 alicyclic group Chemical group 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N alpha-octadecene Natural products CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 229940048506 aluminum zirconium tetrachlorohydrex gly Drugs 0.000 description 2
- WYANSMZYIOPJFV-UHFFFAOYSA-L aluminum;2-aminoacetic acid;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4].NCC(O)=O WYANSMZYIOPJFV-UHFFFAOYSA-L 0.000 description 2
- HAMGNFFXQJOFRZ-UHFFFAOYSA-L aluminum;zirconium(4+);chloride;hydroxide;hydrate Chemical compound O.[OH-].[Al+3].[Cl-].[Zr+4] HAMGNFFXQJOFRZ-UHFFFAOYSA-L 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical group [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 150000003863 ammonium salts Chemical class 0.000 description 2
- 239000002280 amphoteric surfactant Substances 0.000 description 2
- 235000019418 amylase Nutrition 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 239000003005 anticarcinogenic agent Substances 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- 229940125717 barbiturate Drugs 0.000 description 2
- 238000010923 batch production Methods 0.000 description 2
- 239000001654 beetroot red Substances 0.000 description 2
- 235000012677 beetroot red Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 229960000686 benzalkonium chloride Drugs 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- 150000001557 benzodiazepines Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 2
- 235000002185 betanin Nutrition 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 125000006267 biphenyl group Chemical group 0.000 description 2
- 229910052796 boron Inorganic materials 0.000 description 2
- 229940124630 bronchodilator Drugs 0.000 description 2
- 235000014121 butter Nutrition 0.000 description 2
- 229940078580 c30-45 alkyl methicone Drugs 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000009960 carding Methods 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000007766 cera flava Substances 0.000 description 2
- 229910000420 cerium oxide Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- CMDKPGRTAQVGFQ-RMKNXTFCSA-N cinoxate Chemical compound CCOCCOC(=O)\C=C\C1=CC=C(OC)C=C1 CMDKPGRTAQVGFQ-RMKNXTFCSA-N 0.000 description 2
- 229960001063 cinoxate Drugs 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 229960002433 cysteine Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 229960001305 cysteine hydrochloride Drugs 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- 239000007854 depigmenting agent Substances 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 229960005215 dichloroacetic acid Drugs 0.000 description 2
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 2
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 2
- 229960001259 diclofenac Drugs 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 238000007720 emulsion polymerization reaction Methods 0.000 description 2
- 229960000655 ensulizole Drugs 0.000 description 2
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 229940068171 ethyl hexyl salicylate Drugs 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 125000000524 functional group Chemical group 0.000 description 2
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 description 2
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 2
- 229960003883 furosemide Drugs 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 231100000029 gastro-duodenal ulcer Toxicity 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 2
- 229910000271 hectorite Inorganic materials 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 229960004881 homosalate Drugs 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 229960002163 hydrogen peroxide Drugs 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- JXDYKVIHCLTXOP-UHFFFAOYSA-N isatin Chemical compound C1=CC=C2C(=O)C(=O)NC2=C1 JXDYKVIHCLTXOP-UHFFFAOYSA-N 0.000 description 2
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- CSFWPUWCSPOLJW-UHFFFAOYSA-N lawsone Chemical compound C1=CC=C2C(=O)C(O)=CC(=O)C2=C1 CSFWPUWCSPOLJW-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- YNBADRVTZLEFNH-UHFFFAOYSA-N methyl nicotinate Chemical compound COC(=O)C1=CC=CN=C1 YNBADRVTZLEFNH-UHFFFAOYSA-N 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical group [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 2
- UIUXUFNYAYAMOE-UHFFFAOYSA-N methylsilane Chemical compound [SiH3]C UIUXUFNYAYAMOE-UHFFFAOYSA-N 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229920001206 natural gum Polymers 0.000 description 2
- 125000004355 nitrogen functional group Chemical group 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 229940038384 octadecane Drugs 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 2
- 229960000601 octocrylene Drugs 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229940049964 oleate Drugs 0.000 description 2
- 235000021313 oleic acid Nutrition 0.000 description 2
- 229940046947 oleth-10 phosphate Drugs 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- LSTDYDRCKUBPDI-UHFFFAOYSA-N palmityl acetate Chemical compound CCCCCCCCCCCCCCCCOC(C)=O LSTDYDRCKUBPDI-UHFFFAOYSA-N 0.000 description 2
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 235000019175 phylloquinone Nutrition 0.000 description 2
- 239000011772 phylloquinone Substances 0.000 description 2
- 229960001898 phytomenadione Drugs 0.000 description 2
- 229920001983 poloxamer Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 2
- 235000019252 potassium sulphite Nutrition 0.000 description 2
- 229960001621 povidone-iodine Drugs 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 229960000342 retinol acetate Drugs 0.000 description 2
- 235000019173 retinyl acetate Nutrition 0.000 description 2
- 239000011770 retinyl acetate Substances 0.000 description 2
- 229940108325 retinyl palmitate Drugs 0.000 description 2
- 235000019172 retinyl palmitate Nutrition 0.000 description 2
- 239000011769 retinyl palmitate Substances 0.000 description 2
- 229940066675 ricinoleate Drugs 0.000 description 2
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 2
- 229960003656 ricinoleic acid Drugs 0.000 description 2
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 2
- 235000010352 sodium erythorbate Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 description 2
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 2
- GNBVPFITFYNRCN-UHFFFAOYSA-M sodium thioglycolate Chemical compound [Na+].[O-]C(=O)CS GNBVPFITFYNRCN-UHFFFAOYSA-M 0.000 description 2
- 229940046307 sodium thioglycolate Drugs 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- UHCGLDSRFKGERO-UHFFFAOYSA-N strontium peroxide Chemical compound [Sr+2].[O-][O-] UHCGLDSRFKGERO-UHFFFAOYSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- 150000003456 sulfonamides Chemical class 0.000 description 2
- 229910021653 sulphate ion Inorganic materials 0.000 description 2
- 238000010557 suspension polymerization reaction Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- YODZTKMDCQEPHD-UHFFFAOYSA-N thiodiglycol Chemical compound OCCSCCO YODZTKMDCQEPHD-UHFFFAOYSA-N 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical compound OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 description 2
- 229940103494 thiosalicylic acid Drugs 0.000 description 2
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- 229940125725 tranquilizer Drugs 0.000 description 2
- 239000003204 tranquilizing agent Substances 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 2
- 229940093609 tricaprylin Drugs 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- MNTALGTVSQTALQ-UHFFFAOYSA-N trihydroxy(trimethylsilyloxy)silane Chemical compound C[Si](C)(C)O[Si](O)(O)O MNTALGTVSQTALQ-UHFFFAOYSA-N 0.000 description 2
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 2
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 2
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- UEVAMYPIMMOEFW-UHFFFAOYSA-N trolamine salicylate Chemical compound OCCN(CCO)CCO.OC(=O)C1=CC=CC=C1O UEVAMYPIMMOEFW-UHFFFAOYSA-N 0.000 description 2
- KJIOQYGWTQBHNH-UHFFFAOYSA-N undecanol Chemical compound CCCCCCCCCCCO KJIOQYGWTQBHNH-UHFFFAOYSA-N 0.000 description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 2
- 229940099259 vaseline Drugs 0.000 description 2
- 239000011345 viscous material Substances 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 150000003712 vitamin E derivatives Chemical class 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- 125000005023 xylyl group Chemical group 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- HFJGSJDCVJCSMJ-UHFFFAOYSA-N (2-amino-4-nitrophenyl) hydrogen sulfate Chemical compound NC1=CC([N+]([O-])=O)=CC=C1OS(O)(=O)=O HFJGSJDCVJCSMJ-UHFFFAOYSA-N 0.000 description 1
- HSVDGMYRFLHPMS-UHFFFAOYSA-N (2-benzylidene-7,7-dimethyl-3-oxo-4-bicyclo[2.2.1]heptanyl)methanesulfonic acid Chemical compound CC1(C)C2CCC1(CS(O)(=O)=O)C(=O)C2=CC1=CC=CC=C1 HSVDGMYRFLHPMS-UHFFFAOYSA-N 0.000 description 1
- GPOGLVDBOFRHDV-UHFFFAOYSA-N (2-nonylphenyl) dihydrogen phosphite Chemical compound CCCCCCCCCC1=CC=CC=C1OP(O)O GPOGLVDBOFRHDV-UHFFFAOYSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- GWHLYFOWAINYAH-UHFFFAOYSA-N (3-azaniumyl-4-methoxyphenyl)-(2-hydroxyethyl)azanium;sulfate Chemical compound OS(O)(=O)=O.COC1=CC=C(NCCO)C=C1N GWHLYFOWAINYAH-UHFFFAOYSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- DIWRORZWFLOCLC-HNNXBMFYSA-N (3s)-7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-1,4-benzodiazepin-2-one Chemical compound N([C@H](C(NC1=CC=C(Cl)C=C11)=O)O)=C1C1=CC=CC=C1Cl DIWRORZWFLOCLC-HNNXBMFYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-AAGLSAJLSA-N (3z)-3-[(2e)-2-[1-[(e)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol Chemical compound C1CCC2(C)C(C(C)/C=C/C(C)C(C)C)CCC2\C1=C\C=C1\CC(O)CCC1=C MECHNRXZTMCUDQ-AAGLSAJLSA-N 0.000 description 1
- YRTPZXMEBGTPLM-UVTDQMKNSA-N (3z)-3-benzylidene-2-benzofuran-1-one Chemical compound C12=CC=CC=C2C(=O)O\C1=C/C1=CC=CC=C1 YRTPZXMEBGTPLM-UVTDQMKNSA-N 0.000 description 1
- XRALJHVEDJNLBL-UHFFFAOYSA-N (4-azaniumyl-2-nitrophenyl)azanium;sulfate Chemical compound OS(O)(=O)=O.NC1=CC=C(N)C([N+]([O-])=O)=C1 XRALJHVEDJNLBL-UHFFFAOYSA-N 0.000 description 1
- AALXZHPCKJILAZ-UHFFFAOYSA-N (4-propan-2-ylphenyl)methyl 2-hydroxybenzoate Chemical compound C1=CC(C(C)C)=CC=C1COC(=O)C1=CC=CC=C1O AALXZHPCKJILAZ-UHFFFAOYSA-N 0.000 description 1
- GBBSUAFBMRNDJC-MRXNPFEDSA-N (5R)-zopiclone Chemical compound C1CN(C)CCN1C(=O)O[C@@H]1C2=NC=CN=C2C(=O)N1C1=CC=C(Cl)C=N1 GBBSUAFBMRNDJC-MRXNPFEDSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WDMFHQNUSVLQMS-XFYQWYMDSA-N (e,5z)-5-(3,3-dimethyl-2-bicyclo[2.2.1]heptanylidene)pent-3-en-2-one Chemical compound C1CC2C(C)(C)C(=C/C=C/C(=O)C)\C1C2 WDMFHQNUSVLQMS-XFYQWYMDSA-N 0.000 description 1
- HBOQXIRUPVQLKX-BBWANDEASA-N 1,2,3-trilinoleoylglycerol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)COC(=O)CCCCCCC\C=C/C\C=C/CCCCC HBOQXIRUPVQLKX-BBWANDEASA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- JEFSTMHERNSDBC-UHFFFAOYSA-N 1,2-dimethylcyclohexa-2,4-dien-1-ol Chemical class CC1=CC=CCC1(C)O JEFSTMHERNSDBC-UHFFFAOYSA-N 0.000 description 1
- NFASPFSZJVDDDG-UHFFFAOYSA-N 1,3-benzoxazole;naphthalene Chemical compound C1=CC=C2OC=NC2=C1.C1=CC=CC2=CC=CC=C21 NFASPFSZJVDDDG-UHFFFAOYSA-N 0.000 description 1
- BOKGTLAJQHTOKE-UHFFFAOYSA-N 1,5-dihydroxynaphthalene Chemical compound C1=CC=C2C(O)=CC=CC2=C1O BOKGTLAJQHTOKE-UHFFFAOYSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- MCCACAIVAXEFAL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole;nitric acid Chemical compound O[N+]([O-])=O.ClC1=CC(Cl)=CC=C1COC(C=1C(=CC(Cl)=CC=1)Cl)CN1C=NC=C1 MCCACAIVAXEFAL-UHFFFAOYSA-N 0.000 description 1
- AOSFMYBATFLTAQ-UHFFFAOYSA-N 1-amino-3-(benzimidazol-1-yl)propan-2-ol Chemical group C1=CC=C2N(CC(O)CN)C=NC2=C1 AOSFMYBATFLTAQ-UHFFFAOYSA-N 0.000 description 1
- RWNUSVWFHDHRCJ-UHFFFAOYSA-N 1-butoxypropan-2-ol Chemical compound CCCCOCC(C)O RWNUSVWFHDHRCJ-UHFFFAOYSA-N 0.000 description 1
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 1
- RCMLKQSZCSYLLS-UHFFFAOYSA-N 1-hydroxy-2,3-dihydroindole Chemical compound C1=CC=C2N(O)CCC2=C1 RCMLKQSZCSYLLS-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LALVCWMSKLEQMK-UHFFFAOYSA-N 1-phenyl-3-(4-propan-2-ylphenyl)propane-1,3-dione Chemical compound C1=CC(C(C)C)=CC=C1C(=O)CC(=O)C1=CC=CC=C1 LALVCWMSKLEQMK-UHFFFAOYSA-N 0.000 description 1
- QXHHHPZILQDDPS-UHFFFAOYSA-N 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole Chemical compound S1C=CC(COC(CN2C=NC=C2)C=2C(=CC(Cl)=CC=2)Cl)=C1Cl QXHHHPZILQDDPS-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 1
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 description 1
- PGNRLPTYNKQQDY-UHFFFAOYSA-N 2,3-dihydroxyindole Chemical compound C1=CC=C2C(O)=C(O)NC2=C1 PGNRLPTYNKQQDY-UHFFFAOYSA-N 0.000 description 1
- VHWSRELATOUTAG-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-aminobenzoate Chemical compound NC1=CC=CC=C1C(=O)OCC(O)CO VHWSRELATOUTAG-UHFFFAOYSA-N 0.000 description 1
- WHQOKFZWSDOTQP-UHFFFAOYSA-N 2,3-dihydroxypropyl 4-aminobenzoate Chemical compound NC1=CC=C(C(=O)OCC(O)CO)C=C1 WHQOKFZWSDOTQP-UHFFFAOYSA-N 0.000 description 1
- HUYSCRCIPIWDPL-UHFFFAOYSA-N 2,3-dipentylbenzene-1,4-diol Chemical compound CCCCCC1=C(O)C=CC(O)=C1CCCCC HUYSCRCIPIWDPL-UHFFFAOYSA-N 0.000 description 1
- YXGOYRIWPLGGKN-UHFFFAOYSA-N 2,3-ditert-butylbenzene-1,4-diol Chemical compound CC(C)(C)C1=C(O)C=CC(O)=C1C(C)(C)C YXGOYRIWPLGGKN-UHFFFAOYSA-N 0.000 description 1
- SKDGWNHUETZZCS-UHFFFAOYSA-N 2,3-ditert-butylphenol Chemical compound CC(C)(C)C1=CC=CC(O)=C1C(C)(C)C SKDGWNHUETZZCS-UHFFFAOYSA-N 0.000 description 1
- MJAVQHPPPBDYAN-UHFFFAOYSA-N 2,6-dimethylbenzene-1,4-diamine Chemical compound CC1=CC(N)=CC(C)=C1N MJAVQHPPPBDYAN-UHFFFAOYSA-N 0.000 description 1
- VYHSWZULFYFDMO-UHFFFAOYSA-N 2-(2-hydroxyethylamino)phenol Chemical compound OCCNC1=CC=CC=C1O VYHSWZULFYFDMO-UHFFFAOYSA-N 0.000 description 1
- SBUMIGFDXJIPLE-UHFFFAOYSA-N 2-(3-amino-4-methoxyanilino)ethanol Chemical compound COC1=CC=C(NCCO)C=C1N SBUMIGFDXJIPLE-UHFFFAOYSA-N 0.000 description 1
- QNJWQAYYVNKOKR-UHFFFAOYSA-N 2-(4-amino-2-chloro-5-nitroanilino)ethanol Chemical compound NC1=CC(Cl)=C(NCCO)C=C1[N+]([O-])=O QNJWQAYYVNKOKR-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- WCBLXRCPLCDWCS-UHFFFAOYSA-N 2-(4-methoxy-2-nitroanilino)ethanol Chemical compound COC1=CC=C(NCCO)C([N+]([O-])=O)=C1 WCBLXRCPLCDWCS-UHFFFAOYSA-N 0.000 description 1
- IYAZLDLPUNDVAG-UHFFFAOYSA-N 2-(benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 IYAZLDLPUNDVAG-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- DOPJTDJKZNWLRB-UHFFFAOYSA-N 2-Amino-5-nitrophenol Chemical compound NC1=CC=C([N+]([O-])=O)C=C1O DOPJTDJKZNWLRB-UHFFFAOYSA-N 0.000 description 1
- IZLVFLOBTPURLP-UHFFFAOYSA-N 2-Methoxy-4-nitrophenol Chemical compound COC1=CC([N+]([O-])=O)=CC=C1O IZLVFLOBTPURLP-UHFFFAOYSA-N 0.000 description 1
- MJTPMXWJHPOWGH-UHFFFAOYSA-N 2-Phenoxyethyl isobutyrate Chemical compound CC(C)C(=O)OCCOC1=CC=CC=C1 MJTPMXWJHPOWGH-UHFFFAOYSA-N 0.000 description 1
- LTVDFSLWFKLJDQ-IEOSBIPESA-N 2-[(3r,7r,11r)-3-hydroxy-3,7,11,15-tetramethylhexadecyl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O LTVDFSLWFKLJDQ-IEOSBIPESA-N 0.000 description 1
- DKOOQFYYTJIURT-UHFFFAOYSA-N 2-[(4-methylphenyl)methyl]pyrazole-3,4-diamine;sulfuric acid Chemical compound OS(O)(=O)=O.C1=CC(C)=CC=C1CN1C(N)=C(N)C=N1 DKOOQFYYTJIURT-UHFFFAOYSA-N 0.000 description 1
- UOFCAQWHTQFNHS-UHFFFAOYSA-N 2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCO UOFCAQWHTQFNHS-UHFFFAOYSA-N 0.000 description 1
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 description 1
- OIALAIQRYISUEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]e Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO OIALAIQRYISUEV-UHFFFAOYSA-N 0.000 description 1
- VBCFPAKCBOGUBW-UHFFFAOYSA-N 2-amino-5-ethylphenol Chemical compound CCC1=CC=C(N)C(O)=C1 VBCFPAKCBOGUBW-UHFFFAOYSA-N 0.000 description 1
- MBRHNTMUYWQHMR-UHFFFAOYSA-N 2-aminoethanol;6-cyclohexyl-1-hydroxy-4-methylpyridin-2-one Chemical class NCCO.ON1C(=O)C=C(C)C=C1C1CCCCC1 MBRHNTMUYWQHMR-UHFFFAOYSA-N 0.000 description 1
- CHBXJILUWUHDER-UHFFFAOYSA-N 2-aminoethyl 2-sulfanylacetate Chemical class NCCOC(=O)CS CHBXJILUWUHDER-UHFFFAOYSA-N 0.000 description 1
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- LVYLCBNXHHHPSB-UHFFFAOYSA-N 2-hydroxyethyl salicylate Chemical compound OCCOC(=O)C1=CC=CC=C1O LVYLCBNXHHHPSB-UHFFFAOYSA-N 0.000 description 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical compound COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 description 1
- HAGUXKMTUITVQW-UHFFFAOYSA-N 2-methoxybenzene-1,4-diamine;sulfuric acid Chemical compound OS(O)(=O)=O.COC1=CC(N)=CC=C1N HAGUXKMTUITVQW-UHFFFAOYSA-N 0.000 description 1
- FCMRHMPITHLLLA-UHFFFAOYSA-N 2-methyl-6-nitroaniline Chemical compound CC1=CC=CC([N+]([O-])=O)=C1N FCMRHMPITHLLLA-UHFFFAOYSA-N 0.000 description 1
- ZTMADXFOCUXMJE-UHFFFAOYSA-N 2-methylbenzene-1,3-diol Chemical compound CC1=C(O)C=CC=C1O ZTMADXFOCUXMJE-UHFFFAOYSA-N 0.000 description 1
- CNPVJWYWYZMPDS-UHFFFAOYSA-N 2-methyldecane Chemical compound CCCCCCCCC(C)C CNPVJWYWYZMPDS-UHFFFAOYSA-N 0.000 description 1
- BZSXEZOLBIJVQK-UHFFFAOYSA-N 2-methylsulfonylbenzoic acid Chemical compound CS(=O)(=O)C1=CC=CC=C1C(O)=O BZSXEZOLBIJVQK-UHFFFAOYSA-N 0.000 description 1
- HVHNMNGARPCGGD-UHFFFAOYSA-N 2-nitro-p-phenylenediamine Chemical compound NC1=CC=C(N)C([N+]([O-])=O)=C1 HVHNMNGARPCGGD-UHFFFAOYSA-N 0.000 description 1
- VTJQZXFQQIDLRW-UHFFFAOYSA-N 2-nitrobenzene-1,4-diamine;dihydrochloride Chemical compound Cl.Cl.NC1=CC=C(N)C([N+]([O-])=O)=C1 VTJQZXFQQIDLRW-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- MOTOSAGBNXXRRE-UHFFFAOYSA-N 2-phenylsulfanylacetic acid Chemical compound OC(=O)CSC1=CC=CC=C1 MOTOSAGBNXXRRE-UHFFFAOYSA-N 0.000 description 1
- HEMGYNNCNNODNX-UHFFFAOYSA-N 3,4-diaminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1N HEMGYNNCNNODNX-UHFFFAOYSA-N 0.000 description 1
- JBUDWWMYELDYIJ-UHFFFAOYSA-N 3,4-ditert-butyl-2-ethenylphenol Chemical compound CC(C)(C)C1=CC=C(O)C(C=C)=C1C(C)(C)C JBUDWWMYELDYIJ-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ODJQKYXPKWQWNK-UHFFFAOYSA-L 3-(2-carboxylatoethylsulfanyl)propanoate Chemical group [O-]C(=O)CCSCCC([O-])=O ODJQKYXPKWQWNK-UHFFFAOYSA-L 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- GLDPYUIJFRYAHC-UHFFFAOYSA-N 3-[3-(methylamino)-4-nitrophenyl]propane-1,2-diol Chemical compound CNC1=CC(CC(O)CO)=CC=C1[N+]([O-])=O GLDPYUIJFRYAHC-UHFFFAOYSA-N 0.000 description 1
- SDUIURJVOCHJCO-UHFFFAOYSA-N 3-[5-(Aminosulfonyl)benzoxazol-2-yl]-7-(diethylamino)coumarin Chemical compound NS(=O)(=O)C1=CC=C2OC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 SDUIURJVOCHJCO-UHFFFAOYSA-N 0.000 description 1
- 229940018563 3-aminophenol Drugs 0.000 description 1
- AACHVWXCVWWMSI-UHFFFAOYSA-N 3-hydroxypropyl(trimethyl)azanium Chemical class C[N+](C)(C)CCCO AACHVWXCVWWMSI-UHFFFAOYSA-N 0.000 description 1
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- XPLTXYDVYDWSSO-UHFFFAOYSA-N 4-(ethylamino)-3-nitrobenzoic acid Chemical compound CCNC1=CC=C(C(O)=O)C=C1[N+]([O-])=O XPLTXYDVYDWSSO-UHFFFAOYSA-N 0.000 description 1
- WHODQVWERNSQEO-UHFFFAOYSA-N 4-Amino-2-nitrophenol Chemical compound NC1=CC=C(O)C([N+]([O-])=O)=C1 WHODQVWERNSQEO-UHFFFAOYSA-N 0.000 description 1
- ZNBNBTIDJSKEAM-UHFFFAOYSA-N 4-[7-hydroxy-2-[5-[5-[6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]-5-methyloxolan-2-yl]-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-2-methyl-3-propanoyloxypentanoic acid Chemical group C1C(O)C(C)C(C(C)C(OC(=O)CC)C(C)C(O)=O)OC11OC(C)(C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CC1 ZNBNBTIDJSKEAM-UHFFFAOYSA-N 0.000 description 1
- XWNSFEAWWGGSKJ-UHFFFAOYSA-N 4-acetyl-4-methylheptanedinitrile Chemical compound N#CCCC(C)(C(=O)C)CCC#N XWNSFEAWWGGSKJ-UHFFFAOYSA-N 0.000 description 1
- IQXUIDYRTHQTET-UHFFFAOYSA-N 4-amino-3-nitrophenol Chemical compound NC1=CC=C(O)C=C1[N+]([O-])=O IQXUIDYRTHQTET-UHFFFAOYSA-N 0.000 description 1
- QWVSDCVMXDUGML-UHFFFAOYSA-N 4-aminobenzoic acid;(2,5-dioxoimidazolidin-4-yl)urea Chemical compound NC1=CC=C(C(O)=O)C=C1.NC(=O)NC1NC(=O)NC1=O QWVSDCVMXDUGML-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- QAILABCGXUUVHT-UHFFFAOYSA-N 4-dodecoxy-4-oxo-3-sulfobutanoic acid Chemical compound CCCCCCCCCCCCOC(=O)C(S(O)(=O)=O)CC(O)=O QAILABCGXUUVHT-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- BQEXDUKMTVYBRK-UHFFFAOYSA-N 4-methyl-3-nitrophenol Chemical compound CC1=CC=C(O)C=C1[N+]([O-])=O BQEXDUKMTVYBRK-UHFFFAOYSA-N 0.000 description 1
- GLUKPDKNLKRLHX-UHFFFAOYSA-N 4-n,4-n-dimethylbenzene-1,4-diamine;sulfuric acid Chemical compound OS(O)(=O)=O.CN(C)C1=CC=C(N)C=C1 GLUKPDKNLKRLHX-UHFFFAOYSA-N 0.000 description 1
- XDDAGVUFLQKVEA-SJTHZTAVSA-N 4-o-[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-hydroxy-5-oxo-2h-furan-4-yl] 1-o-[(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (z)-but-2-enedioate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)\C=C/C(=O)OC1=C(O)[C@@H]([C@@H](O)CO)OC1=O XDDAGVUFLQKVEA-SJTHZTAVSA-N 0.000 description 1
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 1
- ODACNRQBNVVGAI-UHFFFAOYSA-N 5-[2-chloroethyl(2-fluoroethyl)amino]-6-methyl-1h-pyrimidine-2,4-dione Chemical compound CC=1NC(=O)NC(=O)C=1N(CCF)CCCl ODACNRQBNVVGAI-UHFFFAOYSA-N 0.000 description 1
- UPALIKSFLSVKIS-UHFFFAOYSA-N 5-amino-2-[2-(dimethylamino)ethyl]benzo[de]isoquinoline-1,3-dione Chemical compound NC1=CC(C(N(CCN(C)C)C2=O)=O)=C3C2=CC=CC3=C1 UPALIKSFLSVKIS-UHFFFAOYSA-N 0.000 description 1
- PKTNQSUCNTYVGX-UHFFFAOYSA-N 5-amino-4-fluoro-2-methylphenol;sulfuric acid Chemical compound OS(O)(=O)=O.CC1=CC(F)=C(N)C=C1O PKTNQSUCNTYVGX-UHFFFAOYSA-N 0.000 description 1
- 125000006043 5-hexenyl group Chemical group 0.000 description 1
- PFGOOGAEVIKREH-UHFFFAOYSA-N 6,7-diamino-2,3-dihydro-1h-pyrazolo[1,2-a]pyrazol-5-one;methanesulfonic acid Chemical compound CS(O)(=O)=O.CS(O)(=O)=O.C1CCN2C(N)=C(N)C(=O)N21 PFGOOGAEVIKREH-UHFFFAOYSA-N 0.000 description 1
- RFRMMZAKBNXNHE-UHFFFAOYSA-N 6-[4,6-dihydroxy-5-(2-hydroxyethoxy)-2-(hydroxymethyl)oxan-3-yl]oxy-2-(hydroxymethyl)-5-(2-hydroxypropoxy)oxane-3,4-diol Chemical compound CC(O)COC1C(O)C(O)C(CO)OC1OC1C(O)C(OCCO)C(O)OC1CO RFRMMZAKBNXNHE-UHFFFAOYSA-N 0.000 description 1
- FQLZTPSAVDHUKS-UHFFFAOYSA-N 6-amino-2-(2,4-dimethylphenyl)benzo[de]isoquinoline-1,3-dione Chemical compound CC1=CC(C)=CC=C1N(C1=O)C(=O)C2=C3C1=CC=CC3=C(N)C=C2 FQLZTPSAVDHUKS-UHFFFAOYSA-N 0.000 description 1
- 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
- 241000218642 Abies Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QZCLKYGREBVARF-UHFFFAOYSA-N Acetyl tributyl citrate Chemical compound CCCCOC(=O)CC(C(=O)OCCCC)(OC(C)=O)CC(=O)OCCCC QZCLKYGREBVARF-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- JBMKAUGHUNFTOL-UHFFFAOYSA-N Aldoclor Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NC=NS2(=O)=O JBMKAUGHUNFTOL-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 239000004261 Ascorbyl stearate Substances 0.000 description 1
- LITUBCVUXPBCGA-WMZHIEFXSA-N Ascorbyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O LITUBCVUXPBCGA-WMZHIEFXSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- SBGWKRLXNJHJJJ-UHFFFAOYSA-N C(C)OC1(C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])O)N Chemical compound C(C)OC1(C(C(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-])O)N SBGWKRLXNJHJJJ-UHFFFAOYSA-N 0.000 description 1
- NSASNNPBPGAMLN-UHFFFAOYSA-N C(C)ONC1=C(C=C(C=C1)C)[N+](=O)[O-] Chemical compound C(C)ONC1=C(C=C(C=C1)C)[N+](=O)[O-] NSASNNPBPGAMLN-UHFFFAOYSA-N 0.000 description 1
- RLLYCJZEWSKBKX-UHFFFAOYSA-N C(C1=CC=CC=C1)C(C)C.[O] Chemical compound C(C1=CC=CC=C1)C(C)C.[O] RLLYCJZEWSKBKX-UHFFFAOYSA-N 0.000 description 1
- DVOZCPGZRDLIFJ-UHFFFAOYSA-N C(C1CO1)N1CCN(CC1)CC1CO1.N1CCNCC1 Chemical compound C(C1CO1)N1CCN(CC1)CC1CO1.N1CCNCC1 DVOZCPGZRDLIFJ-UHFFFAOYSA-N 0.000 description 1
- PXIPADAVYDMHRN-UHFFFAOYSA-N C(CCCCCCCCC)SC1=NC=C2NC=NC2=N1 Chemical compound C(CCCCCCCCC)SC1=NC=C2NC=NC2=N1 PXIPADAVYDMHRN-UHFFFAOYSA-N 0.000 description 1
- CNSWQDDDHDWRMI-UHFFFAOYSA-N C1(=CC=CC=C1)C(OON(C=O)C=O)C1=CC=CC=C1 Chemical compound C1(=CC=CC=C1)C(OON(C=O)C=O)C1=CC=CC=C1 CNSWQDDDHDWRMI-UHFFFAOYSA-N 0.000 description 1
- KOHMVJOZTHFMQC-UHFFFAOYSA-N C1(=CC=CC=C1)C1=CC=CC=2N=C(NC21)S(=O)(=O)O.[K] Chemical compound C1(=CC=CC=C1)C1=CC=CC=2N=C(NC21)S(=O)(=O)O.[K] KOHMVJOZTHFMQC-UHFFFAOYSA-N 0.000 description 1
- YFKTWWJKGDLJDH-UHFFFAOYSA-N CC(O)CO.CCCCCCCCC(O)=O Chemical class CC(O)CO.CCCCCCCCC(O)=O YFKTWWJKGDLJDH-UHFFFAOYSA-N 0.000 description 1
- VDRCOCXLJNTMGX-UHFFFAOYSA-N CC1(C(C(CC1)=O)CCCCCC)C(=O)O.COC(=O)C1C(C(CC1)=O)CCCCCC Chemical compound CC1(C(C(CC1)=O)CCCCCC)C(=O)O.COC(=O)C1C(C(CC1)=O)CCCCCC VDRCOCXLJNTMGX-UHFFFAOYSA-N 0.000 description 1
- ONAIRGOTKJCYEY-XXDXYRHBSA-N CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 Chemical compound CCCCCCCCCCCCCCCCCC(O)=O.O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ONAIRGOTKJCYEY-XXDXYRHBSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 241000388393 Caesalpinia violacea Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 239000004343 Calcium peroxide Substances 0.000 description 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000001884 Cassia gum Substances 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 229920002160 Celluloid Polymers 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- ZKLPARSLTMPFCP-UHFFFAOYSA-N Cetirizine Chemical compound C1CN(CCOCC(=O)O)CCN1C(C=1C=CC(Cl)=CC=1)C1=CC=CC=C1 ZKLPARSLTMPFCP-UHFFFAOYSA-N 0.000 description 1
- 241001310324 Cetraria islandica Species 0.000 description 1
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000033870 Citrullus lanatus subsp. vulgaris Species 0.000 description 1
- 235000012840 Citrullus vulgaris Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 244000235531 Cupressus funebris Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 229940123780 DNA topoisomerase I inhibitor Drugs 0.000 description 1
- 229940124087 DNA topoisomerase II inhibitor Drugs 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- PQUCIEFHOVEZAU-UHFFFAOYSA-N Diammonium sulfite Chemical compound [NH4+].[NH4+].[O-]S([O-])=O PQUCIEFHOVEZAU-UHFFFAOYSA-N 0.000 description 1
- 239000004338 Dichlorodifluoromethane Substances 0.000 description 1
- HECLRDQVFMWTQS-UHFFFAOYSA-N Dicyclopentadiene Chemical group C1C2C3CC=CC3C1C=C2 HECLRDQVFMWTQS-UHFFFAOYSA-N 0.000 description 1
- GHKOFFNLGXMVNJ-UHFFFAOYSA-N Didodecyl thiobispropanoate Chemical compound CCCCCCCCCCCCOC(=O)CCSCCC(=O)OCCCCCCCCCCCC GHKOFFNLGXMVNJ-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- 239000003508 Dilauryl thiodipropionate Substances 0.000 description 1
- RPWFJAMTCNSJKK-UHFFFAOYSA-N Dodecyl gallate Chemical group CCCCCCCCCCCCOC(=O)C1=CC(O)=C(O)C(O)=C1 RPWFJAMTCNSJKK-UHFFFAOYSA-N 0.000 description 1
- 239000004908 Emulsion polymer Substances 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 241000390128 Eutrema Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-M Glycolate Chemical compound OCC([O-])=O AEMRFAOFKBGASW-UHFFFAOYSA-M 0.000 description 1
- 241000350160 Haematoxylum Species 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
- 108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 241000981924 Juniperus oxycedrus Species 0.000 description 1
- 241001446187 Kermes Species 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical group CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 108010029541 Laccase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 244000208060 Lawsonia inermis Species 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical group O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- MKYLOMHWHWEFCT-UHFFFAOYSA-N Manthidine Natural products C1C2=CC=3OCOC=3C=C2C2C3=CC(OC)C(O)CC3N1C2 MKYLOMHWHWEFCT-UHFFFAOYSA-N 0.000 description 1
- 241000378467 Melaleuca Species 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Chemical group COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 1
- QWZLBLDNRUUYQI-UHFFFAOYSA-M Methylbenzethonium chloride Chemical compound [Cl-].CC1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 QWZLBLDNRUUYQI-UHFFFAOYSA-M 0.000 description 1
- SNFRINMTRPQQLE-JQWAAABSSA-N Montanin Chemical compound O[C@H]([C@@]1(CO)O[C@H]1[C@H]1[C@H]2O3)[C@]4(O)C(=O)C(C)=C[C@H]4[C@]11OC3(CCCCCCCCCCC)O[C@@]2(C(C)=C)C[C@H]1C SNFRINMTRPQQLE-JQWAAABSSA-N 0.000 description 1
- SNFRINMTRPQQLE-OFGNMXNXSA-N Montanin Natural products O=C1[C@@]2(O)[C@@H](O)[C@@]3(CO)O[C@H]3[C@@H]3[C@H]4[C@@]5(C(=C)C)O[C@](CCCCCCCCCCC)(O4)O[C@@]3([C@H](C)C5)[C@@H]2C=C1C SNFRINMTRPQQLE-OFGNMXNXSA-N 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 241001508687 Mustela erminea Species 0.000 description 1
- BZORFPDSXLZWJF-UHFFFAOYSA-N N,N-dimethyl-1,4-phenylenediamine Chemical compound CN(C)C1=CC=C(N)C=C1 BZORFPDSXLZWJF-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-methyltaurine Natural products CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 239000005662 Paraffin oil Substances 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 1
- VQDBNKDJNJQRDG-UHFFFAOYSA-N Pirbuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=N1 VQDBNKDJNJQRDG-UHFFFAOYSA-N 0.000 description 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004153 Potassium bromate Substances 0.000 description 1
- 229940122767 Potassium sparing diuretic Drugs 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- VYOCUUHEYNUVQD-UHFFFAOYSA-N S(=O)(=O)(O)O.C(C)ONC1=CC=C(C=C1)N Chemical compound S(=O)(=O)(O)O.C(C)ONC1=CC=C(C=C1)N VYOCUUHEYNUVQD-UHFFFAOYSA-N 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 229910020175 SiOH Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Natural products NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 1
- QPMIVFWZGPTDPN-UHFFFAOYSA-N Tetrabromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C(C(Br)=C(Br)C(Br)=C2Br)=C2S(=O)(=O)O1 QPMIVFWZGPTDPN-UHFFFAOYSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229940121792 Thiazide diuretic Drugs 0.000 description 1
- IUJDSEJGGMCXSG-UHFFFAOYSA-N Thiopental Chemical compound CCCC(C)C1(CC)C(=O)NC(=S)NC1=O IUJDSEJGGMCXSG-UHFFFAOYSA-N 0.000 description 1
- 102000004377 Thiopurine S-methyltransferases Human genes 0.000 description 1
- 108090000958 Thiopurine S-methyltransferases Proteins 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000000365 Topoisomerase I Inhibitor Substances 0.000 description 1
- 239000000317 Topoisomerase II Inhibitor Substances 0.000 description 1
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 229940122803 Vinca alkaloid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- QTZPBQMTXNEKRX-UHFFFAOYSA-N Voacristine pseudoindoxyl Natural products N1C2=CC=C(OC)C=C2C(=O)C21CCN(C1)C3C(C(C)O)CC1CC32C(=O)OC QTZPBQMTXNEKRX-UHFFFAOYSA-N 0.000 description 1
- 235000000760 Wasabia japonica Nutrition 0.000 description 1
- 244000195452 Wasabia japonica Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- FMRLDPWIRHBCCC-UHFFFAOYSA-L Zinc carbonate Chemical compound [Zn+2].[O-]C([O-])=O FMRLDPWIRHBCCC-UHFFFAOYSA-L 0.000 description 1
- YMCOHQVWOBMDCZ-UHFFFAOYSA-L Zinc undecylenate Chemical compound [Zn+2].[O-]C(=O)CCCCCCCCC=C.[O-]C(=O)CCCCCCCCC=C YMCOHQVWOBMDCZ-UHFFFAOYSA-L 0.000 description 1
- XJKITIOIYQCXQR-DOTGLYPQSA-N [(2z,4e,6z,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC\C=C(\C)/C=C/C=C(/C)\C=C\C1=C(C)CCCC1(C)C XJKITIOIYQCXQR-DOTGLYPQSA-N 0.000 description 1
- UCTLHLZWKJIXJI-LXIBVNSESA-N [(3s,8r,9s,10r,13s,14s)-17-chloro-16-formyl-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C([C@@H]12)C[C@]3(C)C(Cl)=C(C=O)C[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)C)C1 UCTLHLZWKJIXJI-LXIBVNSESA-N 0.000 description 1
- AVTXVDFKYBVTKR-DPAQBDIFSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] dihydrogen phosphate Chemical compound C1C=C2C[C@@H](OP(O)(O)=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 AVTXVDFKYBVTKR-DPAQBDIFSA-N 0.000 description 1
- OCKWAZCWKSMKNC-UHFFFAOYSA-N [3-octadecanoyloxy-2,2-bis(octadecanoyloxymethyl)propyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC OCKWAZCWKSMKNC-UHFFFAOYSA-N 0.000 description 1
- FYOZXGGELZLRJK-UHFFFAOYSA-L [Na+].[Na+].S(=O)(=O)(O)C(C(=O)OCCCCCCCCCCCC)CC(=O)[O-].C(CC(O)(C(=O)O)CC(=O)O)(=O)O.C(CCCCCCCCCCC)OC(C(CC(=O)[O-])S(=O)(=O)O)=O Chemical compound [Na+].[Na+].S(=O)(=O)(O)C(C(=O)OCCCCCCCCCCCC)CC(=O)[O-].C(CC(O)(C(=O)O)CC(=O)O)(=O)O.C(CCCCCCCCCCC)OC(C(CC(=O)[O-])S(=O)(=O)O)=O FYOZXGGELZLRJK-UHFFFAOYSA-L 0.000 description 1
- UCMLZSVVCQDDHA-UHFFFAOYSA-N [Na].C=12NC(S(=O)(=O)O)=NC2=CC=CC=1C1=CC=CC=C1 Chemical compound [Na].C=12NC(S(=O)(=O)O)=NC2=CC=CC=1C1=CC=CC=C1 UCMLZSVVCQDDHA-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- BQODPTQLXVVEJG-UHFFFAOYSA-N [O].C=C Chemical group [O].C=C BQODPTQLXVVEJG-UHFFFAOYSA-N 0.000 description 1
- TUPZKTSKLSDAFI-UHFFFAOYSA-N [O].C[SiH](C)C Chemical compound [O].C[SiH](C)C TUPZKTSKLSDAFI-UHFFFAOYSA-N 0.000 description 1
- UCNYUACNGPRCDC-UHFFFAOYSA-N [S]C(=O)C1=CC=CC=C1 Chemical compound [S]C(=O)C1=CC=CC=C1 UCNYUACNGPRCDC-UHFFFAOYSA-N 0.000 description 1
- ADANNTOYRVPQLJ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilyl]oxy-dimethylsilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C ADANNTOYRVPQLJ-UHFFFAOYSA-N 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- TWIIVLKQFJBFPW-UHFFFAOYSA-N acetaminosalol Chemical compound C1=CC(NC(=O)C)=CC=C1OC(=O)C1=CC=CC=C1O TWIIVLKQFJBFPW-UHFFFAOYSA-N 0.000 description 1
- 229950007008 acetaminosalol Drugs 0.000 description 1
- BZKPWHYZMXOIDC-UHFFFAOYSA-N acetazolamide Chemical compound CC(=O)NC1=NN=C(S(N)(=O)=O)S1 BZKPWHYZMXOIDC-UHFFFAOYSA-N 0.000 description 1
- 229960000571 acetazolamide Drugs 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 229940048299 acetylated lanolin alcohols Drugs 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- QAWIHIJWNYOLBE-OKKQSCSOSA-N acivicin Chemical compound OC(=O)[C@@H](N)[C@@H]1CC(Cl)=NO1 QAWIHIJWNYOLBE-OKKQSCSOSA-N 0.000 description 1
- 229950008427 acivicin Drugs 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- NDAUXUAQIAJITI-UHFFFAOYSA-N albuterol Chemical compound CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 NDAUXUAQIAJITI-UHFFFAOYSA-N 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 150000008055 alkyl aryl sulfonates Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 150000008052 alkyl sulfonates Chemical class 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 125000001118 alkylidene group Chemical group 0.000 description 1
- XJKITIOIYQCXQR-SCUNHAKFSA-N all-trans-retinyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C XJKITIOIYQCXQR-SCUNHAKFSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 229960001422 aluminium chlorohydrate Drugs 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910021502 aluminium hydroxide Inorganic materials 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- XSDQTOBWRPYKKA-UHFFFAOYSA-N amiloride Chemical compound NC(=N)NC(=O)C1=NC(Cl)=C(N)N=C1N XSDQTOBWRPYKKA-UHFFFAOYSA-N 0.000 description 1
- 229960002576 amiloride Drugs 0.000 description 1
- UBNYRXMKIIGMKK-RMKNXTFCSA-N amiloxate Chemical compound COC1=CC=C(\C=C\C(=O)OCCC(C)C)C=C1 UBNYRXMKIIGMKK-RMKNXTFCSA-N 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- ZZTCCAPMZLDHFM-UHFFFAOYSA-N ammonium thioglycolate Chemical compound [NH4+].[O-]C(=O)CS ZZTCCAPMZLDHFM-UHFFFAOYSA-N 0.000 description 1
- 229960004701 amonafide Drugs 0.000 description 1
- 239000012164 animal wax Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002682 anti-psoriatic effect Effects 0.000 description 1
- 239000003416 antiarrhythmic agent Substances 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 229940053195 antiepileptics hydantoin derivative Drugs 0.000 description 1
- 229940006133 antiglaucoma drug and miotics carbonic anhydrase inhibitors Drugs 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940045985 antineoplastic platinum compound Drugs 0.000 description 1
- 239000002249 anxiolytic agent Substances 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000019276 ascorbyl stearate Nutrition 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Chemical group O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Chemical group O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 230000002716 ataractic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- IRERQBUNZFJFGC-UHFFFAOYSA-L azure blue Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[S-]S[S-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-].[O-][Si]([O-])([O-])[O-] IRERQBUNZFJFGC-UHFFFAOYSA-L 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 229940095077 behentrimonium methosulfate Drugs 0.000 description 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 1
- WYLQRHZSKIDFEP-UHFFFAOYSA-N benzene-1,4-dithiol Chemical compound SC1=CC=C(S)C=C1 WYLQRHZSKIDFEP-UHFFFAOYSA-N 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- 108010019077 beta-Amylase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 1
- PXTQQOLKZBLYDY-UHFFFAOYSA-N bis(2-ethylhexyl) carbonate Chemical compound CCCCC(CC)COC(=O)OCC(CC)CCCC PXTQQOLKZBLYDY-UHFFFAOYSA-N 0.000 description 1
- FSIJKGMIQTVTNP-UHFFFAOYSA-N bis(ethenyl)-methyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C=C)C=C FSIJKGMIQTVTNP-UHFFFAOYSA-N 0.000 description 1
- DSVRVHYFPPQFTI-UHFFFAOYSA-N bis(ethenyl)-methyl-trimethylsilyloxysilane;platinum Chemical compound [Pt].C[Si](C)(C)O[Si](C)(C=C)C=C DSVRVHYFPPQFTI-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 229950000757 bornelone Drugs 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- ZDIGNSYAACHWNL-UHFFFAOYSA-N brompheniramine Chemical compound C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Br)C=C1 ZDIGNSYAACHWNL-UHFFFAOYSA-N 0.000 description 1
- 229960000725 brompheniramine Drugs 0.000 description 1
- JBRBWHCVRGURBA-UHFFFAOYSA-N broxaterol Chemical compound CC(C)(C)NCC(O)C1=CC(Br)=NO1 JBRBWHCVRGURBA-UHFFFAOYSA-N 0.000 description 1
- 229950008847 broxaterol Drugs 0.000 description 1
- MAEIEVLCKWDQJH-UHFFFAOYSA-N bumetanide Chemical compound CCCCNC1=CC(C(O)=O)=CC(S(N)(=O)=O)=C1OC1=CC=CC=C1 MAEIEVLCKWDQJH-UHFFFAOYSA-N 0.000 description 1
- 229960004064 bumetanide Drugs 0.000 description 1
- OCWYEMOEOGEQAN-UHFFFAOYSA-N bumetrizole Chemical compound CC(C)(C)C1=CC(C)=CC(N2N=C3C=C(Cl)C=CC3=N2)=C1O OCWYEMOEOGEQAN-UHFFFAOYSA-N 0.000 description 1
- 229950007917 bumetrizole Drugs 0.000 description 1
- 229960002092 busulfan Drugs 0.000 description 1
- IUWVALYLNVXWKX-UHFFFAOYSA-N butamben Chemical compound CCCCOC(=O)C1=CC=C(N)C=C1 IUWVALYLNVXWKX-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- JGVDBODXXHHCJH-UHFFFAOYSA-N butyl acetate;ethyl acetate Chemical compound CCOC(C)=O.CCCCOC(C)=O JGVDBODXXHHCJH-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940113899 c12-13 pareth-23 Drugs 0.000 description 1
- 229940113911 c12-13 pareth-3 Drugs 0.000 description 1
- 229940096584 c12-15 pareth-3 Drugs 0.000 description 1
- 229940104939 c12-15 pareth-7 Drugs 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 235000019402 calcium peroxide Nutrition 0.000 description 1
- 229940118258 calcium undecylenate Drugs 0.000 description 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 description 1
- 229940127093 camptothecin Drugs 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229960002504 capsaicin Drugs 0.000 description 1
- 235000017663 capsaicin Nutrition 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000001722 capsicum frutescens oleoresin Substances 0.000 description 1
- 229940050948 capsicum oleoresin Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 150000001719 carbohydrate derivatives Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000003489 carbonate dehydratase inhibitor Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000002327 cardiovascular agent Substances 0.000 description 1
- 229940125692 cardiovascular agent Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000019318 cassia gum Nutrition 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000007765 cera alba Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229940073642 ceteareth-30 Drugs 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229940056318 ceteth-20 Drugs 0.000 description 1
- 229960001803 cetirizine Drugs 0.000 description 1
- 229940049297 cetyl acetate Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 229960002155 chlorothiazide Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 description 1
- 229960001380 cimetidine Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- CBGUOGMQLZIXBE-XGQKBEPLSA-N clobetasol propionate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CCl)(OC(=O)CC)[C@@]1(C)C[C@@H]2O CBGUOGMQLZIXBE-XGQKBEPLSA-N 0.000 description 1
- 229960004703 clobetasol propionate Drugs 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229960001338 colchicine Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- XCJYREBRNVKWGJ-UHFFFAOYSA-N copper(II) phthalocyanine Chemical compound [Cu+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 XCJYREBRNVKWGJ-UHFFFAOYSA-N 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229930003836 cresol Natural products 0.000 description 1
- ZXJXZNDDNMQXFV-UHFFFAOYSA-M crystal violet Chemical compound [Cl-].C1=CC(N(C)C)=CC=C1[C+](C=1C=CC(=CC=1)N(C)C)C1=CC=C(N(C)C)C=C1 ZXJXZNDDNMQXFV-UHFFFAOYSA-M 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- UFULAYFCSOUIOV-UHFFFAOYSA-N cysteamine Chemical compound NCCS UFULAYFCSOUIOV-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 239000013527 degreasing agent Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000002951 depilatory effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- WCOATMADISNSBV-UHFFFAOYSA-K diacetyloxyalumanyl acetate Chemical compound [Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WCOATMADISNSBV-UHFFFAOYSA-K 0.000 description 1
- LVYZJEPLMYTTGH-UHFFFAOYSA-H dialuminum chloride pentahydroxide dihydrate Chemical compound [Cl-].[Al+3].[OH-].[OH-].[Al+3].[OH-].[OH-].[OH-].O.O LVYZJEPLMYTTGH-UHFFFAOYSA-H 0.000 description 1
- 235000019404 dichlorodifluoromethane Nutrition 0.000 description 1
- 229940087091 dichlorotetrafluoroethane Drugs 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 235000019304 dilauryl thiodipropionate Nutrition 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 1
- 229960004352 diosmin Drugs 0.000 description 1
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- 239000000982 direct dye Substances 0.000 description 1
- JMGZBMRVDHKMKB-UHFFFAOYSA-L disodium;2-sulfobutanedioate Chemical compound [Na+].[Na+].OS(=O)(=O)C(C([O-])=O)CC([O-])=O JMGZBMRVDHKMKB-UHFFFAOYSA-L 0.000 description 1
- VTIIJXUACCWYHX-UHFFFAOYSA-L disodium;carboxylatooxy carbonate Chemical compound [Na+].[Na+].[O-]C(=O)OOC([O-])=O VTIIJXUACCWYHX-UHFFFAOYSA-L 0.000 description 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- QIVLQXGSQSFTIF-UHFFFAOYSA-M docosyl(trimethyl)azanium;methyl sulfate Chemical compound COS([O-])(=O)=O.CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C QIVLQXGSQSFTIF-UHFFFAOYSA-M 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 239000000555 dodecyl gallate Chemical group 0.000 description 1
- 235000010386 dodecyl gallate Nutrition 0.000 description 1
- 229940080643 dodecyl gallate Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960000979 drometrizole Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- QELUYTUMUWHWMC-UHFFFAOYSA-N edaravone Chemical compound O=C1CC(C)=NN1C1=CC=CC=C1 QELUYTUMUWHWMC-UHFFFAOYSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- BXOUVIIITJXIKB-UHFFFAOYSA-N ethene;styrene Chemical group C=C.C=CC1=CC=CC=C1 BXOUVIIITJXIKB-UHFFFAOYSA-N 0.000 description 1
- OPCRGEVPIBLWAY-QNRZBPGKSA-N ethyl (2E,4Z)-deca-2,4-dienoate Chemical compound CCCCC\C=C/C=C/C(=O)OCC OPCRGEVPIBLWAY-QNRZBPGKSA-N 0.000 description 1
- ATJVZXXHKSYELS-FNORWQNLSA-N ethyl (e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate Chemical group CCOC(=O)\C=C\C1=CC=C(O)C(OC)=C1 ATJVZXXHKSYELS-FNORWQNLSA-N 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- CBZHHQOZZQEZNJ-UHFFFAOYSA-N ethyl 4-[bis(2-hydroxypropyl)amino]benzoate Chemical compound CCOC(=O)C1=CC=C(N(CC(C)O)CC(C)O)C=C1 CBZHHQOZZQEZNJ-UHFFFAOYSA-N 0.000 description 1
- DHNGCHLFKUPGPX-RMKNXTFCSA-N ethyl trans-p-methoxycinnamate Chemical compound CCOC(=O)\C=C\C1=CC=C(OC)C=C1 DHNGCHLFKUPGPX-RMKNXTFCSA-N 0.000 description 1
- UKAJDOBPPOAZSS-UHFFFAOYSA-N ethyl(trimethyl)silane Chemical compound CC[Si](C)(C)C UKAJDOBPPOAZSS-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- ATJVZXXHKSYELS-UHFFFAOYSA-N ferulic acid ethyl ester Chemical group CCOC(=O)C=CC1=CC=C(O)C(OC)=C1 ATJVZXXHKSYELS-UHFFFAOYSA-N 0.000 description 1
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 description 1
- 229960003592 fexofenadine Drugs 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Substances O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 244000177546 frostweed Species 0.000 description 1
- 235000010708 frostweed Nutrition 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 229960001235 gentian violet Drugs 0.000 description 1
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N geranyl acetate Chemical compound CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- GWOFUCIGLDBNKM-UHFFFAOYSA-N glafenine Chemical compound OCC(O)COC(=O)C1=CC=CC=C1NC1=CC=NC2=CC(Cl)=CC=C12 GWOFUCIGLDBNKM-UHFFFAOYSA-N 0.000 description 1
- 229960001650 glafenine Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229940074046 glyceryl laurate Drugs 0.000 description 1
- DOGJSOZYUGJVKS-UHFFFAOYSA-N glyceryl monothioglycolate Chemical compound OCC(O)COC(=O)CS DOGJSOZYUGJVKS-UHFFFAOYSA-N 0.000 description 1
- 150000002332 glycine derivatives Chemical class 0.000 description 1
- 229960002389 glycol salicylate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000001033 granulometry Methods 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- PKWIYNIDEDLDCJ-UHFFFAOYSA-N guanazole Chemical compound NC1=NNC(N)=N1 PKWIYNIDEDLDCJ-UHFFFAOYSA-N 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 108010002430 hemicellulase Proteins 0.000 description 1
- 229940059442 hemicellulase Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- HTDJPCNNEPUOOQ-UHFFFAOYSA-N hexamethylcyclotrisiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O1 HTDJPCNNEPUOOQ-UHFFFAOYSA-N 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 229940073561 hexamethyldisiloxane Drugs 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000001469 hydantoins Chemical class 0.000 description 1
- 235000011167 hydrochloric acid Nutrition 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- DLINORNFHVEIFE-UHFFFAOYSA-N hydrogen peroxide;zinc Chemical compound [Zn].OO DLINORNFHVEIFE-UHFFFAOYSA-N 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229940071826 hydroxyethyl cellulose Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910000378 hydroxylammonium sulfate Inorganic materials 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 235000013847 iso-butane Nutrition 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N iso-octadecanoic acid Natural products CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- 229940078546 isoeicosane Drugs 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 239000008633 juniper tar Substances 0.000 description 1
- CXORMDKZEUMQHX-UHFFFAOYSA-N kermesic acid Chemical compound O=C1C2=C(O)C(O)=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C CXORMDKZEUMQHX-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical group OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Chemical group OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- SIXIIKVOZAGHPV-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=C[CH]C2=N1 SIXIIKVOZAGHPV-UHFFFAOYSA-N 0.000 description 1
- 229960003174 lansoprazole Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229940062711 laureth-9 Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- HBOQXIRUPVQLKX-UHFFFAOYSA-N linoleic acid triglyceride Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002171 loop diuretic Substances 0.000 description 1
- UTEFBSAVJNEPTR-RGEXLXHISA-N loprazolam Chemical compound C1CN(C)CCN1\C=C/1C(=O)N2C3=CC=C([N+]([O-])=O)C=C3C(C=3C(=CC=CC=3)Cl)=NCC2=N\1 UTEFBSAVJNEPTR-RGEXLXHISA-N 0.000 description 1
- 229960003019 loprazolam Drugs 0.000 description 1
- JCCNYMKQOSZNPW-UHFFFAOYSA-N loratadine Chemical compound C1CN(C(=O)OCC)CCC1=C1C2=NC=CC=C2CCC2=CC(Cl)=CC=C21 JCCNYMKQOSZNPW-UHFFFAOYSA-N 0.000 description 1
- 229960003088 loratadine Drugs 0.000 description 1
- 229960004391 lorazepam Drugs 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 229950007687 macrogol ester Drugs 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical group [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960003951 masoprocol Drugs 0.000 description 1
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical group COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 1
- 229960003987 melatonin Drugs 0.000 description 1
- LWYJUZBXGAFFLP-OCNCTQISSA-N menogaril Chemical compound O1[C@@]2(C)[C@H](O)[C@@H](N(C)C)[C@H](O)[C@@H]1OC1=C3C(=O)C(C=C4C[C@@](C)(O)C[C@H](C4=C4O)OC)=C4C(=O)C3=C(O)C=C12 LWYJUZBXGAFFLP-OCNCTQISSA-N 0.000 description 1
- 229950002676 menogaril Drugs 0.000 description 1
- 229960003151 mercaptamine Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- CBKLICUQYUTWQL-XWGBWKJCSA-N methyl (3s,4r)-3-methyl-1-(2-phenylethyl)-4-(n-propanoylanilino)piperidine-4-carboxylate;oxalic acid Chemical compound OC(=O)C(O)=O.CCC(=O)N([C@]1([C@H](CN(CCC=2C=CC=CC=2)CC1)C)C(=O)OC)C1=CC=CC=C1 CBKLICUQYUTWQL-XWGBWKJCSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 229940044591 methyl glucose dioleate Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- PHLASVAENYNAOW-UHFFFAOYSA-N methyl-bis[[methyl(diphenyl)silyl]oxy]-phenylsilane Chemical compound C=1C=CC=CC=1[Si](C)(C=1C=CC=CC=1)O[Si](C=1C=CC=CC=1)(C)O[Si](C)(C=1C=CC=CC=1)C1=CC=CC=C1 PHLASVAENYNAOW-UHFFFAOYSA-N 0.000 description 1
- 229960002285 methylbenzethonium chloride Drugs 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 229960001238 methylnicotinate Drugs 0.000 description 1
- BFXIKLCIZHOAAZ-UHFFFAOYSA-N methyltrimethoxysilane Chemical compound CO[Si](C)(OC)OC BFXIKLCIZHOAAZ-UHFFFAOYSA-N 0.000 description 1
- 229960005040 miconazole nitrate Drugs 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 150000002762 monocarboxylic acid derivatives Chemical class 0.000 description 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- NALMPLUMOWIVJC-UHFFFAOYSA-N n,n,4-trimethylbenzeneamine oxide Chemical compound CC1=CC=C([N+](C)(C)[O-])C=C1 NALMPLUMOWIVJC-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- KWUZCAVKPCRJPO-UHFFFAOYSA-N n-ethyl-4-(6-methyl-1,3-benzothiazol-2-yl)aniline Chemical compound C1=CC(NCC)=CC=C1C1=NC2=CC=C(C)C=C2S1 KWUZCAVKPCRJPO-UHFFFAOYSA-N 0.000 description 1
- LCXGFVXUJZJODY-UHFFFAOYSA-N n-methylmethanamine;toluene Chemical compound CNC.CC1=CC=CC=C1 LCXGFVXUJZJODY-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- ZUVBIBLYOCVYJU-UHFFFAOYSA-N naphthalene-1,7-diol Chemical compound C1=CC=C(O)C2=CC(O)=CC=C21 ZUVBIBLYOCVYJU-UHFFFAOYSA-N 0.000 description 1
- 229940086319 nattokinase Drugs 0.000 description 1
- 108010073682 nattokinase Proteins 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- LQNUZADURLCDLV-UHFFFAOYSA-N nitrobenzene Chemical compound [O-][N+](=O)C1=CC=CC=C1 LQNUZADURLCDLV-UHFFFAOYSA-N 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- ZHDCVEXTJJYIGZ-UHFFFAOYSA-N nona-1,4-diene Chemical compound CCCCC=CCC=C ZHDCVEXTJJYIGZ-UHFFFAOYSA-N 0.000 description 1
- AZRLPRUNACPLIV-UHFFFAOYSA-N nona-1,5-diene Chemical compound CCCC=CCCC=C AZRLPRUNACPLIV-UHFFFAOYSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 229950004841 octrizole Drugs 0.000 description 1
- CBFCDTFDPHXCNY-UHFFFAOYSA-N octyldodecane Natural products CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 1
- 239000008601 oleoresin Substances 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- SBQLYHNEIUGQKH-UHFFFAOYSA-N omeprazole Chemical compound N1=C2[CH]C(OC)=CC=C2N=C1S(=O)CC1=NC=C(C)C(OC)=C1C SBQLYHNEIUGQKH-UHFFFAOYSA-N 0.000 description 1
- 229960000381 omeprazole Drugs 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000012860 organic pigment Substances 0.000 description 1
- 125000005375 organosiloxane group Chemical group 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 150000002923 oximes Chemical group 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- ATGUVEKSASEFFO-UHFFFAOYSA-N p-aminodiphenylamine Chemical compound C1=CC(N)=CC=C1NC1=CC=CC=C1 ATGUVEKSASEFFO-UHFFFAOYSA-N 0.000 description 1
- IWDCLRJOBJJRNH-UHFFFAOYSA-N p-cresol Chemical compound CC1=CC=C(O)C=C1 IWDCLRJOBJJRNH-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- LXTZRIBXKVRLOA-UHFFFAOYSA-N padimate a Chemical compound CCCCCOC(=O)C1=CC=C(N(C)C)C=C1 LXTZRIBXKVRLOA-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 229960005489 paracetamol Drugs 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 229940038597 peroxide anti-acne preparations for topical use Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008251 pharmaceutical emulsion Substances 0.000 description 1
- 239000008253 pharmaceutical paste Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- 229960002695 phenobarbital Drugs 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 1
- 229960001553 phloroglucinol Drugs 0.000 description 1
- YSWYYGKGAYSAOJ-UHFFFAOYSA-N phosphane Chemical compound P.P YSWYYGKGAYSAOJ-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- NXGWSWBWEQYMND-UHFFFAOYSA-N piperazine;prop-2-enamide Chemical compound NC(=O)C=C.NC(=O)C=C.C1CNCCN1 NXGWSWBWEQYMND-UHFFFAOYSA-N 0.000 description 1
- 229960005414 pirbuterol Drugs 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- CLSUSRZJUQMOHH-UHFFFAOYSA-L platinum dichloride Chemical compound Cl[Pt]Cl CLSUSRZJUQMOHH-UHFFFAOYSA-L 0.000 description 1
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 1
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 description 1
- 229960000502 poloxamer Drugs 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002037 poly(vinyl butyral) polymer Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 238000006068 polycondensation reaction Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 235000019396 potassium bromate Nutrition 0.000 description 1
- 229940094037 potassium bromate Drugs 0.000 description 1
- VKJKEPKFPUWCAS-UHFFFAOYSA-M potassium chlorate Chemical compound [K+].[O-]Cl(=O)=O VKJKEPKFPUWCAS-UHFFFAOYSA-M 0.000 description 1
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 description 1
- 229940043349 potassium metabisulfite Drugs 0.000 description 1
- 235000010263 potassium metabisulphite Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 235000019394 potassium persulphate Nutrition 0.000 description 1
- 239000003286 potassium sparing diuretic agent Substances 0.000 description 1
- 229940097241 potassium-sparing diuretic Drugs 0.000 description 1
- 229960001289 prazosin Drugs 0.000 description 1
- IENZQIKPVFGBNW-UHFFFAOYSA-N prazosin Chemical compound N=1C(N)=C2C=C(OC)C(OC)=CC2=NC=1N(CC1)CCN1C(=O)C1=CC=CO1 IENZQIKPVFGBNW-UHFFFAOYSA-N 0.000 description 1
- DQMZLTXERSFNPB-UHFFFAOYSA-N primidone Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NCNC1=O DQMZLTXERSFNPB-UHFFFAOYSA-N 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 229940126409 proton pump inhibitor Drugs 0.000 description 1
- 239000000612 proton pump inhibitor Substances 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical compound OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 description 1
- OYSBZLVHMPNJMR-UHFFFAOYSA-N pyridine-3-carboxylic acid Chemical compound OC(=O)C1=CC=CN=C1.OC(=O)C1=CC=CN=C1 OYSBZLVHMPNJMR-UHFFFAOYSA-N 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- MQEFDQWUCTUJCP-UHFFFAOYSA-N pyrimidine-2,4,5,6-tetramine;sulfuric acid Chemical compound OS(O)(=O)=O.NC1=NC(N)=C(N)C(N)=N1 MQEFDQWUCTUJCP-UHFFFAOYSA-N 0.000 description 1
- YBBJKCMMCRQZMA-UHFFFAOYSA-N pyrithione Chemical compound ON1C=CC=CC1=S YBBJKCMMCRQZMA-UHFFFAOYSA-N 0.000 description 1
- 229960002026 pyrithione Drugs 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 238000007348 radical reaction Methods 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 239000003087 receptor blocking agent Substances 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000004170 rice bran wax Substances 0.000 description 1
- 235000019384 rice bran wax Nutrition 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- XMVJITFPVVRMHC-UHFFFAOYSA-N roxarsone Chemical group OC1=CC=C([As](O)(O)=O)C=C1[N+]([O-])=O XMVJITFPVVRMHC-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229960002052 salbutamol Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003902 salicylic acid esters Chemical class 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 229940065287 selenium compound Drugs 0.000 description 1
- 150000003343 selenium compounds Chemical class 0.000 description 1
- VIDTVPHHDGRGAF-UHFFFAOYSA-N selenium sulfide Chemical compound [Se]=S VIDTVPHHDGRGAF-UHFFFAOYSA-N 0.000 description 1
- 229960005265 selenium sulfide Drugs 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 229940000634 serratiopeptidase Drugs 0.000 description 1
- 108010038132 serratiopeptidase Proteins 0.000 description 1
- 239000010686 shark liver oil Substances 0.000 description 1
- 229940069764 shark liver oil Drugs 0.000 description 1
- 239000008257 shaving cream Substances 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000010378 sodium ascorbate Nutrition 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- XUXNAKZDHHEHPC-UHFFFAOYSA-M sodium bromate Chemical compound [Na+].[O-]Br(=O)=O XUXNAKZDHHEHPC-UHFFFAOYSA-M 0.000 description 1
- 229940080281 sodium chlorate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- CSMWJXBSXGUPGY-UHFFFAOYSA-L sodium dithionate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)S([O-])(=O)=O CSMWJXBSXGUPGY-UHFFFAOYSA-L 0.000 description 1
- 229940075931 sodium dithionate Drugs 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 239000011697 sodium iodate Substances 0.000 description 1
- 229940032753 sodium iodate Drugs 0.000 description 1
- 235000015281 sodium iodate Nutrition 0.000 description 1
- 229940045872 sodium percarbonate Drugs 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- UENNEPPWFZYINW-UHFFFAOYSA-M sodium;2-amino-4,6-dinitrophenolate Chemical compound [Na+].NC1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1[O-] UENNEPPWFZYINW-UHFFFAOYSA-M 0.000 description 1
- KSVSZLXDULFGDQ-UHFFFAOYSA-M sodium;4-aminobenzenesulfonate Chemical compound [Na+].NC1=CC=C(S([O-])(=O)=O)C=C1 KSVSZLXDULFGDQ-UHFFFAOYSA-M 0.000 description 1
- JHJUUEHSAZXEEO-UHFFFAOYSA-M sodium;4-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=C(S([O-])(=O)=O)C=C1 JHJUUEHSAZXEEO-UHFFFAOYSA-M 0.000 description 1
- YKLJGMBLPUQQOI-UHFFFAOYSA-M sodium;oxidooxy(oxo)borane Chemical compound [Na+].[O-]OB=O YKLJGMBLPUQQOI-UHFFFAOYSA-M 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000012177 spermaceti Substances 0.000 description 1
- 229940084106 spermaceti Drugs 0.000 description 1
- LXMSZDCAJNLERA-ZHYRCANASA-N spironolactone Chemical compound C([C@@H]1[C@]2(C)CC[C@@H]3[C@@]4(C)CCC(=O)C=C4C[C@H]([C@@H]13)SC(=O)C)C[C@@]21CCC(=O)O1 LXMSZDCAJNLERA-ZHYRCANASA-N 0.000 description 1
- 229960002256 spironolactone Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- MNQYNQBOVCBZIQ-JQOFMKNESA-A sucralfate Chemical compound O[Al](O)OS(=O)(=O)O[C@@H]1[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](COS(=O)(=O)O[Al](O)O)O[C@H]1O[C@@]1(COS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)O1 MNQYNQBOVCBZIQ-JQOFMKNESA-A 0.000 description 1
- 229960004291 sucralfate Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 229960000368 sulisobenzone Drugs 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960005314 suramin Drugs 0.000 description 1
- FIAFUQMPZJWCLV-UHFFFAOYSA-N suramin Chemical compound OS(=O)(=O)C1=CC(S(O)(=O)=O)=C2C(NC(=O)C3=CC=C(C(=C3)NC(=O)C=3C=C(NC(=O)NC=4C=C(C=CC=4)C(=O)NC=4C(=CC=C(C=4)C(=O)NC=4C5=C(C=C(C=C5C(=CC=4)S(O)(=O)=O)S(O)(=O)=O)S(O)(=O)=O)C)C=CC=3)C)=CC=C(S(O)(=O)=O)C2=C1 FIAFUQMPZJWCLV-UHFFFAOYSA-N 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000011269 tar Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229920001897 terpolymer Polymers 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- IMCGHZIGRANKHV-AJNGGQMLSA-N tert-butyl (3s,5s)-2-oxo-5-[(2s,4s)-5-oxo-4-propan-2-yloxolan-2-yl]-3-propan-2-ylpyrrolidine-1-carboxylate Chemical compound O1C(=O)[C@H](C(C)C)C[C@H]1[C@H]1N(C(=O)OC(C)(C)C)C(=O)[C@H](C(C)C)C1 IMCGHZIGRANKHV-AJNGGQMLSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940008424 tetradecamethylhexasiloxane Drugs 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- UWHCKJMYHZGTIT-UHFFFAOYSA-N tetraethylene glycol Chemical compound OCCOCCOCCOCCO UWHCKJMYHZGTIT-UHFFFAOYSA-N 0.000 description 1
- 229940119168 tetrahexyldecyl ascorbate Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 239000003451 thiazide diuretic agent Substances 0.000 description 1
- 229950006389 thiodiglycol Drugs 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229960004214 tioconazole Drugs 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 229960005196 titanium dioxide Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229940093633 tricaprin Drugs 0.000 description 1
- 229940077400 trideceth-12 Drugs 0.000 description 1
- 229940061629 trideceth-9 Drugs 0.000 description 1
- 229940057400 trihydroxystearin Drugs 0.000 description 1
- 229940081852 trilinolein Drugs 0.000 description 1
- PBSRSWFGYPZDAU-FFIPNUABSA-H trimagnesium;[(2r)-2-[(1s)-1,2-dihydroxyethyl]-3-oxido-5-oxo-2h-furan-4-yl] phosphate Chemical group [Mg+2].[Mg+2].[Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1[O-] PBSRSWFGYPZDAU-FFIPNUABSA-H 0.000 description 1
- 229940117985 trimethyl pentaphenyl trisiloxane Drugs 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229940113164 trimyristin Drugs 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229960004418 trolamine Drugs 0.000 description 1
- 229940030300 trolamine salicylate Drugs 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 239000010679 vetiver oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 239000011667 zinc carbonate Substances 0.000 description 1
- 235000004416 zinc carbonate Nutrition 0.000 description 1
- 229910000010 zinc carbonate Inorganic materials 0.000 description 1
- BOXSVZNGTQTENJ-UHFFFAOYSA-L zinc dibutyldithiocarbamate Chemical compound [Zn+2].CCCCN(C([S-])=S)CCCC.CCCCN(C([S-])=S)CCCC BOXSVZNGTQTENJ-UHFFFAOYSA-L 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229940105296 zinc peroxide Drugs 0.000 description 1
- GAWWVVGZMLGEIW-GNNYBVKZSA-L zinc ricinoleate Chemical compound [Zn+2].CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O.CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O GAWWVVGZMLGEIW-GNNYBVKZSA-L 0.000 description 1
- 229940100530 zinc ricinoleate Drugs 0.000 description 1
- CAAIULQYGCAMCD-UHFFFAOYSA-L zinc;hydroxymethanesulfinate Chemical compound [Zn+2].OCS([O-])=O.OCS([O-])=O CAAIULQYGCAMCD-UHFFFAOYSA-L 0.000 description 1
- 229960000820 zopiclone Drugs 0.000 description 1
- 230000010092 β2-agonistic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/001—Softening compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/046—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/068—Microemulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8105—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- A61K8/8111—Homopolymers or copolymers of aliphatic olefines, e.g. polyethylene, polyisobutene; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/86—Polyethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A61K8/892—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a hydroxy group, e.g. dimethiconol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/896—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate
- A61K8/898—Polysiloxanes containing atoms other than silicon, carbon, oxygen and hydrogen, e.g. dimethicone copolyol phosphate containing nitrogen, e.g. amodimethicone, trimethyl silyl amodimethicone or dimethicone propyl PG-betaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/12—Preparations containing hair conditioners
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/02—Anionic compounds
- C11D1/12—Sulfonic acids or sulfuric acid esters; Salts thereof
- C11D1/22—Sulfonic acids or sulfuric acid esters; Salts thereof derived from aromatic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0008—Detergent materials or soaps characterised by their shape or physical properties aqueous liquid non soap compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0008—Detergent materials or soaps characterised by their shape or physical properties aqueous liquid non soap compositions
- C11D17/0017—Multi-phase liquid compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0008—Detergent materials or soaps characterised by their shape or physical properties aqueous liquid non soap compositions
- C11D17/003—Colloidal solutions, e.g. gels; Thixotropic solutions or pastes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0043—For use with aerosol devices
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/0047—Detergents in the form of bars or tablets
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
- C11D17/06—Powder; Flakes; Free-flowing mixtures; Sheets
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/001—Softening compositions
- C11D3/0015—Softening compositions liquid
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/18—Hydrocarbons
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2093—Esters; Carbonates
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3707—Polyethers, e.g. polyalkyleneoxides
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3726—Polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/373—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds containing silicones
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3746—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3749—Polyolefins; Halogenated polyolefins; Natural or synthetic rubber; Polyarylolefins or halogenated polyarylolefins
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3746—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3757—(Co)polymerised carboxylic acids, -anhydrides, -esters in solid and liquid compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3746—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3769—(Co)polymerised monomers containing nitrogen, e.g. carbonamides, nitriles or amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/30—Characterized by the absence of a particular group of ingredients
- A61K2800/33—Free of surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/594—Mixtures of polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/88—Two- or multipart kits
- A61K2800/882—Mixing prior to application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D2111/00—Cleaning compositions characterised by the objects to be cleaned; Cleaning compositions characterised by non-standard cleaning or washing processes
- C11D2111/10—Objects to be cleaned
- C11D2111/12—Soft surfaces, e.g. textile
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
本发明涉及包含双峰水连续乳液的化妆品组合物。具体地讲,本发明涉及化妆品组合物,所述化妆品组合物包含双峰水连续乳液(E),所述乳液包含至少70重量%的:第一分散相和第二分散相,所述第一分散相包含疏水性油,其中所述疏水性油以非乳化疏水性油形式提供,所述第二分散相包含有机硅,其中所述有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;以及至少一种化妆品成分(C);二者存在于化妆品适用的介质中。本发明还涉及所述化妆品组合物的制备方法及其用途。
Description
相关专利申请的交叉引用
本专利申请要求2012年11月21日提交的美国临时专利申请No.61/729,024的优先权和所有优点,该专利申请的内容以引用方式并入本文。
技术领域
本发明涉及化妆品组合物,其包含乳液(E)和至少一种化妆品成分(C),并存在于化妆品适用的介质中。
背景技术
乳液是使最初不相容的材料相容的有效手段。简单的乳液通常至少由外部连续相和内部分散相以及至少一种用于使不同的相相容的表面活性试剂构成。各种成分的乳液都可用于化妆品应用,其中它们允许在更大的基质中结合不相容的材料,如护肤霜中的维生素,或洗发液中的调理聚合物。
持续需要提供通过减少乳液中包含的水量来降低运输的环境影响的乳液。持续需要提供通过减少乳液中包含的表面活性剂的量或通过减少杀生物剂的量而对消费者健康无害的乳液。
持续需要通过提供易于使用、可倾倒同时包含有限量的允许可用成分具有更大范围的不必要成分的乳液来简化配方师的工作。即,限制水的量,以允许结合更具活性的成分,如染料、护理剂等。
持续需要护理角质基质的调理聚合物的乳液。
发明内容
本发明涉及包含双峰水连续乳液的化妆品组合物。具体地讲,本发明涉及化妆品组合物,所述化妆品组合物包含双峰水连续乳液(E),所述乳液包含至少70重量%的:第一分散相和第二分散相,第一分散相包含疏水性油,其中疏水性油以非乳化疏水性油形式提供,第二分散相包含有机硅,其中有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;以及至少一种化妆品成分(C);二者存在于化妆品适用的介质中。
本发明还涉及制备化妆品组合物的方法以及所述化妆品组合物的用途。
具体实施方式
本发明涉及包含乳液的化妆品组合物。具体地讲,本发明涉及化妆品组合物,所述化妆品组合物包含双峰水连续乳液(E),所述乳液包含至少70重量%的:第一分散相和第二分散相,第一分散相包含疏水性油,其中疏水性油以非乳化疏水性油形式提供,第二分散相包含有机硅,其中有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;以及至少一种化妆品成分(C);二者存在于化妆品适用的介质中。
本发明的双峰乳液(E)是具有两个不同分散相的水连续乳液。如本文所用,“分散相”是指悬浮在乳液的连续水相中的水不溶性粒子。第一分散相含有疏水性油,其可以是有机油或有机硅。独立的第二分散相含有从先前形成的水连续乳液提供的有机硅。每个分散相可以由乳液中自身的平均粒度分布表征,换句话说,这两个独立分散相的平均粒度显示出“双峰”分布。
双峰乳液(E)的第一分散相
该双峰乳液包含第一分散相,所述第一分散相包含疏水性油(本文中命名为组分(A))。本发明双峰乳液的第一分散相中的疏水性油(A)未曾预先乳化。换句话讲,第一分散相中的疏水性油源于净疏水性油或非乳化疏水性油。疏水性油(A)可以选自a)有机油、b)有机硅或它们的组合。
当将疏水性油相视为有机油相时,这意味着该分散相的大部分包含有机化合物或有机聚合物。所述有机油可以选自烃类、酯类、源自天然脂肪或油的油类、有机聚合物类或它们的混合物。
合适的有机油组分的例子包括天然油类,如椰子油;烃,如矿物油、石蜡和氢化聚异丁烯;脂肪醇,如辛基十二烷醇;酯,如苯甲酸C12-C15烷基酯;二酯,如二壬酸丙二醇酯(propylene dipelarganate);以及三酯,如三辛酸甘油酯。
作为合适的有机油的酯的例子可以具有结构QCO-OQ',其中QCO代表羧酸基,并且其中OQ'为醇残基。这些酯的例子包括异壬酸异十三烷酯、PEG-4二庚酸酯、新戊酸异硬脂酯、新戊酸十三烷酯、辛酸十六烷酯、棕榈酸十六烷酯、蓖麻醇酸十六烷基、硬脂酸十六烷酯、肉豆蔻酸十六烷酯、椰油醇-二辛酸酯/癸酸酯、异硬脂酸癸酯、油酸异癸酯、新戊酸异癸酯、新戊酸异己酯、棕榈酸辛酯、苹果酸二辛酯、辛酸十三烷酯、肉豆蔻酸肉豆蔻酯、辛基十二烷醇、或辛基十二烷醇、乙酰化羊毛脂醇、乙酸十六烷酯、异十二烷醇和聚甘油基-3-二异硬脂酸酯的混合物、或它们的混合物。
天然油的例子包括蓖麻油、羊毛脂和羊毛脂衍生物、柠檬酸三异十六烷酯、脱水山梨糖醇倍半油酸酯、C10-18甘油三酸酯、辛酸/癸酸/甘油三酸酯、椰子油、玉米油、棉籽油、甘油三乙酰基羟基硬脂酸酯、甘油三乙酰基蓖麻醇酸酯、三辛酸甘油酯、氢化蓖麻油、亚麻籽油、貂油、橄榄油、棕榈油、蓖麻油、印度赤铁树果脂肪(illipe butter)、菜籽油、大豆油、葵花籽油、松油、牛脂、三癸精、三羟基硬脂精、三异硬脂精、三月桂精、三亚油精、三肉豆蔻精、三油精、三棕榈精、三硬脂精、胡桃油、小麦胚芽油、胆固醇或它们的混合物。
有机油还可以包含有机聚合物,如聚丁烯或聚异丁烯、聚丙烯酸酯、聚苯乙烯、聚丁二烯、聚酰胺、聚酯、聚丙烯酸酯、聚氨酯、聚砜、聚硫化物、环氧官能化聚合物以及含有这些有机聚合物的共聚物或三元共聚物及任何这些物质的混合物。
其他合适的有机油可以在室温下为固体,如有机脂和有机蜡。
脂的例子包括牛油树脂、芒果脂。
有机蜡的例子包括选自合成和天然来源的那些,诸如矿物蜡、动物蜡、植物蜡、氢化油、脂肪酸酯和甘油酯,它们在25℃下为固体。
有机蜡的例子包括衍生自一价饱和C16-C60烷醇和饱和C8-C36一元羧酸的酯、饱和线性C18-C40羧酸的甘油三酯、小烛树蜡、卡洛巴蜡、蜂蜡、饱和线性C16-C18、C20和C22-C40羧酸、硬化蓖麻油、地蜡、聚乙烯蜡、微晶蜡、白蜡、羊毛脂蜡、米糠蜡、褐煤蜡、橙蜡、柠檬蜡和石蜡。
疏水性油(A)可以选自各种有机硅聚合物。在这个实施例中,将疏水性油相视为有机硅油相,这意味着该分散相的大部分包含有机硅聚合物。如本文所用,“有机硅组合物”是指含有至少一种有机聚硅氧烷的组合物。
有机聚硅氧烷是含有独立地选自(R3SiO1/2)、(R2SiO2/2)、(RSiO3/2)或(SiO4/2)甲硅烷氧基单元的甲硅烷氧基单元的聚合物,其中R可以是任何有机基团,或者R是含有1至30个碳的烃基,或者R是含有1至12个碳原子的烷基,或者R是甲基或苯基。这些甲硅烷氧基单元常常分别称为M、D、T和Q单元。它们的分子结构如下列出:
这些甲硅烷氧基单元可以按多种方式组合以形成环状、直链或支链的结构。取决于有机聚硅氧烷中的甲硅烷氧基单元的数目和类型,所得的聚合物结构的化学和物理性质有所变化。
所述有机硅组合物可以含有单一有机聚硅氧烷或多种有机聚硅氧烷的混合物。在某些情况下,有机聚硅氧烷的混合物可以彼此反应,以形成更高分子量的有机聚硅氧烷。此类反应示例为缩合反应或氢化硅烷化反应。
有机硅组合物可包含有机硅流体、有机硅树胶、有机硅橡胶、有机硅弹性体、有机硅树脂、有机硅蜡、糖类-硅氧烷聚合物、用碳硅氧烷树枝状体接枝的烯类聚合物或它们的任何组合。
有机聚硅氧烷可以是三甲基甲硅烷氧基或羟基(SiOH)封端的聚二甲基硅氧烷。三甲氧基封端的聚二甲基硅氧烷具有式Me3SiO(Me2SiO2/2)dpSiMe3,其中聚合度(dp)大于1,或者所述dp足以提供范围可在1至1,000,000mm2/s(10-6m2/s)(在25℃)、或者100至600,000mm2/s(10-6m2/s)(在25℃)、或者1000至600,000mm2/s(10-6m2/s)(在25℃)的运动粘度。
当有机硅组合物包含可通过氢化硅烷化进行反应的有机聚硅氧烷组分时,有机硅组分包含:
b1)每分子具有至少两个硅键合的烯基的有机聚硅氧烷,
b2)每分子具有至少两个SiH基团的有机氢硅氧烷,和
b3)氢化硅烷化催化剂。
每分子具有至少两个硅键合的烯基的有机聚硅氧烷
b1)包含至少两个由下式表示的甲硅烷氧基单元
R2RmSiO(4-1-m)/2
其中R是含有1至30个碳原子的烃基,R2是含有2至12个碳原子的烯基,并且m是0至2。组分b1)的R2烯基示例为:乙烯基、烯丙基、3-丁烯基、4-戊烯基、5-己烯基、6-庚烯基、7-辛烯基、8-壬烯基、9-癸烯基、10-十一碳烯基、4,7-辛二烯基、5,8-壬二烯基、5,9-癸二烯基、6,11-十二碳二烯基和4,8-壬二烯基。
R2烯基可以存在于有机聚硅氧烷中的任何单、二或三甲硅烷氧基单元上,例如:(R2R2SiO1/2)、(R2RSiO2/2)或(R2SiO3/2);以及与其他不包含R2取代基的甲硅烷氧基单元,如(R3SiO1/2)、(R2SiO2/2)、(RSiO3/2)或(SiO4/2)甲硅烷氧基单元组合存在,其中R是含有1至20个碳的烃基、或者含有1至12个碳的烷基、或者含有1至6个碳的烷基或者甲基;前提条件是有机聚硅氧烷中具有至少两个R2取代基。具有1至20个碳原子的单价烃基R示例为烷基,如:甲基、乙基、丙基、丁基、己基、辛基和癸基;脂环族基团,如环己基;芳基,如苯基、甲苯基和二甲苯基;以及芳烷基,如苄基和苯乙基。
组分b1)可以选自三甲基甲硅烷氧基封端的聚二甲基硅氧烷-聚甲基乙烯基硅氧烷共聚物、乙烯基二甲基甲硅烷氧基封端的聚二甲基硅氧烷-聚甲基乙烯基硅氧烷共聚物、三甲基甲硅烷氧基封端的聚二甲基硅氧烷-聚甲基己烯基硅氧烷共聚物、己烯基二甲基甲硅烷氧基封端的聚二甲基硅氧烷-聚甲基己烯基硅氧烷共聚物、三甲基甲硅烷氧基封端的聚甲基乙烯基硅氧烷聚合物、三甲基甲硅烷氧基封端的聚甲基己烯基硅氧烷聚合物、乙烯基二甲基甲硅烷氧基封端的聚二甲基硅氧烷聚合物、己烯基二甲基甲硅烷氧基封端的聚二甲基硅氧烷聚合物或它们的任何组合,各自具有10至300的聚合度,或者具有在25℃时10至1000mPa·s(10-3Pa.s)的粘度。
组分b2)是每分子平均具有超过两个硅键合的氢原子的有机氢硅氧烷。如本文所用,有机氢硅氧烷是含有硅键合的氢原子(SiH)的任何有机聚硅氧烷。
有机氢硅氧烷是具有至少一个含SiH的甲硅烷氧基单元的有机聚硅氧烷,即,有机聚硅氧烷中的至少一个甲硅烷氧基单元具有式(R2HSiO1/2)、(RHSiO2/2)或(HSiO3/2)。因此,在本发明中可用的有机氢硅氧烷可以包含任何数目的(R3SiO1/2)、(R2SiO2/2)、(RSiO3/2)、(R2HSiO1/2)、(RHSiO2/2)、(HSiO3/2)或(SiO4/2)甲硅烷氧基单元,条件是在所述分子中平均存在至少两个SiH甲硅烷氧基单元。组分b2)可以是单一的直链或支链有机氢硅氧烷或包含两种或更多种直链或支链有机氢硅氧烷的组合,所述两种或更多种直链或支链有机氢硅氧烷在以下特性的至少一个方面不同:结构、粘度、平均分子量、硅氧烷单元和顺序。对有机氢硅氧烷的分子量没有特别限制,但有机氢硅氧烷在25℃下的粘度通常为3至10,000mPa.s(10-3Pa.s),或者3至1,000mPa.s(10-3Pa.s),或者10至500mPa.s(10-3Pa.s)。
在有机氢硅氧烷中存在的SiH单元的量可以变动,条件是每有机氢硅氧烷分子有至少两个SiH单元。有机氢硅氧烷中存在的SiH单元的量在本文中表示为%SiH,其为有机氢硅氧烷中氢的重量百分数。通常,所述%SiH的范围为0.01%至10%、或者0.1%至5%、或者0.5%至2%。
所述有机氢硅氧烷可包含以下平均式:
(R3 3SiO1/2)a(R4 2SiO2/2)b(R4HSiO2/2)c,其中
R3为氢或R4,
R4为具有1至10个碳原子的单价烃基,
a≥2,
b≥0,或者b=1至500,或者b=1至200,
c≥2,或者c=2至200,或者c=2至100。
R4可以是取代的或未取代的脂族或芳族烃基。单价未取代的脂族烃基由如下基团示例但不限于如下基团:烷基如甲基、乙基、丙基、戊基、辛基、十一烷基和十八烷基以及环烷基如环己基。单价取代的脂族烃基由如下基团示例但不限于如下基团:卤代烷基如氯甲基、3-氯丙基和3,3,3-三氟丙基。芳族烃基由如下基团示例但不限于如下基团:苯基、甲苯基、二甲苯基、苄基、苯乙烯基和2-苯基乙基。
所使用的组分b1)和b2)的量可以变动,但通常对组分b1)和b2)的量进行选择以便使组合物中烯基与SiH的摩尔比大于1。
组分b3)是氢化硅烷化催化剂。所述氢化硅烷化催化剂可以是选自铂、铑、铱、钯或钌的任何适合的基于VIII族金属的催化剂。可用于催化本发明组合物固化的含VIII族金属的催化剂可以是已知用来催化硅键合的氢原子与硅键合的不饱和烃基反应的那些催化剂中的任一种。用作催化剂以通过氢化硅烷化来实现本发明组合物固化的典型VIII族金属为基于铂的催化剂。用于固化本发明组合物的一些典型的基于铂的氢化硅烷化催化剂为铂金属、铂化合物以及铂络合物。合适的铂催化剂在US2823218(通常称为“Speier催化剂”)和US3923705中有所描述。铂催化剂可以是“Karstedt催化剂”,其在Karstedt的US3715334和US3814730中有所描述。Karstedt催化剂是在诸如甲苯之类的溶剂中的通常含有约1重量%铂的铂-二乙烯基四甲基二硅氧烷络合物。或者,铂催化剂可以是氯铂酸与含末端脂族不饱和基团的有机硅化合物的反应产物,如US3419593中所述。或者,氢化硅烷化催化剂是氯化铂和二乙烯基四甲基二硅氧烷的中和络合物,如US5175325中所述。
所使用的催化剂b3)的量可以变动,但通常使用实现氢化硅烷化反应的量。当催化剂为Pt化合物时,通常添加足量的所述化合物以在有机硅组合物中提供2至500ppm的Pt。
可以向氢化硅烷化反应中添加另外的组分。例如,可以添加七甲基三甲硅烷氧基硅烷作为封端剂来控制有机聚硅氧烷产物的分子量。
当有机硅组合物包含可通过缩合进行反应的有机聚硅氧烷组分时,有机硅组分包含具有至少两个甲硅烷氧基单元的有机聚硅氧烷,其中所述甲硅烷氧基单元具有能够通过缩合进行反应的取代基。所述有机聚硅氧烷的甲硅烷氧基单元上的适合取代基包括硅烷醇、烷氧基、乙酰氧基、肟官能团。在这个实施例中,所述有机硅组合物将进一步含有本领域中已知用于增强有机聚硅氧烷缩合固化的催化剂,如锡或钛催化剂。在另一个实施例中,有机聚硅氧烷是硅烷醇封端的聚二甲基硅氧烷,其具有的运动粘度的范围可以是1至100,000mm2/s(10-6m2/s)(在25℃)、或1至10,000mm2/s(10-6m2/s)(在25℃)。
该有机硅组合物可以包含有机聚硅氧烷,所述有机聚硅氧烷具有至少一个由有机官能团取代的甲硅烷氧基单元。在本发明方法中有用的有机官能化有机聚硅氧烷的特征在于:式RnSiO(4-n)/2中的至少一个R基团是有机官能团。代表性的非限制性有机官能团包括氨基、酰氨基、环氧基、巯基、聚醚(聚氧化亚烷)基以及它们的任何混合物。有机官能化的有机聚硅氧烷的另外的例子包括具有以下基团的那些:烷氧基化基团;羟基,如含有羟烷基官能的聚有机硅氧烷,如EP1081272、US6171515和US6136215中所述;双羟基/甲氧基氨基封端聚二甲基硅氧烷;氨基酸官能化硅氧烷,如通过使选自N-酰基氨基酸和N-芳酰基氨基酸的氨基酸衍生物与氨基官能化硅氧烷反应所获得的那些硅氧烷,在WO2007/141565中进一步描述;季铵盐官能化有机硅,在US6482969和US6607717中有所描述,如有机硅季铵盐-16(CTFA命名);烃基官能化有机聚硅氧烷,其包含式R5R’i SiO(3-i)/2的甲硅烷氧基单元,其中R’为任何单价烃基,但通常为含有1至20个碳原子的烷基、环烷基、烯基、烷芳基、芳烷基或芳基,R5为具有式-R6OCH2CH2OH的烃基基团,其中R6为包含2至6个碳原子的二价烃基,并且i具有0至2的值,如US2823218、US5486566、US6060044和US20020524中所述(CTFA双羟乙氧基丙基聚二甲基硅氧烷);硅氧烷基聚酰胺,如US6051216中所述;有机硅聚醚-酰胺嵌段共聚物,如US2008/0045687中所述。
所述有机官能团可以存在于具有R取代基的任何甲硅烷氧基单元上,即,它们可以存在于任何(R3SiO0.5)、(R2SiO)或(RSiO1.5)单元上。
有机官能团可以是氨基官能团。氨基官能团可以在本文的式中命名为RN并且由具有下式的基团说明:–R8NHR9、–R8NR 9 2或–R8NHR8NHR9,其中每个R8独立地为具有至少2个碳原子的二价烃基,且R9为氢或烷基。每个R8通常为具有2至20个碳原子的亚烷基。合适的氨基官能化烃基的一些例子是:
-CH2CH2NH2、-CH2CH2CH2NH2、-CH2CHCH3NH、-CH2CH2CH2CH2NH2、-CH2CH2CH2CH2CH2NH2、-CH2CH2CH2CH2CH2CH2NH2、-CH2CH2NHCH3、-CH2CH2CH2NHCH3、-CH2(CH3)CHCH2NHCH3、-CH2CH2CH2CH2NHCH3、-CH2CH2NHCH2CH2NH2、-CH2CH2CH2NHCH2CH2NH2、-CH2CH2CH2NHCH2CH2CH2NH2、-CH2CH2CH2CH2NHCH2CH2CH2CH2NH2、-CH2CH2NHCH2CH2NHCH3、-CH2CH2CH2NHCH2CH2CH2NHCH3、-CH2CH2CH2CH2NHCH2CH2CH2CH2NHCH3和-CH2CH2NHCH2CH2NHCH2CH2CH2CH3。
有机硅树脂的例子包括三甲基甲硅烷基硅酸盐(MQ树脂)、倍半硅氧烷树脂(T树脂)、MQ-T树脂、倍半硅氧烷树脂蜡。
三甲基甲硅烷基硅酸盐(MQ树脂)可包含≥80摩尔%的选自(R10 3SiO1/2)a和(SiO4/2)d单元的甲硅烷氧基单元,其中R10为具有1至8个碳原子的烷基、芳基、甲醇基或氨基,前提条件是≥95摩尔%的R10基团为烷基,a和d>0,并且a/d比率=0.5至1.5。
MQ树脂可包含D和T单元,前提条件是≥80摩尔%或者≥90摩尔%的总硅氧烷单元为M和Q单元。MQ树脂还可包含羟基。通常,MQ树脂具有2至10重量%,或者2至5重量%的总重量%羟基含量。MQ树脂还可被进一步“封端”,其中剩余的羟基进一步与M基团发生反应。
倍半硅氧烷树脂(T树脂)可包含≥30摩尔%的R10SiO3/2单元,其中R10如上文所定义。当≥40摩尔%的R10基团为丙基时,T树脂可被命名为丙基倍半硅氧烷树脂。
T树脂可包含M、D和Q单元,前提条件是≥30摩尔%或者≥80摩尔%或者≥90摩尔%的总硅氧烷单元为T单元。T树脂还可以包含羟基和/或烷氧基。通常,T树脂具有总重量%为2至10重量%的羟基含量和总重量%≤20重量%的烷氧基含量;或者6至8重量%的羟基含量和≤10重量%的烷氧基含量。
MQ和T有机聚硅氧烷树脂可以单独使用或结合在一起使用。
MQ-T树脂可具有式(R11 3SiO1/2)a(R12 2SiO2/2)b(R13SiO3/2)c(SiO4/2)d,其中R11、R12和R13独立地表示包含1至8个碳原子的烷基、芳基、甲醇基或氨基,其中0.05≤a≤0.5;0≤b≤0.3;c>0;0.05≤d≤0.6,并且a+b+c+d=1,前提条件是硅氧烷树脂中≥40摩尔%的R13基团为丙基。此类MQ-T树脂的代表在WO2005/075542中提出,该专利以引用方式并入本文。
倍半硅氧烷树脂蜡可包含至少40摩尔%的具有式(R10 2R14SiO1/2)x(R15SiO3/2)y的甲硅烷氧基单元,其中x和y具有0.05至0.95的值,R10如上文所述,R14为具有9至40个碳原子的单价烃基,并且R15为具有1至8个碳原子的单价烃基或芳基。R14和y/x的比率被选择为使得倍半硅氧烷树脂蜡具有≥约30℃的熔点。此类倍半硅氧烷树脂蜡的代表在US7482419中提出,该专利以引用方式并入本文。
有机硅蜡的例子包括C30-45烷基聚甲基硅氧烷和C30-45烯烃(MP>60℃)、Bis-PEG-18甲基乙基二甲基硅烷、硬脂基聚二甲基硅氧烷。
有机硅弹性体为一类三维交联有机硅聚合物。有机硅弹性体的例子包括通过有机氢聚硅氧烷与另一种包含不饱和烃取代基的聚硅氧烷(如乙烯基官能化聚硅氧烷)的交联氢化硅烷化反应,或者通过使有机氢聚硅氧烷与烃二烯或与末端不饱和聚氧化烯交联而获得的那些。这类有机硅弹性体的代表性例子在US5880210和US5760116中提出。在某些情况下,有机官能团已被接枝到有机硅有机弹性体主链上,如烷基、聚醚、胺。这类有机官能化有机硅弹性体的代表性例子在US5811487、US5880210、US6200581、US5236986、US6331604、US6262170、US6531540和US6365670、WO2004/104013以及WO2004/103326中提出。
糖类-硅氧烷聚合物的例子包括官能化的有机硅氧烷聚合物和至少一种包含5至12个碳原子的羟基官能化糖类组分的反应产物,这样有机硅氧烷组分通过连接基共价连接到糖类组分。糖类-硅氧烷聚合物可以是直链或支链的。糖类-硅氧烷聚合物的另外的例子是本领域技术人员已知的,并且在以引用方式并入本文的US20080199417、US20100105582、WO2012027073、WO2012027143中有所描述。
用碳硅氧烷树枝状体接枝的烯类聚合物的例子包括烯类聚合物与至少一种基于碳硅氧烷树枝状体的单元的反应产物。术语“碳硅氧烷树枝状体结构”是指带有高分子量分支基团的结构,在从简单主链开始的径向方向上具有高度规则性。此类碳硅氧烷树枝状体结构在特开平日本专利申请Kokai 9-171 154中以高度支化的硅氧烷-甲硅烷基亚烷基共聚物的形式描述。用碳硅氧烷树枝状体接枝的其他烯类聚合物是本领域技术人员已知的,并且在以引用方式并入本文的EP0963751中有所描述。
双峰乳液(E)的第二分散相
该双峰水连续乳液具有含有有机硅的第二分散相,所述有机硅从含有至少一种表面活性剂的水连续有机硅乳液(本文中命名为组分(B))提供。含有至少一种表面活性剂的水连续有机硅乳液(B)可以是单一水连续有机硅乳液或水连续有机硅乳液的组合。
可用于本发明双峰乳液的水连续有机硅乳液(B)含有至少一种表面活性剂。所述表面活性剂可以变动,但通常是选自增强水连续乳液形成的那些表面活性剂。表面活性剂可以是阴离子表面活性剂、阳离子表面活性剂、非离子表面活性剂、两性表面活性剂或任何这些表面活性剂的混合物。
包含至少一种表面活性剂的水连续有机硅乳液(B)中的有机硅可以是上文中被列为疏水性油(A)的那些中的任何一种以及它们的混合物。
阴离子表面活性剂的例子包括高级脂肪酸的碱金属盐、胺盐或铵盐、烷芳基磺酸盐如十二烷基苯磺酸钠、长链脂肪醇硫酸盐、烯烃硫酸盐和烯烃磺酸盐、硫酸化单酸甘油酯、硫酸化酯、磺化乙氧基化醇、磺基琥珀酸盐、烷磺酸盐、磷酸酯、烷基羟乙磺酸盐、烷基牛磺酸盐、烷基肌氨酸盐以及它们的混合物。
阳离子表面活性剂的例子包括烷基胺盐、季铵盐、锍盐以及鏻鏻盐。合适的非离子表面活性剂的例子包括氧化乙烯与长链脂肪醇或脂肪酸(如C12-16醇)的缩合物、氧化乙烯与胺或酰胺的缩合物、氧化乙烯与氧化丙烯的缩合产物、甘油的酯、蔗糖、山梨糖醇、脂肪酸烷基醇酰胺、蔗糖酯、氟表面活性剂、脂肪胺氧化物以及它们的混合物。
两性表面活性剂的例子包括咪唑啉化合物、烷基氨基酸盐、甜菜碱以及它们的混合物。
非离子表面活性剂的例子包括聚氧乙烯脂肪醇,如聚氧乙烯(23)月桂基醚、聚氧乙烯(4)月桂基醚;乙氧基化醇类,如乙氧基化三甲基壬醇、C12-C14仲醇乙氧基化物、乙氧基化C10-格尔伯特醇、乙氧基化异-C13醇;聚(氧乙烯)-聚(氧丙烯)-聚(氧乙烯)三嵌段共聚物(也称为泊洛沙姆);通过将氧化丙烯与氧化乙烯按顺序加入乙二胺中而获得的四官能化聚(氧乙烯)-聚(氧丙烯)嵌段共聚物(也称为泊洛沙胺)、有机硅聚醚,以及它们的混合物。
当使用含非离子表面活性剂的混合物时,一种非离子表面活性剂可以具有低的亲水亲油平衡值(HLB)并且另一种非离子表面活性剂可以具有高的HLB,使得所述两种非离子表面活性剂具有11至15的联合HLB、或者12.5至14.5的联合HLB。
水连续有机硅乳液(B)可以选自在本领域中视为“巨”或“微”乳液的那些乳液。换句话说,水连续乳液的平均粒度可以从0.001至1000μm、或者0.01至20μm、或者0.02至10μm变动。
水连续有机硅乳液(B)为平均粒度小于100nm的微乳液。
可以将水连续有机硅乳液(B)视为“乳液聚合物”,换句话说,通过乳液聚合技术形成的乳液。通过乳液聚合技术产生的合适的有机硅乳液的例子在US2891920、US3294725、US5661215、US5817714和US6316541中提出,它们以引用方式并入本文。
水连续有机硅乳液(B)可以是机械乳液。如本文所用,机械乳液是指在本领域中通过使用(如来自高剪切力的)机械能而产生的那些乳液。通过机械技术产生的有机硅乳液的例子在US6395790中提出,所述专利以引用的方式并入本文。
可以用悬浮聚合技术制备水连续有机硅乳液。用悬浮聚合技术产生的有机硅乳液的例子在US4618645、US6248855和US6395790中提出。
本发明的双峰水连续乳液(E)可以通过包括以下步骤的方法制备:
I)形成混合物,该混合物包含:
A)100重量份的疏水性油,
B)1至1000重量份的具有至少一种表面活性剂的水连续有机硅乳液,
II)将另外量的所述水连续乳液和/或水混合到来自步骤I)的混合物中以形成双峰乳液。
上述方法步骤I)中的组分(A)可以是如上文描述为第一分散相中组分(A)的任何疏水性油。
上述方法步骤I)中的组分(B)可以是如上文描述为第二分散相中组分(B)的任何水连续有机硅乳液。
步骤I)中的混合可以通过本领域已知的用来实现高粘度材料的混合的任何方法来完成。该混合可以分批工艺、半连续工艺或连续工艺进行。混合可例如用如下装置来进行:中等/低剪切力分批混合装置,包括换罐式混合器、双行星混合器、锥形螺杆混合器、带式掺合器、双臂混合器或弓刀混合器;具有高剪切和高速度分散器的批处理设备,包括美国纽约州的查尔斯·罗斯父子公司(Charles Ross&Sons(NY))、美国新泽西州的豪美设备公司(Hockmeyer Equipment Corp.(NJ))制造的那些设备;高剪切作用分批混合装置,包括班伯里型(纽约的布拉本德仪器公司(CW BrabenderInstruments Inc.,NJ))和亨舍尔型(德克萨斯州的美国亨舍尔混合器公司(Henschel mixers America,TX))。连续混合机/混炼机的示例性例子包括挤出机,单螺旋、双螺旋和多螺旋挤出机、共旋转挤出机,如新泽西州拉姆齐的克鲁伯·维尔纳和普夫莱德雷尔公司(Krupp Werner&Pfleiderer Corp(Ramsey,NJ))和美国新泽西州的莱斯特瑞兹公司(Leistritz(NJ))制造的那些挤出机;反转双螺杆挤出机、两级挤出机、双转子连续混合器、动态或静态混合器或者这些装置的组合。
虽然在步骤I)混合时的温度和压力并不关键,但通常在环境温度和压力下进行混合。通常,由于剪切如此高粘度的材料时相关的机械能,混合物的温度将在混合过程期间升高。
通常,在步骤I)混合物中对于每100重量份的组分(A),混合1至1000重量份的水连续乳液,或者在步骤I)混合物中每100重量份的组分(A)混合5至500份的水连续乳液,或者在步骤I)混合物中每100重量份的组分(A)混合5至100份的水连续乳液。
步骤I)可涉及形成基本上由以下组分组成的混合物:
A)100重量份的疏水性油,
B)1至1000重量份的具有至少一种表面活性剂的水连续乳液。在这个实施例中,在步骤I)中形成的混合物“基本上不含”除组分(A)和(B)以外的任何其他表面活性剂化合物或组分。如本文所用,“基本上不含”意指除了(B)水连续乳液中存在的表面活性剂之外不向步骤I)中形成的混合物添加其他表面活性剂化合物。
所述方法的步骤II)涉及将另外量的所述水连续乳液和/或水混合到来自步骤I)的混合物中以形成双峰乳液。
在步骤II)中使用的另外量的水连续乳液和/或水的量可以根据组分(A)和(B)的选择而变动。通常在本发明方法的步骤II)中混合的另外的水连续乳液和/或水的量可以从步骤I)混合物的1至1000重量份,或者5至500份/100重量份,或者5至100份/100重量份变动。
在本发明方法的步骤II)中,另外量的水连续乳液可以单独使用,或者与不同量的水组合。或者,可以单独添加另外量的水,而不添加任何另外量的水连续乳液。选择单独使用另外量的水连续乳液、将其与不同量的水组合使用或单独使用水将取决于水连续乳液的最初选择和所生成的双峰乳液的所需物理特性。例如,高固含量双峰乳液可以通过只添加水连续乳液来制备。相反地,低固含量双峰乳液还要求添加水。
将水连续乳液和/或水以使得在伴随另外的搅拌的情况下以致形成步骤I)混合物的乳液的速率添加至来自步骤I)的混合物中。添加至来自步骤I)的混合物中的水连续乳液可以以增量部分来完成,借此每个增量部分占小于50重量%的来自步骤I)的混合物、或者25重量%的来自步骤I)的混合物,并且将每个水连续乳液增量部分相继于前一个水连续乳液增量部分分散之后添加,其中添加足够的水连续乳液增量部分以形成双峰乳液。
添加至来自步骤I)的混合物中的水连续乳液和/或水的增量部分数目可以变动,但通常添加至少2个、或者至少3个增量部分。
步骤II)中的混合可以通过本领域已知的用于实现高粘度材料的混合和/或实现乳液的形成的任何方法来完成。该混合可以分批工艺、半连续工艺或连续工艺进行。任何针对步骤I)所述的混合方法均可用于进行步骤II)中的混合。或者,步骤II)中的混合还可以经由本领域已知的用于提供高剪切混合从而实现乳液形成的那些技术来进行。这类高剪切技术的代表包括:高速搅拌器、匀化器、微射流均质机Ross混合机、Eppenbach胶体磨、Flacktek以及其他类似的剪切装置。
可任选地是,可根据任选步骤III)进一步剪切步骤II)中形成的乳液以减小粒度和/或改善长期贮存稳定性。可通过上面论述的混合技术中的任一者来进行剪切。
通过本发明的方法制备的双峰水连续乳液可以由它们的双峰粒度分布表征。该粒度可以通过对乳液进行激光衍射来测定。合适的激光衍射技术是本领域公知的。粒度由粒度分布(PSD)获得。PSD可以基于体积、表面和长度来测定。体积粒度等于具有与给定颗粒相同的体积的球体的直径。如本文所用,术语Dv表示分散粒子的平均体积粒度。Dv 50是以对应于累积粒子数(cumulative particle population)的50%的体积所测量的粒度。换句话说,如果Dv 50=10μm,则50%的粒子具有低于10μm的平均体积粒度,而50%的粒子具有高于10μm的平均体积粒度。Dv 90是以对应于累积粒子数的90%的体积所测量的粒度。峰(mode)1是双峰粒度分布内分散相粒子数其中一者的分布的中值,而峰2是另一者的分布的中值。
在一些情况下,可能有必要进行两次单独的粒度评价,尤其在所生成的双峰乳液的粒度分布展现出宽的尺寸变化的时候。在这些情况下,2000可以用来获得在0.5至1000μm范围内的粒度分布,而可以用来测量在小于0.5μm范围内的粒度分布。
油/水乳液中分散粒子的平均体积粒度在0.001μm至1000μm范围内;或0.01μm至20μm范围内;或0.02μm至10μm范围内。
或者,可以报告每个独特的分散相(即第一分散相和第二分散相)的平均体积粒度。油/水乳液中第一分散粒子的平均体积粒度在0.1μm至500μm范围内;或0.1μm至100μm范围内;或0.2μm至30μm范围内。油/水乳液中第二分散粒子的平均体积粒度在0.1μm至500μm范围内;或0.1μm至100μm范围内;或0.2μm至30μm范围内。
虽然不希望受任何理论的束缚,据信第一分散相的粒度分布由疏水性油的乳化而引起,而第二分散相的粒度分布由源于本发明方法中所使用的水连续乳液的粒子而引起。然而,可能存在某些这样的情况,其中这二者充分重叠以致于使用上述粒度测定技术不能观察到双峰分布。
所述双峰粒度分布还可以使用光学显微镜术来观察。
在一些情况下,可以将所述双峰乳液视为“高固含量”乳液,其中双峰乳液含有至少75重量%的组分(A)和(B),或者双峰乳液含有至少80重量%的组分(A)和(B),或者双峰乳液含有至少85重量%的组分(A)和(B),或者双峰乳液含有至少90重量%的组分(A)和(B)。
“高固含量”双峰乳液可以保持可倾倒。因此,双峰乳液可以具有在25℃下测量的小于600,000mPa.s(10-3Pa.s)或者小于200,000mPa.s(10-3Pa.s)或者小于100,000mPa.s(10-3Pa.s)的粘度。
双峰乳液中的总表面活性剂浓度小于4.0重量%,或者小于1.0重量%,或者小于0.2重量%。
通过本发明方法产生的双峰有机硅乳液包含小于1.0重量%的环硅氧烷,或者包含小于0.5重量%的环硅氧烷,或者包含小于0.1重量%的环硅氧烷。
双峰水连续乳液(E)与化妆品成分(C)结合而存在于化妆品组合物中,任选地存在于化妆品适用的介质中。
化妆品组合物包括旨在放置为与人体外部器官(皮肤(表皮)、毛发系统、指/趾甲、粘膜等,也称为“角质基质”)或口腔中的牙齿或黏膜相接触,目的在于专门或主要地对所述器官进行清洁、使其具有香气、改变其外观、使其得到保护、使其处于良好状态或调整人体气味的那些组合物。在某些情况下,化妆品组合物也可以包括保健组合物。
化妆品应用(在某些情况下,保健应用)包括皮肤护理、毛发护理,或指/趾甲护理应用。
化妆品成分为已知可用于化妆品应用的那些成分。对这类成分的全面查看可见于CTFA化妆品成分手册。
化妆品适用的介质包括水、溶剂、稀释剂或它们的混合物和乳液。
化妆品成分包括润肤剂、蜡、保湿剂、表面活性物质(例如表面活性剂或洗涤剂或乳化剂)、增稠剂、水相稳定剂、pH控制剂、防腐剂和化妆品杀生物剂、皮脂吸收剂或皮脂控制剂、植物性提取物或植物提取物、维生素、蛋白质或氨基酸以及它们的衍生物、颜料、着色剂、填充剂、有机硅调理剂、阳离子调理剂、疏水性调理剂、紫外线吸收剂、防晒剂、去屑剂、防汗剂、除臭剂、护肤剂、毛发染料、指/趾甲护理成分、芳香剂或香料、抗氧化剂、氧化剂、还原剂、推进剂气体、成膜剂以及它们的混合物。
可用于化妆品组合物的另外成分包括脂肪醇、色彩护理添加剂、消脂肪团剂、珠光剂、螯合剂、定型剂、神经酰胺、助悬剂以及其他。
保健成分包括抗痤疮剂、抗菌剂、抗真菌剂、治疗活性剂、外用止痛剂、皮肤漂白剂、抗癌剂、利尿剂、用于治疗胃十二指肠溃疡的制剂、蛋白水解酶、抗组胺剂或H1-组胺阻断剂、镇静剂、支气管扩张剂、稀释剂。
可用于保健组合物中的另外成分包括抗生素、防腐剂、抗菌剂、抗炎剂、收敛剂、激素、戒烟组合物、心血管剂、抗心律失常剂、α-I受体阻断剂、β受体阻断剂、血管紧张素转化酶抑制剂、抗凝剂、非甾族抗炎剂(如双氯芬酸)、抗牛皮癣剂(如丙酸氯倍他索)、抗皮炎剂、神经松弛剂、抗惊厥剂、抗凝血剂、愈合因子、细胞生长营养物、多肽、皮质类固醇药物、止痒剂以及其他。
化妆品成分可在保健组合物中使用,例如蜡以及其他;而保健成分可在化妆品组合物中使用,例如抗痤疮剂以及其他。
润肤剂的例子包括挥发性或非挥发性硅油;有机硅树脂,如聚丙基倍半硅氧烷和聚苯基三甲基硅氧烷;有机硅弹性体,如聚二甲基硅氧烷交联聚合物;烷基甲基硅氧烷,如C30-45烷基聚甲基硅氧烷;挥发性或非挥发性烃化合物,如角鲨烯、石蜡油、凡士林油和萘油;氢化或部分氢化的聚异丁烯;异二十烷;角鲨烷;异链烷烃;异十二烷;异癸烷或异十六烷;支链的C8-C16酯;新戊酸异己酯;酯油,如异壬酸异壬酯、辛酸十六/十八烷酯、肉豆蔻酸异丙酯、棕榈酸酯衍生物、硬脂酸酯衍生物、异硬脂酸异硬脂醇酯以及醇或多元醇的庚酸酯、辛酸酯、癸酸酯或蓖麻醇酸酯,或它们的混合物;植物源烃油,所述植物源诸如小麦胚芽、向日葵、葡萄籽、蓖麻、乳木果、鳄梨、橄榄、大豆、甜杏仁、棕榈、油菜籽、棉花籽、榛果、澳洲坚果、霍霍巴、黑加仑、月见草;或辛酸/癸酸的三甘油酯;高级脂肪酸,例如油酸、亚油酸或亚麻酸,以及它们的混合物。
蜡的例子包括烃蜡例如蜂蜡、羊毛脂蜡、米蜡、卡洛巴蜡、小烛树蜡、微晶蜡、石蜡、地蜡、聚乙烯蜡、合成蜡、纯地蜡、羊毛脂、羊毛脂衍生物、椰子油、紫胶蜡、糠蜡、木棉蜡、甘蔗蜡、蒙旦蜡、鲸蜡、杨梅蜡、有机硅蜡(如聚甲基硅氧烷烷基、烷氧基和/或酯,C30-45烷基二甲基甲硅烷基聚丙基倍半硅氧烷),以及它们的混合物。
保湿剂的例子包括低分子量的脂族二醇,如丙二醇和丁二醇;多元醇,如甘油和山梨醇;以及聚氧乙烯聚合物,如聚乙二醇200;透明质酸及其衍生物,以及它们的混合物。
表面活性物质的例子可以为阴离子、阳离子或非离子的,并包括有机改性的有机硅化合物,如聚二甲基硅氧烷共聚多元醇;甘油的氧乙烯化酯和/或氧丙烯化酯;脂肪醇的氧乙烯化酯和/或氧丙烯化酯,如鲸蜡硬脂醇聚醚-30、C12-15链烷醇聚醚-7;聚乙二醇的脂肪酸酯,如PEG-50硬脂酸酯、PEG-40单硬脂酸酯;糖酯和醚,如蔗糖硬脂酸酯、蔗糖椰油酸酯和脱水山梨醇硬脂酸酯以及它们的混合物;磷酸酯及其盐,如油醇聚醚-10磷酸酯DEA盐(DEA oleth-10phosphate);磺基琥珀酸盐,如PEG-5柠檬酸月桂基磺基琥珀酸酯二钠(PEG-5citrate lauryl sulphosuccinate)和蓖麻醇酸酰胺MEA磺基琥珀酸酯二钠(disodium ricinoleamido MEA sulphosuccinate);烷基醚硫酸盐,如月桂基乙醚硫酸钠;羟乙基磺酸盐;甜菜碱衍生物;以及它们的混合物。
非离子型表面活性剂的另外的例子包括聚氧乙烯烷基醚、聚氧乙烯烷基酚醚、聚氧乙烯月桂基醚、聚氧乙烯山梨聚糖单油酸酯、聚氧乙烯烷基酯、聚氧乙烯山梨聚糖烷基酯、聚乙二醇、聚丙二醇、二甘醇、乙氧基化的三甲基壬醇、聚氧化烯取代的有机硅化合物(耙形或ABn型)、有机硅烷醇酰胺、有机硅酯、有机硅糖苷,以及它们的混合物。
非离子型表面活性剂包括聚二甲基硅氧烷共聚多元醇、多元醇的脂肪酸酯(例如一-、二-、三-或倍半油酸山梨酯或甘油酯或一-、二-、三-或倍半硬脂酸山梨酯或甘油酯、月桂酸甘油酯或月桂酸聚乙二醇酯);聚乙二醇的脂肪酸酯(聚乙二醇单硬脂酸酯或单月桂酸酯);山梨醇的聚氧乙烯化的脂肪酸酯(硬脂酸酯或油酸酯);聚氧乙烯化的烷基(月桂基、十六烷基、硬脂基或辛基)醚。
阴离子表面活性剂包括羧酸盐(2-(2-羟基烷氧基)乙酸钠)、氨基酸衍生物(N-酰基谷氨酸盐、N-酰基甘氨酸盐或酰基肌氨酸盐)、烷基硫酸盐、烷基醚硫酸盐及其氧乙烯化衍生物、磺酸盐、羟乙基磺酸盐和N-酰基羟乙基磺酸盐、牛磺酸酯(taurates)和N-酰基N-甲基牛磺酸酯、磺基丁二酸酯、烷基磺基乙酸酯、磷酸酯和烷基磷酸酯、多肽、烷基聚葡萄糖苷的阴离子衍生物(酰基-D-半乳糖苷糖醛酸盐)和脂肪酸皂,以及它们的混合物。
两性和两性离子型表面活性剂包括甜菜碱、N-烷基氨基甜菜碱及其衍生物、蛋白质及其衍生物、甘氨酸衍生物、磺基甜菜碱、烷基聚氨基羧酸酯和烷基两性基乙酸酯,以及它们的混合物。
增稠剂的例子包括丙烯酰胺聚合物和共聚物、丙烯酸酯共聚物及其盐(如聚丙烯酸酯钠)、黄原胶及衍生物、纤维素胶和纤维素衍生物(如甲基纤维素、甲基羟丙基纤维素、羟丙基纤维素、聚丙基羟乙基纤维素)、淀粉和淀粉衍生物(如羟乙基直链淀粉和淀粉酶)、聚氧乙烯、卡波姆、锂蒙脱石和锂蒙脱石衍生物、藻酸钠、阿拉伯树胶、肉桂胶、瓜耳胶和瓜耳胶衍生物、椰油酰胺衍生物、烷基醇类、明胶、PEG衍生物、糖类(如果糖、葡萄糖)和糖类衍生物(如PEG-120甲基葡萄糖二油酸酯),以及它们的混合物。
水相稳定剂的例子包括电解质(如碱金属盐和碱土金属盐,特别是钠、钾、钙和镁的氯化物、硼酸盐、柠檬酸盐和硫酸盐,以及水合氯化铝和聚合电解质,特别是透明质酸和透明质酸钠)、多元醇(甘油、丙二醇、丁二醇和山梨醇)、醇类(如乙醇)和水解胶体,以及它们的混合物。
pH控制剂的例子包括任何水溶性酸(诸如羧酸)或矿物酸(诸如盐酸、硫酸和磷酸)、一元羧酸(诸如乙酸和乳酸)以及多元羧酸(诸如琥珀酸、己二酸和柠檬酸),以及它们的混合物。
防腐剂和化妆品杀生物剂的例子包括对羟基苯甲酸酯衍生物、乙内酰脲衍生物、氯己定及其衍生物、咪唑烷基脲、苯氧基乙醇、银的衍生物、水杨酸盐衍生物、三氯生、环吡酮乙醇胺盐、去氧苯比妥、羟喹啉及其衍生物、聚维酮碘、锌盐及其衍生物例如吡硫锌,以及它们的混合物。
皮脂吸收剂或皮脂控制剂的例子包括甲硅烷基化二氧化硅、二甲基甲硅烷基化二氧化硅、聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷交联聚合物、聚甲基丙烯酸甲酯、交联甲基丙烯酸甲酯和淀粉辛烯基琥珀酸铝,以及它们的混合物。
植物性提取物或植物提取物的例子以油溶或水溶形式衍生自植株(草本植物、根、花、果实或种子),如椰子、绿茶、白茶、红茶、问荆、银杏、向日葵、麦芽、海藻、橄榄、葡萄、石榴、芦荟、杏仁、杏、胡萝卜、番茄、烟草、菜豆、马铃薯、赤豆、儿茶、橙、黄瓜、鳄梨、西瓜、香蕉、柠檬或棕榈。草本提取物的例子包括莳萝、山葵、燕麦、苦楝、甜菜、西兰花、茶、南瓜、大豆、大麦、胡桃木、亚麻、人参、罂粟、鳄梨、豌豆、芝麻,以及它们的混合物。
维生素的例子包括多种不同的有机化合物,如醇类、酸类、甾醇类和醌类。它们可以分成两个可溶性组:脂溶性维生素和水溶性维生素。可用于个人护理配方的脂溶性维生素包括视黄醇(维生素A)、钙化醇(维生素D2)、胆钙化醇(维生素D3)、叶绿醌(维生素K1)和生育酚(维生素E)。可用于个人护理配方的水溶性维生素包括抗坏血酸(维生素C)、硫胺(维生素B1)、尼克酸(烟酸)、烟酰胺(维生素B3)、核黄素(维生素B2)、泛酸(维生素B5)、生物素、叶酸、吡哆素(维生素B6)和氰钴胺(维生素B12)。维生素的另外例子包括维生素衍生物,如视黄醇棕榈酸酯(维生素A棕榈酸酯)、视黄醇乙酸酯(维生素A乙酸酯)、视黄醇亚油酸酯(维生素A亚油酸酯)和视黄醇丙酸酯(维生素A丙酸酯)、生育酚乙酸酯(维生素E乙酸酯)、生育酚亚油酸酯(维生素E亚油酸酯)、生育酚琥珀酸酯(维生素E琥珀酸酯)、生育酚聚醚-5、生育酚聚醚-10、生育酚聚醚-12、生育酚聚醚-18、生育酚聚醚-50(乙氧基化维生素E衍生物)、PPG-2生育酚聚醚-5、PPG-5生育酚聚醚-2、PPG-10生育酚聚醚-30、PPG-20生育酚聚醚-50、PPG-30生育酚聚醚-70、PPG-70生育酚聚醚-100(丙氧基化和乙氧基化维生素E衍生物)、生育酚磷酸酯钠、抗坏血酸棕榈酸酯、抗坏血酸二棕榈酸酯、抗坏血酸基葡糖苷、抗坏血酸四异棕榈酸酯、四-十六烷基抗坏血酸酯、抗坏血酸生育酚马来酸酯、磷酸抗坏血酸酯生育酚酯钾、生育酚烟酸酯,以及它们的混合物。
蛋白质或氨基酸以及它们的衍生物的例子包括从小麦、大豆、水稻、玉米、角蛋白、弹性蛋白或丝中提取的那些。蛋白质可以是水解形式,并且它们也可以是季铵化的,例如水解弹性蛋白、水解小麦粉、水解丝。蛋白质的例子包括酶例如水解酶、角质酶、氧化酶、转移酶、还原酶、半纤维素酶、酯酶、异构酶、果胶酶、乳糖酶、过氧化物酶、漆酶、过氧化氢酶,以及它们的混合物。水解酶的例子包括蛋白酶(细菌蛋白酶、真菌蛋白酶、酸性蛋白酶、中性蛋白酶或碱性蛋白酶)、淀粉酶(α淀粉酶或β淀粉酶)、脂肪酶、甘露聚糖酶、纤维素酶、胶原酶、溶菌酶、超氧化物歧化酶、过氧化氢酶,以及它们的混合物。
颜料和着色剂的例子包括经表面处理的或未处理的铁氧化物、经表面处理或未处理的二氧化钛、经表面处理或未处理的云母、氧化银、硅酸盐、铬氧化物、类胡萝卜素、炭黑、群青、叶绿酸衍生物和黄土。有机颜料的例子包括芳族类型,该类型包括偶氮、靛青类、三苯甲烷、蒽醌和黄嘌呤染料,其被指定为D&C和FD&C蓝、棕、绿、橙、红、黄等,以及它们的混合物。表面处理包括基于卵磷脂、有机硅、硅烷、氟化合物和它们的混合物的那些处理。
填充剂的例子包括滑石粉、云母、高岭土、锌或钛的氧化物、钙或镁的碳酸盐、二氧化硅、甲硅烷基化二氧化硅、二氧化钛、玻璃或陶瓷珠、聚甲基丙烯酸甲酯珠、氮化硼、硅酸铝、淀粉辛烯基琥珀酸铝、膨润土、硅酸镁铝、尼龙、丝粉、衍生自具有8-22个碳原子的羧酸的金属皂、非膨胀的合成聚合物粉末、来自天然有机化合物的膨胀粉末和粉末(如谷类食物淀粉,其可为交联的或非交联的)、共聚物微球、甲基丙烯酸酯高聚物(polytrap)、有机硅树脂微珠,以及它们的混合物。填充剂可经过表面处理,以改良其与剩余成分的亲和力或相容性。
有机硅调理剂的例子包括硅油,如聚二甲基硅氧烷;有机硅树胶如聚二甲基硅氧烷醇;有机硅树脂如三甲基甲硅烷氧基硅酸盐、聚丙基倍半硅氧烷;有机硅弹性体;烷基甲基硅氧烷;有机改性的硅油,如氨基封端聚二甲基硅氧烷、氨丙基苯基聚三甲基硅氧烷、聚苯基三甲基硅氧烷、三甲基五苯基三硅氧烷、聚硅氧烷季铵盐-16/环氧丙氧基聚二甲基硅氧烷交联聚合物、聚硅氧烷季铵盐-16;糖官能化硅氧烷;甲醇官能化硅氧烷;有机硅聚醚;硅氧烷共聚物(二乙烯基聚二甲基硅氧烷/聚二甲基硅氧烷共聚物);丙烯酸酯或丙烯酸官能化硅氧烷;以及它们的混合物或乳液。
阴离子调理剂的例子包括瓜耳衍生物,如瓜耳胶的羟基丙基三甲基铵衍生物;阳离子纤维素衍生物、阳离子淀粉衍生物;纤维素醚的季氮衍生物;二甲基二烯丙基氯化铵的均聚物;丙烯酰胺和二甲基二烯丙基氯化铵的共聚物;含有通过酯或酰胺键附接到聚合物的阳离子氮官能团的衍生自丙烯酸或甲基丙烯酸的均聚物或共聚物;与脂肪烷基二甲基铵取代的环氧化物反应的羟乙基纤维素的聚合物型季铵盐;N,N'-双(2,3-环氧丙基)哌嗪(N,N'-bis-(2,3-epoxypropyl)-piperazine)或哌嗪双丙烯酰胺和哌嗪的缩聚产物;以及乙烯基吡咯烷酮和丙烯酸酯与季氮官能团的共聚物。具体的材料包括各种聚季铵盐类聚季铵盐-7、聚季铵盐-8、聚季铵盐-10、聚季铵盐-11和聚季铵盐-23。其他类别的调理剂包括阳离子表面活性剂,如十六烷基三甲基氯化铵、十六烷基三甲基溴化铵、十八烷基三甲基氯化铵,以及它们的混合物。在某些情况下,阳离子调理剂还是经疏水改性的,例如经疏水改性的季铵化的羟乙基纤维素聚合物;阳离子疏水改性的半乳甘露聚糖醚;以及它们的混合物。
疏水性调理剂的例子包括瓜耳衍生物;半乳甘露聚糖凝胶衍生物;纤维素衍生物;以及它们的混合物。
紫外线吸收剂和防晒剂包括吸收约290-320纳米(UV-B区)的紫外线的那些以及吸收320-400纳米范围(UV-A区)内的紫外线的那些。
防晒剂的一些例子为氨基苯甲酸、西诺沙酯、甲氧基肉桂酸DEA盐、棓酰棓酸三油酸酯、二羟苯腙、4-[双(羟丙基)]氨基苯甲酸乙酯、氨基苯甲酸甘油酯、胡莫柳酯、具有二羟基丙酮的指甲花醌、邻氨基苯甲酸薄荷酯、氰双苯丙烯酸辛酯、甲氧基肉桂酸乙基己酯、水杨酸辛酯、羟甲氧二苯酮、对二甲氨基苯甲酸异辛酯、苯基苯并咪唑磺酸、红矿脂、磺异苯酮、二氧化钛、水杨酸三乙醇胺,以及它们的混合物。
紫外线吸收剂的一些例子为醋氨沙洛、尿囊素PABA、亚苄基酞、二苯甲酮、二苯甲酮1-12、3-苯亚甲基樟脑、苯亚甲基樟脑水解的胶原磺酰胺、苯亚甲基樟脑磺酸、水杨酸苄酯、波尼酮、布美三唑、丁基甲氧基二苯甲酰基甲烷、丁基PABA、二氧化铈/二氧化硅、二氧化铈/二氧化硅滑石、西诺沙酯、甲氧基肉桂酸DEA盐、二苯并噁唑萘、二叔丁基羟基苯亚甲基樟脑、棓酰棓酸三油酸酯、二异丙基甲基肉桂酸酯、二甲基PABA乙基鲸蜡硬脂基二甲基铵甲苯磺酸盐、二辛基丁酰胺基三嗪酮、二苯基甲氧甲酰基乙酰氧基萘并吡喃、双乙苯基三氨基三嗪茋二磺酸二钠、联苯乙烯二苯基三氨基三嗪茋二磺酸二钠、联苯乙烯二苯基二磺酸二钠、甲酚曲唑、甲酚曲唑三硅氧烷、乙基二羟基丙基PABA、乙基二异丙基肉桂酸酯、乙基甲氧基肉桂酸酯、乙基PABA、尿刊酸乙酯、阿魏酸氰双苯丙烯酸乙酯、甘油乙基己酸酯二甲氧基肉桂酸酯、甘油基PABA、乙二醇水杨酸酯、胡莫柳酯、异戊基对甲氧基肉桂酸酯、异丙基苄基水杨酸酯、异丙基二苯甲酰甲烷、异丙基甲氧基肉桂酸酯、邻氨基苯甲酸薄荷酯、薄荷醇水杨酸酯、4-甲基亚苄基、樟脑、氰双苯丙烯酸辛酯、辛酚三唑、辛基二甲基PABA、甲氧基肉桂酸乙基己酯、水杨酸辛酯、辛基三嗪酮、PABA、PEG-25PABA、戊基二甲基PABA、苯基苯并咪唑磺酸、聚丙烯酰胺甲基亚苄基樟脑、甲氧基肉桂酸钾、苯基苯并咪唑磺酸钾、红矿脂、苯基苯并咪唑磺酸钠、尿刊酸钠、TEA-苯基苯并咪唑磺酸盐、TEA-水杨酸盐、对苯二亚甲基二樟脑磺酸、二氧化钛、三PABA泛醇、咪唑丙烯酸、VA/巴豆酸酯/甲基丙烯酰氧二苯甲酮-1共聚物,以及它们的混合物。
去屑剂的例子包括吡啶硫酮盐,诸如二硫化硒的硒化合物、可溶性去屑剂,以及它们的混合物。
防汗剂和除臭剂的例子包括氯化铝、四氯羟铝锆GLY配位化合物、四氯羟铝锆PEG配位化合物、氯化羟铝二元醇配位化合物、四氯羟铝锆PG配位化合物、氯化羟铝PEG配位化合物、三氯羟铝锆、氯化羟铝PG配位化合物、三氯羟铝锆GLY配位化合物、六氯酚、苯扎氯铵、倍半氯化羟铝、碳酸氢钠、倍半氯化羟铝PEG配位化合物、叶绿酸-铜络合物、三氯生、八氯羟铝锆、蓖麻醇酸锌,以及它们的混合物。
护肤剂的例子包括尿囊素、乙酸铝、氢氧化铝、硫酸铝、炉甘石、可可油、鳕鱼肝油、胶状燕麦、聚二甲基硅氧烷、甘油、高岭土、羊毛脂、矿物油、凡士林、鲨鱼肝油、碳酸氢钠、滑石、金缕梅、醋酸锌、碳酸锌、氧化锌,以及它们的混合物。
毛发染料的例子包括1-乙酰氧基-2-甲基萘;酸性染料;5-氨基-4-氯邻甲酚;5-氨基-2,6-二甲氧基-3-羟基吡啶;3-氨基-2,6-二甲基苯酚;2-氨基-5-乙基苯酚盐酸盐;5-氨基-4-氟-2-甲酚硫酸盐;2-氨基-4-羟乙氨基茴香醚;2-氨基-4-羟乙氨基茴香醚硫酸盐;2-氨基-5-硝基苯酚;4-氨基-2-硝基苯酚;4-氨基-3-硝基苯酚;2-氨基-4-硝基苯酚硫酸盐;间氨基苯酚盐酸盐;对氨基苯酚盐酸盐;间氨基苯酚;邻氨基苯酚;4,6-双(2-羟乙氧基)间苯二胺盐酸盐;2,6-双(2-羟乙氧基)-3,5-吡啶二胺盐酸盐;2-氯-6-乙氨基-4-硝基苯酚;2-氯-5-硝基-N-羟乙基对苯二胺;2-氯对苯二胺;3,4-二氨基苯甲酸;4,5-二氨基-1-((4-氯苯基)甲基)-1H-吡唑硫酸盐;2,3-二氨基二氢吡唑并吡唑啉酮二甲基硫酸盐(2,3-diaminodihydropyrazolo pyrazolonedimethosulfonate);2,6-二氨基吡啶;2,6-二氨基-3-((吡啶-3-基)偶氮)吡啶;二羟基吲哚;羟基二氢吲哚;N,N-二甲基对苯二胺;2,6-二甲基对苯二胺;N,N-二甲基对苯二胺硫酸盐;直接染料;4-乙氧基间苯二胺硫酸盐;3-乙氨基对甲酚硫酸盐;N-乙基-3-硝基PABA;葡糖酰胺丙基氨丙基聚二甲基硅氧烷;巴西彩木(Haematoxylon brasiletto)提取物;HC染料;指甲花(Lawsonia inermis)提取物;羟乙基-3,4-亚甲二氧基苯胺盐酸盐;羟乙基-2-硝基对甲苯胺;羟乙基对苯二胺硫酸盐;2-羟乙基苦氨酸;羟吡啶酮;羟基琥珀酰亚胺基C21-22异烷基酸化物(羟基succinimidyl C21-22isoalkylacidate);靛红;欧洲菘蓝(Isatis tinctoria)叶粉;2-甲氧基甲基对苯二胺硫酸盐;2-甲氧基对苯二胺硫酸盐;6-甲氧基-2,3-吡啶二胺盐酸盐;4-甲基苄基-4,5-二氨基吡唑硫酸盐;2,2'-亚甲基双4-氨基苯酚;2,2'-亚甲基双4-氨基苯酚盐酸盐;3,4-亚甲二氧基苯胺;2-甲基间苯二酚;甲紫;1,5-萘二酚;1,7-萘二酚;3-硝基对甲酚;2-硝基-5-甘油基甲基苯胺;4-硝基愈创木酚;3-硝基对羟乙基氨基苯酚;2-硝基-N-羟乙基对茴香胺;硝基苯酚;4-硝基苯氨基乙基脲;4-硝基邻苯二胺二盐酸盐;2-硝基对苯二胺二盐酸盐;4-硝基邻苯二胺盐酸盐;4-硝基间苯二胺;4-硝基邻苯二胺;2-硝基对苯二胺;4-硝基间苯二胺硫酸盐;4-硝基邻苯二胺硫酸盐;2-硝基对苯二胺硫酸盐;6-硝基-2,5-吡啶二胺;6-硝基邻甲苯胺;PEG-32,2'-二对苯二胺;对苯二胺盐酸盐;对苯二胺硫酸盐;苯基甲基吡唑啉酮;N-苯基对苯二胺盐酸盐;颜料蓝15:1;颜料紫23;颜料黄13;焦性儿茶酚;连苯三酚;间苯二酚;苦氨酸钠;氨基苯磺酸钠;溶剂黄85;溶剂黄172;四氨基嘧啶硫酸盐;四溴酚蓝;2,5,6-三氨基-4-嘧啶醇硫酸盐;1,2,4-三羟基苯。
指/趾甲护理成分的例子包括乙酸丁酯;乙酸乙酯;硝酸纤维素;柠檬酸乙酰基三丁酯;异丙醇;己二酸/新戊二醇/偏苯三甲酸酐共聚物;司拉氯铵膨润土;丙烯酸酯共聚物;泛酸钙;冰岛地衣(Cetraria islandica)提取物;皱波角叉菜(Chondrus crispus);苯乙烯/丙烯酸酯共聚物;三甲基戊二醇二苯甲酸酯;聚乙烯醇缩丁醛;正丁醇;丙二醇;丁二醇;云母;二氧化硅;氧化锡;硼硅酸钙;合成氟金云母;聚对苯二甲酸乙二醇酯;山梨坦月桂酸酯衍生物;滑石;霍霍巴提取物;金刚石粉;异丁苯氧基环氧树脂;丝粉;以及它们的混合物。
芳香剂或香料的例子包括己基肉桂醛;茴香醛;2-正己基-3-氧代环戊烷羧酸甲酯(methyl-2-n-hexyl-3-oxo-cyclopentane carboxylate);丙位十二内酯;醋酸α-甲基苄酯;4-乙酰基-6-叔丁基-1,1-二甲基茚满;广藿香;乳香树脂;岩蔷薇;香根草油;古配巴香脂;冷杉香胶;4-(4-羟基-4-甲基戊基)-3-环己烯-1-甲醛;氨茴酸甲酯;香叶醇;乙酸香叶酯;里哪醇;香茅醇;乙酸萜品酯;水杨酸苄酯;2-甲基-3-(对异丙基苯基)丙醛;异丁酸苯氧乙酯;柏木乙缩醛(cedryl acetal);对茴香醛;麝香香精;大环酮;大环内酯麝香香精;乙烯基十三酸酯;以及它们的混合物。另外的香料成分在标准的教科书参考文献如Perfume and Flavour Chemicals,1969,S.Arctander,Montclair,New Jersey(《香料和芳香化学品》,1969年,S.Arctander,美国新泽西州蒙特克莱尔)中进行了详细描述。
抗氧化剂的例子为乙酰基半胱氨酸、熊果苷、抗坏血酸、抗坏血酸多肽、抗坏血酸二棕榈酸酯、抗坏血酸甲基硅烷醇果胶酸酯、抗坏血酸棕榈酸酯、抗坏血酸硬脂酸酯、BHA、对羟基茴香醚、BHT、叔丁基对苯二酚、咖啡酸、茶(Camellia sinensis)油、脱乙酰壳多糖抗坏血酸盐、脱乙酰壳多糖甘醇酸盐、脱乙酰壳多糖水杨酸盐、绿原酸、半胱氨酸、半胱氨酸盐酸盐、癸基巯甲基咪唑、异抗坏血酸、二戊基氢醌、二特丁基对苯二酚、二鲸蜡醇硫代二丙酸酯、二环戊二烯/叔丁基甲酚共聚物、棓酰棓酸三油酸酯、硫代二丙酸二月桂酯、二肉豆蔻醇硫代二丙酸酯、二油基生育酚甲基硅烷醇、异槲皮苷、地奥司明、抗坏血酸硫酸酯二钠、芸香亭基硫酸二钠、硫代二丙酸双十八醇酯、双十三醇硫代二丙酸酯、没食子酸月桂酯、阿魏酸乙酯、阿魏酸、氢醌、羟胺盐酸盐、羟胺硫酸盐、巯基乙酸异辛酯、曲酸、羟基积雪草苷、抗坏血酸镁、抗坏血酸磷酸酯镁、褪黑激素、甲氧基-PEG-7芸香苷琥珀酸酯、亚甲基二叔丁基甲酚、甲基硅烷醇抗坏血酸、去甲二氢愈创木酸、没食子酸辛酯、苯基巯基乙酸、间苯三酚、磷酸抗坏血酸酯生育酚酯钾、硫代二乙酰胺、亚硫酸钾、没食子酸丙酯、迷迭香酸、芦丁、抗坏血酸钠、抗坏血酸/胆甾醇磷酸酯钠、亚硫酸氢钠、异抗坏血酸钠、焦亚硫酸钠、亚硫酸钠、硫代乙醇酸钠、山梨醇缩糠醛、茶树(Melaleuca aftemifolia)油、醋酸生育酚、四己基癸醇抗坏血酸酯、四氢二阿魏酰甲烷、生育酚亚油酸酯/油酸酯、硫二甘醇、生育酚琥珀酸酯、硫代二乙醇酸、硫代乙醇酸、硫代乳酸、硫代水杨酸、硫代牛磺酸、视黄醇、生育酚聚醚-5、生育酚聚醚-10、生育酚聚醚-12、生育酚聚醚-18、生育酚聚醚-50、生育酚、托可索仑、生育酚亚油酸酯、生育酚烟酸酯、托可醌、邻甲苯基双胍、三(壬基酚)亚磷酸酯、泛醌、二丁基二硫代氨基甲酸锌,以及它们的混合物。
氧化剂的例子为过硫酸铵、过氧化钙、过氧化氢、过氧化镁、过氧化蜜胺、溴酸钾、卡卢酸钾、氯酸钾、过硫酸钾、溴酸钠、过碳酸钠、氯酸钠、碘酸钠、过硼酸钠、过硫酸钠、二氧化锶、过氧化锶、过氧化脲、过氧化锌,以及它们的混合物。
还原剂的例子为亚硫酸氢铵、亚硫酸铵、巯基乙酸铵、硫羟乳酸铵、半胱胺盐酸盐、半胱氨酸、半胱氨酸盐酸盐、乙醇胺巯基乙酸盐、谷胱甘肽、甘油巯基乙酸酯、甘油巯基丙酸酯、氢醌、对羟基茴香醚、巯基乙酸异辛酯、巯基乙酸镁、巯基丙酸、焦亚硫酸钾、亚硫酸钾、巯基乙酸钾、亚硫酸氢钠、连二硫酸钠、羟甲烷磺酸钠、焦亚硫酸钠、亚硫酸钠、巯基乙酸钠、巯基乙酸锶、过氧化物歧化酶、硫甘油、巯基乙酸、硫代乳酸、硫代水杨酸、甲醛合次硫酸锌,以及它们的混合物。
推进剂气体的例子包括二氧化碳、氮气、一氧化二氮、挥发性的烃(如丁烷、异丁烷或丙烷)、氯化的或氟化的烃(如二氯二氟甲烷和二氯四氟乙烷)或二甲基醚;以及它们的混合物。
成膜剂的例子包括能够自己或在辅助性成膜剂存在下在载体上,尤其是角蛋白材料上形成宏观上连续的膜(优选地为内聚膜,更好地是其内聚力和机械性能使得所述膜能与所述载体分离的膜)的那些聚合物。
抗痤疮剂的例子包括水杨酸、苯甲酰硫、过氧化物、维甲酸,以及它们的混合物。
抗菌剂的例子包括葡萄糖酸氯己定、醇、苯扎氯铵、苄索氯铵、过氧化氢、甲苄索氯铵、酚、泊洛沙姆188、聚维酮碘,以及它们的混合物。
抗真菌剂的例子包括硝酸咪康唑、十一碳烯酸钙、十一碳烯酸、十一碳烯酸锌,以及它们的混合物。
治疗活性剂的例子包括青霉素、头孢菌素、四环素、大环内酯类、肾上腺素、安非他命、阿司匹林、对乙酰氨基酚、巴比妥类、儿茶酚胺、苯二氮卓类、硫喷妥钠、可待因、吗啡、普鲁卡因、利多卡因、苯佐卡因、磺胺类、噻康唑(ticonazole)、吡布特罗(perbuterol)、速尿(furosamide)、哌唑嗪、激素、前列腺素、羧苄青霉素、沙丁胺醇、氟派啶醇、苏拉明、吲哚美辛(indomethicane)、双氯芬酸、格拉非宁、双嘧达莫、茶碱、氢化可的松、类固醇、东莨菪碱,以及它们的混合物。
外用止痛剂的例子为苄醇、辣椒油树脂(小米椒(Capsicum frutescens)油树脂)、水杨酸甲酯、樟脑、苯酚、辣椒素、杜松焦油(刺杜松(Juniperus oxycedrus)焦油)、苯酚钠、辣椒(小米椒)、薄荷醇、间苯二酚、烟酸甲酯、松节油(松脂),以及它们的混合物。
皮肤漂白剂的例子为氢醌。
抗癌剂的例子包括烷化剂(诸如白消安、氟多潘)、抗有丝分裂剂(诸如秋水仙碱、力索新)、拓扑异构酶I抑制剂(诸如喜树碱及其衍生物)、拓扑异构酶II抑制剂(诸如美诺立尔、氨萘非特)、RNA/DNA或DNA代谢拮抗剂(诸如阿西维辛、胍唑)、植物生物碱和萜类化合物、抗肿瘤剂和一些衍生自植物的化合物(诸如足叶草毒素、长春花生物碱),以及它们的混合物。
利尿剂的例子包括髓袢利尿剂(诸如布美他尼、速尿灵)、噻嗪类利尿剂(诸如氯噻嗪、氢氟甲噻)、保钾利尿剂(诸如阿米洛利、螺甾内酯)、碳酸酐酶抑制剂(诸如乙酰唑胺)、渗透性利尿剂(诸如甘露糖醇),以及它们的混合物。
用于治疗胃十二指肠溃疡的制剂的例子包括质子泵抑制剂(诸如兰索拉唑、奥美拉唑)、酸阻断剂或H2-组胺阻断剂(诸如西咪替丁、雷尼替丁)、铋、硫糖铝,以及它们的混合物。
蛋白水解酶的例子包括纳豆激酶、沙氏菌蛋白酶、菠萝蛋白酶、木瓜蛋白酶,以及它们的混合物。
抗组胺剂或H1-组胺阻断剂的例子包括溴苯那敏、克立马丁、西替利嗪、氯雷他定、非索非那丁,以及它们的混合物。
镇静剂的例子包括巴比妥类(诸如苯巴比妥)、苯二氮卓类(诸如劳拉西泮)、草本镇静剂、苯二氮卓类药物(诸如佐沛眠、佐匹克隆),以及它们的混合物。
支气管扩张剂的例子包括短效β2-受体激动剂、长效β2-受体激动剂、抗胆碱能剂,以及它们的混合物。
本发明的配方还包含稀释剂。此类稀释剂经常是必需的,以便为应用而充分降低配方的粘度。
稀释剂的例子包括含硅稀释剂例如六甲基二硅氧烷、八甲基三硅氧烷,以及其他短链线性硅氧烷(诸如八甲基三硅氧烷、十甲基四硅氧烷、十二甲基五硅氧烷、十四甲基六硅氧烷、十六甲基七硅氧烷、七甲基-3-{(三甲基甲硅烷基)氧基)}三硅氧烷)、环状硅氧烷(诸如六甲基环三硅氧烷、八甲基环四硅氧烷、十甲基环五硅氧烷、十二甲基环六硅氧烷);有机稀释剂诸如乙酸丁酯、烷烃类、醇类、酮、酯、醚、二醇类、二醇醚、氢氟烃或任何其他能够稀释配方而对化妆品组合物的任何组分材料没有不利影响的材料。烃包括异十二烷、异十六烷、Isopar L(C11-C13)、Isopar H(C11-C12)、氢化聚癸烯。醚和酯包括新戊酸异癸酯、庚酸新戊二醇酯、二硬脂酸二醇酯、碳酸二辛酯、碳酸二乙基己酯、丙二醇正丁基醚、乙基-3乙氧基丙酸酯、丙二醇甲醚乙酸酯、新戊酸十三烷酯、丙二醇甲醚乙酸酯(PGMEA)、丙二醇甲醚(PGME)、新戊酸十八烷酯、己二酸二异丁酯、己二酸二异丙酯、二辛酸丙二醇酯/二癸酸丙二醇酯和棕榈酸辛酯。另外的有机稀释剂包括脂肪、油类、脂肪酸,以及脂肪醇。
适用于个人护理和保健的其他材料是本领域技术人员熟知的,并在许多教科书以及其他出版物中描述。
相对于化妆品组合物的总重量,化妆品组合物中的双峰水连续乳液(E)的一般含量可从0.1%变化至80%(重量百分比)、或者从0.2%变化至10%(重量百分比)、或者从0.5%变化至5%(重量百分比)。相对于化妆品组合物的总重量,化妆品成分(C)以0.01%至99.99%(重量百分比)的含量存在。化妆品成分(C)可以是上文列出的化妆品成分(C)的混合物。
在一些情况下,双峰水连续乳液(E)与选自阳离子调理剂、疏水性调理剂或它们的混合物的化妆品成分(C)在化妆品适用的介质中结合使用。
化妆品组合物可以通过包括以下步骤的方法制备:
i.混合双峰水连续乳液(E),所述双峰水连续乳液(E)包含至少70重量%的:第一分散相(i)和第二分散相(ii),第一分散相(i)包含疏水性油,其中疏水性油以非乳化疏水性油形式提供,第二分散相(ii)包含有机硅,其中有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;
ii.与至少一种化妆品成分(C);
iii.任选地在化妆品适用的介质存在下进行。
化妆品组合物可以通过将水相中的双峰水连续乳液(E)与合适的水相成分混合,并且任选地提供非水相,并任选地在加热下将水相与非水相混合到一起制备而成。
该方法可以使用简单的螺旋桨搅拌器、反转搅拌器或均质化搅拌器,在15至90℃或者20至60℃的温度范围下、或者在室温(25℃)下进行。通常不需要特殊的设备或加工条件。制备方法将随所制备的组合物的类型而不同,但这类方法是本领域熟知的。
化妆品组合物可以是乳剂、凝胶、粉末(自由流动的粉末或压制的粉末)、糊剂、固体、可自由倾倒的液体、气雾剂的形式。化妆品组合物还可以是以下形式:单相体系、双相的或交替的多相体系;乳液,如水包油、油包水、水包有机硅、有机硅包水;多重乳液,如油包水包油、水包有机硅包多元醇、多元醇包水包油。
皮肤护理组合物包括沐浴露、肥皂、水凝胶、乳剂、洗剂和香膏;防汗剂;除臭剂,例如除臭棒、除臭软膏、滚抹除臭剂、除臭气雾剂以及泵式除臭剂;护肤霜;护肤液;保湿剂;面部护理剂,诸如皱纹控制或减少护理剂;去角质剂;身体和面部清洁剂;浴油;香水;古龙水;香粉;防晒剂;摩丝;贴剂;须前水和须后水;剃须皂;剃须膏;脱毛剂;化妆品;彩妆;粉底;遮瑕膏;胭脂;唇膏;眼线膏;睫毛膏;去油剂;彩妆卸妆液、散粉,以及它们的套装。
毛发护理组合物包括洗发液、洗去型护发素、免洗护发素和造型辅助品、凝胶、喷雾、润发油、摩丝、蜡、毛鳞片修护素、毛发着色剂、毛发松弛剂、毛发直顺剂、烫发剂,以及它们的套装。
指/趾甲护理组合物包括彩色面漆、底漆、指/趾甲强化剂,以及它们的套装。
保健组合物可以是以下形式:药膏、乳剂、凝胶、摩丝、糊剂、贴剂、喷雾绷带、泡沫和/或气雾剂等,药物乳剂、糊剂或者喷剂(包括抗痤疮剂、牙科卫生剂、抗生素、愈合促进剂,其可以是预防性的和/或治疗性的药剂),以及它们的套装。
化妆品组合物可通过标准的方法来使用,诸如使用施用器具、刷子将它们施用到人或动物的身体(如,皮肤或毛发),通过手来施用,将它们倒出和/或可能地将组合物摩擦或按摩到身体上或者身体内。去除方法(例如彩妆的去除方法)也是熟知的标准方法,包括洗涤、擦拭、剥离等。
本发明还包括处理角质基质(例如毛发或皮肤)的方法,具体方式为向其施加根据本发明的第一方面的化妆品组合物。
化妆品组合物可以用常规的方式在毛发上使用。将有效量的毛发洗涤或调理组合物施用到毛发。这种有效量通常在约1g至约50g、优选地约1g至约20g的范围内。施用于毛发通常包括使化妆品组合物透入毛发,使得毛发的大部分或者全部与化妆品组合物接触。这些步骤可按需重复多次以达到所需的效果。
在毛发上使用该化妆品组合物得到的有益效果包括以下效果中的一者或多者:毛发调理、柔软、易于梳理、有机硅沉积、防静电、防卷曲、润滑、有光泽、强韧、有粘性、触感佳、湿梳、干梳、对着色方法的改进、保色、拉直、热保护、定型或卷曲保持。
化妆品组合物可以用常规的方式在皮肤上使用。将有效量的用于该目的的组合物施用到皮肤。这种有效量通常可在约1mg/cm2至约3mg/cm2。施用于皮肤通常包括使化妆品组合物透入皮肤中。这个施用于皮肤的方法包括使皮肤与有效量的化妆品组合物接触的步骤和然后将组合物揉擦到皮肤中的步骤。这些步骤可按需重复多次以达到所需的效果。
在皮肤上使用该化妆品组合物得到的有益效果包括以下效果中的一者或多者:皮肤柔软性、弹性、保湿、皮肤感觉、泡沫生成。
洗涤角质纤维的方法包括以下步骤:
i.混合双峰水连续乳液(E)与至少一种化妆品成分(C),所述双峰水连续乳液(E)包含至少70重量%的:第一分散相和第二分散相,第一分散相包含疏水性油,其中疏水性油以非乳化疏水性油形式提供,第二分散相包含有机硅,其中有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;
任选地在化妆品适用的介质存在下进行;
ii.将该混合物施加到角质纤维上;
iii.任选地让混合物停留在角质纤维上;
iv.任选地冲洗角质纤维。
调理角质纤维的方法包括以下步骤:
i.混合双峰水连续乳液(E)与至少一种化妆品成分(C),所述双峰水连续乳液(E)包含至少70重量%的:第一分散相和第二分散相,第一分散相包含疏水性油,其中疏水性油以非乳化疏水性油形式提供,第二分散相包含有机硅,其中有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;
所述至少一种化妆品成分(C)选自阳离子调理聚合物、疏水性调理聚合物;任选地在化妆品适用的介质存在下进行;
ii.将该混合物施加到角质纤维上;
iii.任选地让混合物停留在角质纤维上;
iv.任选地冲洗角质纤维。
护理或调理角质纤维的方法的任选的停留时间可以在10秒至1小时,或者30秒至30分钟,或者30秒至10分钟范围内。
化妆品组合物可用于护理角质基质,即,对毛发进行清洁、调理、清新、化妆、卸妆、修整。
实例
将如下实例包括在内以阐述本发明的优选实施例。本领域的技术人员应该理解,随后的实例中公开的技术代表本发明人发现在实践本发明中表现良好的技术,因而可视为构成其实践的优选模式。然而,根据本公开本领域的技术人员应该理解,可以在所公开的具体实施例中做出许多改变且仍可获得类似或相同的结果而不背离本发明的精神和范围。所有的百分数为重量%。除非另外指明,否则所有的测量均在23℃下进行。
INSTRON程序是标准的、公认的和工业上接受的协议,参见例如美国专利5,389,364(1995年2月14日)、5,409,695(1995年4月25日)、5,419,627(1995年5月30日)和5,504,149(1996年4月2日)。
INSTRON COMBING是通过易于湿梳和易于干梳确定得自头发组合物的护发成分的业界公认的测试。该测试使用INSTRON应变仪,其被装配用于测量梳理头发所需的力。调理性能基于具体头发护理配方(如洗发液或护发剂)减小梳理头发所需的力(用INSTRON应变仪测量)的能力。该力被报告为平均梳理负荷(ACL)。ACL值越低,正在测试的配方所赋予的调理效果越好。通常,最初使用只用月桂基硫酸钠溶液洗涤过的未处理过的发束确定ACL基准。然后可将处理效果表示为处理过的发束的ACL或用以下关系式计算的ACL百分比减小值:(未处理过的头发ACL-处理过的头发ACL)×100除以未处理过的头发ACL。
将得自DeMeo Brothers的稍微漂白的欧洲人头发用于测试本文中制备的组合物。每个发束重约2.0g。40℃自来水流下将每个发束冲洗15秒。使用移液管施加包含9%月桂基硫酸钠的1.0g溶液,并使发束起泡30秒。在自来水下将发束冲洗30秒。通过使发束从手的食指和中指之间穿过来除去发束上过量的水。将发束放置在用纸巾覆盖的托盘上,干燥过夜。用梳的窄齿将每个发束手动梳理三次,并用INSTRON湿梳和INSTRON干梳程序进行评估。
对于涉及洗发液组合物的测试而言,用40℃的自来水将发束冲洗30秒。将0.8g测试组合物施加到发束上,并将发束捋30秒。在40℃的自来水下将发束冲洗30秒。通过拉动发束穿过手的食指和中指来除去过量的水。允许发束在室温下单独在纸巾上干燥过夜。进行INSTRON研究之前梳理发束。
根据INSTRON湿梳方法,首先通过将头发浸入蒸馏水中将头发润湿,然后通过将发束梳理三次使头发不缠结。然后通过将发束浸入蒸馏水中三次使其重新缠结。通过使发束从手的食指和中指之间穿过两次来除去过量的水。将发束放置在挂钩上并进行INSTRON梳理。重复重新缠结和INSTRON梳理,直到收集到所有数据点。对于每次处理,测量三个发束的平均梳理力。
根据INSTRON干梳方法,通过将发束梳理3次使头发不缠结。然后通过将发束顺时针缠绕3次并且逆时针缠绕3次使头发重新缠结。然后将发束放置在挂钩上并进行INSTRON梳理。重复重新缠结和Instron梳理,直到收集到所有数据点。对于每次处理,测量三个发束的平均梳理力。
乳液1
用聚二甲基硅氧烷醇和十二烷基苯磺酸TEA盐的乳液(B-60%有机硅)对聚二甲基硅氧烷100,000mPa.s(A)进行乳化:将32.74g的100,000mPa.s聚二甲基硅氧烷称取到杯中,然后加入6.55g乳液(B)。将该杯封闭并置于DAC-150Speed内部,使该杯在最大速度(3450RPM)下旋转30秒。将该杯打开并用刮刀刮擦杯壁,并且再次使该杯在最大速度旋转30秒。将5g乳液(B)称取到杯中,使该杯在大约2500RPM下旋转30秒。加入15.7g乳液(B),并再次使该杯在大约2500RPM下旋转30秒。所得的乳液(E1)由总有机硅含量为大约81.05%的有机硅聚合物的水性水包油(o/w)乳液组成。以干重计,该乳液(E1)包含大约77%的作为大粒子的100,000mPa.s聚二甲基硅氧烷和23%的作为较小粒子的聚二甲基硅氧烷醇。乳液(E1)的粒度用Malvern来测定。粒度曲线显示两个不同的峰,一个以6.5μm为中心,另一个以35μm为中心。通过该仪器计算的粒度如下:Dv50=8.68μm,Dv90=19.82μm,峰1=0.73μm,峰2=11.81μm。
乳液2
用聚二甲基硅氧烷醇和十二烷基苯磺酸TEA盐的乳液(B-60%有机硅)和用甲硅烷氧化聚醚EO/PO共聚物对聚二甲基硅氧烷100,000mPa.s(A)进行乳化。如实例1所述处理该实例,其中添加2.99g甲硅烷氧化聚醚EO/PO共聚物。粒度曲线显示两个不同的峰,一个以6.5μm为中心,另一个以35μm为中心。通过该仪器计算的粒度如下:Dv50=9.3μm,Dv90=21.16μm,峰1=0.73μm,峰2=12.38μm。
比较乳液1
聚二甲基硅氧烷醇和十二烷基苯磺酸TEA盐(B)的乳液,60%(重量百分比)有机硅
比较乳液2
乳液混合物:聚二甲基硅氧烷醇和十二烷基苯磺酸TEA盐的乳液+乳液聚二甲基硅氧烷和椰油酰氨基丙基甜菜碱和C12-15链烷醇聚醚-3和瓜耳羟丙基三甲基氯化铵
以2%(重量百分比)有机硅将乳液1和2与比较乳液1和2配制在洗发液组合物中,并比较湿梳和干梳性能。
与比较乳液1相比,乳液1和2的干梳和湿梳(Instron)性能显示有所提高。
乳液1和2的干梳和湿梳(Instron)性能显示与比较乳液2相同。
在将包含乳液1和2的洗发液施加到头发上时,显示出非常好的感官舒适度。
乳液3至6
以与上述乳液1和2类似的方式制备这些乳液,其中内容物如表1所列,并且在洗发液组合物中的用量(各自包含2重量%有机硅)如表2所列。随后根据上文所述的Instron技术评估洗发液组合物。
表1
洗发液制备(表2):将去离子水加入混合容器中。为了在整个测试过程中使活性有机硅装载量保持恒定,有必要根据所使用的各种乳液中的活性有机硅百分比来调整添加的水含量。通过适度搅拌,使聚季铵盐-10分散,直到完全溶解,并添加月桂基乙醚硫酸钠。然后将其加热至75℃,并在持续搅拌下添加PEG-150季戊四醇四硬脂酸酯。将加热降至40℃,并添加椰油酰胺DEA和椰油酰氨基丙基甜菜碱。完全结合时,将有机硅乳液加入基础洗发液中。将洗发液混合5-10分钟,然后加入DMDM乙内酰脲。补偿水损耗(至总计100重量%),然后将配方再混合5分钟。洗发液配方的最终pH在5.5至6.0范围内。
使用表2中的洗发液进行的INSTRON湿梳和干梳的结果也示于表2中。
INSTRON湿梳:结果显示,分别包含双峰乳液3至6的所有实例洗发液1至4均导致湿梳力减小。实例洗发液1、3和4与相应的比较洗发液1、3和4在性能上类似,这意味着它们能够提高头发的湿调理特性。
INSTRON干梳:结果显示,分别包含双峰乳液3至6的所有实例洗发液1至4均导致干梳力减小。实例洗发液1至4与相应的比较洗发液1至4在性能上类似,这意味着它们能够提高头发的干调理特性。
用实例洗发液1至4处理过的发束的湿感/顺滑度、干感/顺滑度、光滑度、光泽和量与用相应比较洗发液1至4处理过的发束类似。
乳液7
用聚二甲基硅氧烷60,000mPa.s和月桂基聚氧乙烯醚-4和月桂基聚氧乙烯醚-23的乳液(B)(B–58.5%有机硅)对鳄梨油、氢化聚异丁烯、聚二甲基硅氧烷和聚二甲基硅氧烷交联聚合物的混合物(A)进行乳化:将8.15g乳液(B)、3.15g鳄梨油和3.15g氢化聚异丁烯称取到杯中。将该杯封闭并置于DAC-150Speed内部,使该杯在最大速度(3450RPM)下旋转60秒。将6.30g聚二甲基硅氧烷和聚二甲基硅氧烷交联聚合物加入杯中,并使该杯在3450RPM下旋转60秒。加入1.66g玻璃珠,以提供另外的剪切,使混合物在3450RPM下旋转60秒。加入0.50g水,并使混合物在3450RPM下旋转30秒。加入另外的0.50g水,并使混合物在3450RPM下旋转30秒。再加入另外的0.74g水,并使混合物在3450RPM下旋转30秒。加入另外的0.5g和0.74g水之后,乳液的体积粘度从不可流动降至可流动。
所得的乳液(E7)由总内相含量(有机硅+有机油)为大约81.78%(重量百分比)的有机硅聚合物和有机油的水性水包油(o/w)乳液组成。以干重计,该乳液(E7)包含大约27.5%的60,000mPa.s聚二甲基硅氧烷、18.1%的鳄梨油、18.1%的氢化聚异丁烯以及36.3%的聚二甲基硅氧烷和聚二甲基硅氧烷交联聚合物。乳液(E7)的粒度用Malvern来测定。通过该仪器计算的粒度如下:Dv50=2.095μm,Dv90=21.162μm,峰1=1.458μm,峰2=11.294μm。
乳液8
用聚二甲基硅氧烷和聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷交联聚合物和PEG-20失水山梨醇椰油酸酯的乳液(B)(B-65%有机硅)对月桂基聚氧乙烯醚-7、季戊四醇四乙基己酸酯、氢化聚异丁烯的混合物(A)进行乳化:将8.00g乳液(B)、0.16g月桂基聚氧乙烯醚-7、4.00g季戊四醇四乙基己酸酯、4.00g氢化聚异丁烯称取到杯中。将该杯封闭并置于DAC-150Speed内部,使该杯在最大速度(3450RPM)下旋转30秒。加入0.50g水,并使混合物在3450RPM下旋转30秒。所得的乳液(E8)由总内相含量(有机硅+有机油)为大约78.73%(重量百分比)的有机硅聚合物和有机油的水性水包油(o/w)乳液组成。以干重计,该乳液(E8)包含大约39.0%的聚二甲基硅氧烷和聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷交联聚合物、30.5%的季戊四醇四乙基己酸酯,以及30.5%的氢化聚异丁烯。乳液(E8)的粒度用Malvern来测定。通过该仪器计算的粒度如下:Dv50=3.488μm,Dv90=6.903μm,峰1=1.02μm,峰2=4.689μm。
但任选地,月桂基聚氧乙烯醚-7可被月桂基聚氧乙烯醚-4、月桂基聚氧乙烯醚-23、聚山梨醇酯-20或十三烷醇聚醚-9替代。
聚二甲基硅氧烷和聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷交联聚合物以及PEG-20失水山梨醇椰油酸酯的乳液(B)可被聚二甲基硅氧烷和聚二甲基硅氧烷/乙烯基聚二甲基硅氧烷交联聚合物以及鲸蜡醇聚醚-6和鲸蜡醇聚醚-20的乳液(B)替代。
可以添加另外的水,以降低乳液的体积粘度。
乳液9
用双-二异丙醇氨基-PG-丙基聚二甲基硅氧烷/双-异丁基PEG-14共聚物和聚山梨醇酯20以及丁基辛醇的乳液(B)(B-56%有机硅)对双-二异丙醇氨基-PG-丙基聚二甲基硅氧烷/双-异丁基PEG-14共聚物和聚山梨醇酯20的混合物(A)进行乳化:将10.00g乳液(B)、10.00g双-二异丙醇氨基-PG-丙基聚二甲基硅氧烷/双-异丁基PEG-14共聚物和0.05g聚山梨醇酯20称取到杯中。将该杯封闭并置于DAC-150Speed内部,使该杯在最大速度(3450RPM)下旋转30秒。加入另外的5.00g乳液(B)并使混合物在3450RPM下旋转30秒。
所得的乳液(E9)由总有机硅含量为大约74.31%(重量百分比)的有机硅聚合物的水性水包油(o/w)乳液组成。整个内相(小粒子和大粒子)为双-二异丙醇氨基-PG-丙基聚二甲基硅氧烷/双-异丁基PEG-14共聚物。乳液(E9)的粒度用Malvern来测定。通过该仪器计算的粒度如下:Dv50=6.059μm,Dv90=11.395μm,峰1=0.924μm,峰2=6.250μm。
乳液10
用双-二异丙醇氨基-PG-丙基聚二甲基硅氧烷/双-异丁基PEG-14共聚物和聚山梨醇酯20以及丁基辛醇的乳液(B)(B-56%有机硅)对聚二甲基硅氧烷醇80Pa.s、月桂基聚氧乙烯醚-4和月桂基聚氧乙烯醚-23的混合物(A)进行乳化:将8.00g乳液(B)、42.86g聚二甲基硅氧烷醇、0.03g月桂基聚氧乙烯醚-4和0.08g月桂基聚氧乙烯醚-23(70%活性熔液)称取到杯中。将该杯封闭并置于DAC-150Speed内部,使该杯在最大速度(3450RPM)下旋转30秒。加入第一另外的4.00g乳液(B),并使混合物在3450RPM下旋转30秒。加入第二另外的4.00g乳液(B),并使混合物在3450RPM下旋转30秒。加入第三另外的4.00g乳液(B),并使混合物在3450RPM下旋转30秒。加入第四另外的4.00g乳液(B),并使混合物在3450RPM下旋转30秒。加入最后另外的10.00g乳液(B),并使混合物在3450RPM下旋转30秒。
所得的乳液(E10)由总有机硅含量为大约81.05%(重量百分比)的有机硅聚合物的水性水包油(o/w)乳液组成。以干重计,该乳液(E10)包含大约68.6%的作为大粒子的80Pa.s聚二甲基硅氧烷醇和31.4%(重量百分比)的作为较小粒子的双-二异丙醇氨基-PG-丙基聚二甲基硅氧烷/双-异丁基PEG-14共聚物。乳液(E10)的粒度用Malvern来测定。通过该仪器计算的粒度如下:Dv50=7.041μm,Dv90=14.265μm,峰1=1.045μm,峰2=7.665μm。
乳液11
用有机硅季铵盐-16和十一烷醇聚醚-11以及丁基辛醇和十一烷醇聚醚-5的(微)乳液(B)(B-22%有机硅–Dv50=0.0463μm)对聚二甲基硅氧烷醇80Pa.s(A)进行乳化:将5.00g乳液(B)和28.20g聚二甲基硅氧烷醇称取到杯中。加入10.00g玻璃珠,以提供另外的剪切。将该杯封闭并置于DAC-150Speed内部,使该杯在最大速度(3450RPM)下旋转30秒。加入第一另外的5.00g乳液(B),并使混合物在3450RPM下旋转30秒。加入第二另外的2.50g乳液(B),并使混合物在3450RPM下旋转30秒。加入第三另外的2.50g乳液(B),并使混合物在3450RPM下旋转30秒。
所得的乳液(E11)由总有机硅含量为大约75.00%(重量百分比)的有机硅聚合物的水性水包油(o/w)乳液组成。以干重计,该乳液(E11)包含大约87.0%(重量百分比)的作为大粒子的聚二甲基硅氧烷醇和13.0%(重量百分比)的作为较小粒子的有机硅季铵盐-16。乳液(E11)的粒度用Malvern来测定,只有较大粒子具有峰2=6.579μm。通过MicrotracNanotrac 150测量的初始乳液(B)的Dv50为0.0463μm。当存在较大粒子时,由于较大粒子在测量设备上的光学效应,无法有效地测量这些较小粒子。然而,通过乳液11的可流动特征证明存在此类较小粒子,如果在此类高有机硅含量下只存在大粒子则不会是这种情况。
乳液12
用氨基封端聚二甲基硅氧烷和C11-15链烷醇聚醚-7和月桂基聚氧乙烯醚-9以及甘油和十三烷醇聚醚-12的(微)乳液(B)(B-20%有机硅–Dv50=0.0146μm)对聚二甲基硅氧烷醇80Pa.s(A)进行乳化:将2.50g乳液(B)和27.74g聚二甲基硅氧烷醇称取到杯中。加入10.00g玻璃珠,以提供另外的剪切。将该杯封闭并置于DAC-150Speed内部,使该杯在最大速度(3450RPM)下旋转30秒。加入第一另外的2.50g乳液(B),并使混合物在3450RPM下旋转30秒。加入另一个另外的5.00g乳液(B),并使混合物在3450RPM下旋转30秒。加入最后另外的2.50g乳液(B),并使混合物在3450RPM下旋转30秒。
所得的乳液(E12)由总有机硅含量为大约75.15%(重量百分比)的有机硅聚合物的水性水包油(o/w)乳液组成。以干重计,该乳液(E12)包含大约91.7%(重量百分比)的作为大粒子的聚二甲基硅氧烷醇和8.3%(重量百分比)的作为较小粒子的氨基封端聚二甲基硅氧烷。乳液(E12)的粒度用Malvern来测定,只有较大粒子具有峰2=6.698μm。通过Microtrac Nanotrac 150测量的初始乳液(B)的Dv50为0.0146μm。当存在较大粒子时,由于较大粒子在测量设备上的光学效应,无法有效地测量这些较小粒子。然而,通过乳液12的可流动特征证明存在此类较小粒子,如果在此类高有机硅含量下只存在大粒子则不会是这种情况。
乳液13
用二乙烯基聚二甲基硅氧烷/聚二甲基硅氧烷共聚物以及C12-13链烷醇聚醚-23和C12-13链烷醇聚醚-3的乳液(B)(B-60%有机硅)对聚二甲基硅氧烷600Pa.s和氨基封端聚二甲基硅氧烷的混合物(A)进行乳化:将3.60g乳液(B)、39.84g聚二甲基硅氧烷600Pa.s、9.96g氨基封端聚二甲基硅氧烷和1.20g水称取到杯中。将该杯封闭并置于DAC-150Speed内部,使该杯在最大速度(3450RPM)下旋转30秒。加入第一另外的5.40g乳液(B),并使混合物在3450RPM下旋转30秒。加入另一个另外的5.00g乳液(B),并使混合物在3450RPM下旋转30秒。加入最后另外的5.80g乳液(B),并使混合物在3450RPM下旋转30秒。
所得的乳液(E13)由总有机硅含量为大约86.81%(重量百分比)的有机硅聚合物的水性水包油(o/w)乳液组成。以干重计,该乳液(E13)包含大约64.8%(重量百分比)的聚二甲基硅氧烷、16.2%(重量百分比)的氨基封端聚二甲基硅氧烷和19.0%(重量百分比)的二乙烯基聚二甲基硅氧烷/聚二甲基硅氧烷共聚物。大乳液粒子(E13)的粒度用Malvern来测定;大粒子具有Dv50=12.968μm。使用Microtrac Nanotrac 150确定小乳液粒子(E)的粒度;小粒子具有Dv50=0.683μm。
乳液9至13可用于头发护理应用,如着色洗发液、永久或半永久性着色霜、定型助剂、洗发液、冲洗型调理剂、免洗型调理剂和发膜。此类乳液在头发护理方面的其他应用对于本领域技术人员而言将是显而易见的。
化妆品组合物实例
实例5:O/W乳液
制备实例5的O/W乳液的工序
1.将成分10稀释在5g成分7中。
2.将成分1和5溶解在成分2和3中。
3.添加成分4。
4.将成分6分散在成分7的其余部分中。
5.添加成分8和9。
6.在搅拌下将相B添加到相A中。
7.添加成分10和5g成分7的混合物。
8.添加成分11。
9.添加相D并混合。
10.使用高剪切混合器混合均匀。
实例6:泡沫洁面乳
制备实例6的泡沫洁面乳的工序
1.将相B的成分混合到一起。
2.在搅拌下添加成分2。
3.在搅拌下添加成分9。
4.在搅拌下添加成分1、3和4。
5.添加成分10和11并混合。
实例7:水凝胶
实例7的成分:水凝胶 | 重量% | |
相A | ||
1 | 乳液7 | 10.00 |
2 | 环戊硅氧烷 | 13.00 |
3 | 丙烯酸酯/C10-30丙烯酸烷基酯交联聚合物 | 0.60 |
4 | 蒸馏水 | 至100.00重量% |
相B | ||
5 | 蒸馏水 | 5.00 |
6 | 三乙醇胺 | 0.13 |
C相 | ||
7 | 防腐剂 | 适量 |
制备实例7的水凝胶的工序
1.制备成分3在成分4中的溶液。
2.将相B的成分混合在一起。
3.结合相A成分并混合。
4.在搅拌下将相B添加到相A中。
5.在搅拌下添加相C。
实例8:O/W粉底
制备实例8的O/W粉底的工序
1.将成分12添加到成分13、14、15、16和17中,形成颜料混合物。混合,然后在3辊研磨机中研磨三次。
2.结合相A成分并混合。
3.加热至80℃。
4.将蒸馏水加热至85℃。
5.将成分18添加到蒸馏水中。
6.将相A添加到蒸馏水中并在高速下剪切。
7.降低剪切并添加颜料混合物。
8.混合5分钟。
9.添加成分11。
10.添加成分10。
实例9:双相免洗型调理剂
制备实例9的双相免洗型调理剂的工序
1.将相A的成分混合在一起直至均匀。
2.将相B的成分混合到一起。
3.在搅拌下将相B添加到相A中。
4.混合相C并添加到相AB中。
5.混合,直到获得均匀的溶液。
实例10:W/O乳液
实例10的成分:W/O乳液 | 重量% | |
相A | ||
1 | 环戊硅氧烷(和)PEG/PPG-18/18聚二甲基硅氧烷 | 10.0 |
2 | 环戊硅氧烷 | 15.5 |
3 | 环戊硅氧烷(和)三甲基甲硅烷氧基硅酸酯 | 3.0 |
相B | ||
4 | 乳液7 | 2.3 |
5 | 氯化钠 | 2.0 |
6 | 蒸馏水 | 至100重量% |
制备实例10的W/O乳液的工序
1.将相A的成分混合到一起。
2.将相B的成分混合到一起。
3.在连续搅拌下将相B缓慢(逐滴地)添加到相A中。
4.使用高剪切混合器混合均匀。
实例11:防晒剂和美黑霜
制备实例11的防晒剂和美黑霜的工序
1.将相B的成分混合到一起并加热至80℃。
2.按顺序结合相A成分。
3.将相A成分加热至70-75℃。
4.在搅拌下将相B添加到相A中。
5.冷却至45℃。
6.将相C的成分混合到一起。
7.将相C添加到A/B中并混合均匀。
8.在搅拌下按所列顺序添加相D成分,并混合至均匀。
9.添加芳香剂并混合均匀。
实例12:冲洗型调理剂
制备实例12的冲洗型调理剂的工序
1.将相A的成分混合到一起并加热至80℃。
2.将相B的成分混合到一起并加热至80℃。
3.在高剪切混合下将相A添加到相B中。
4.在搅拌下逐渐冷却至45℃。
5.混合相C的成分,直到完全溶解。将相C的混合物添加到相AB中。
6.将相D的成分一次一种地添加到ABC的混合物中。
7.混合直至均匀。
实例13:AP/走珠香体液
实例13的成分:AP/走珠香体液 | 重量% | |
相A | ||
1 | 蒸馏水 | 41.0 |
2 | 硬脂醇聚醚-20 | 0.6 |
相B | ||
3 | 山嵛基三甲基硫酸甲酯铵(和)鲸蜡硬脂醇 | 1.0 |
4 | 硬脂醇聚醚-2 | 1.4 |
5 | PPG-3肉豆蔻醇醚 | 3.0 |
C相 | ||
6 | 蒸馏水 | 15.0 |
7 | 四氯羟铝锆GLY配位化合物 | 30.0 |
相D | ||
8 | 乳液7 | 3.0 |
9 | 蒸馏水 | 5.0 |
制备实例13的AP/走珠香体液的工序
1.将相A的成分混合到一起。
2.将相B的成分混合到一起。
3.单独将相A和相B加热至70℃。
4.在搅拌下将相B添加到相A中。
5.冷却至50℃。
6.将相C的成分混合到一起。
7.将相C添加到前面的混合物中。冷却至室温。
8.将相D的成分混合到一起。
9.在缓慢搅拌下添加相D。
Claims (12)
1.一种化妆品组合物,包含
i.双峰水连续乳液(E),所述双峰水连续乳液(E)包含至少70重量%的:第一分散相和第二分散相,所述第一分散相包含疏水性油,其中所述疏水性油以非乳化疏水性油形式提供,所述第二分散相包含有机硅,其中所述有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;
ii.以及至少一种化妆品成分(C);
iii.任选地存在于化妆品适用的介质中。
2.根据权利要求1所述的化妆品组合物,其中所述第一分散相的所述疏水性油选自有机油、有机硅或它们的组合。
3.根据权利要求1和2所述的化妆品组合物,其中所述包含有机硅的分散相选自“巨”或“微”乳液。
4.根据权利要求1至3所述的化妆品组合物,其中所述化妆品成分(C)选自润肤剂、蜡、保湿剂、表面活性材料、增稠剂、水相稳定剂、pH控制剂、防腐剂和化妆品杀生物剂、皮脂吸收剂、皮脂控制剂、蔬菜提取物、植物提取物、维生素、蛋白质和它们的衍生物、氨基酸和它们的衍生物、颜料、着色剂、填充剂、有机硅调理剂、阳离子调理剂、紫外线吸收剂、防晒剂、去屑剂、防汗剂、除臭剂、护肤剂、毛发染料、指/趾甲护理成分、芳香剂、香料、抗氧化剂、氧化剂、还原剂、成膜剂、推进剂气体、脂肪醇、色彩护理添加剂、珠光剂、螯合剂、成膜剂、定型剂、神经酰胺、助悬剂以及它们的混合物。
5.根据前述权利要求中任一项所述的化妆品组合物,其中所述化妆品成分选自阳离子调理剂、疏水性调理剂,以及它们的混合物。
6.根据前述权利要求中任一项所述的化妆品组合物,其形式为霜、凝胶、粉末(自由流动的粉末或压制的粉末)、糊剂、固体、可自由倾倒的液体、气雾剂。
7.根据前述权利要求中任一项所述的化妆品组合物,其形式为洗发液、霜、冲洗型调理剂、免洗型调理剂、凝胶。
8.一种用于制备化妆品组合物的方法,包括以下步骤:
i.混合双峰水连续乳液(E),所述双峰水连续乳液(E)包含至少70重量%的:第一分散相和第二分散相,所述第一分散相包含疏水性油,其中所述疏水性油以非乳化疏水性油形式提供,所述第二分散相包含有机硅,其中所述有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;
ii.以及至少一种化妆品成分(C);
iii.任选地在化妆品适用的介质存在下进行。
9.根据权利要求6所述的方法,其中所述化妆品组合物通过将水相中的所述双峰水连续乳液(E)与所述合适的水相成分混合,并且任选地提供非水相,并任选地在加热条件下将所述水相和所述非水相混合到一起制备而成。
10.一种洗涤角质纤维的方法,所述方法包括以下步骤:
i.混合双峰水连续乳液(E)与至少一种化妆品成分(C),所述双峰水连续乳液(E)包含至少70重量%的:第一分散相和第二分散相,所述第一分散相包含疏水性油,其中所述疏水性油以非乳化疏水性油形式提供,所述第二分散相包含有机硅,其中所述有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;
任选地在化妆品适用的介质存在下进行;
ii.将所述混合物施加到所述角质纤维上;
iii.任选地让所述混合物停留在所述角质纤维上;
iv.任选地冲洗所述角质纤维。
11.一种调理角质纤维的方法,所述方法包括以下步骤:
i.混合双峰水连续乳液(E)与至少一种化妆品成分(C),所述双峰水连续乳液(E)包含至少70重量%的:第一分散相和第二分散相,所述第一分散相包含疏水性油,其中所述疏水性油以非乳化疏水性油形式提供,所述第二分散相包含有机硅,其中所述有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;
所述至少一种化妆品成分(C)选自阳离子调理聚合物、疏水性调理聚合物;任选地在化妆品适用的介质存在下进行;
ii.将所述混合物施加到所述角质纤维上;
iii.任选地让所述混合物停留在所述角质纤维上;
iv.任选地冲洗所述角质纤维。
12.使用一种化妆品组合物护理角质基质,所述化妆品组合物包含
i.双峰水连续乳液(E),所述双峰水连续乳液(E)包含至少70重量%的:第一分散相和第二分散相,所述第一分散相包含疏水性油,其中所述疏水性油以非乳化疏水性油形式提供,所述第二分散相包含有机硅,其中所述有机硅由包含至少一种表面活性剂的水连续有机硅乳液提供;
ii.以及至少一种化妆品成分(C);
iii.任选地存在于化妆品适用的介质中。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261729024P | 2012-11-21 | 2012-11-21 | |
US61/729,024 | 2012-11-21 | ||
PCT/US2013/071252 WO2014081939A1 (en) | 2012-11-21 | 2013-11-21 | Cosmetic composition comprising bi-modal emulsion |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104736131A true CN104736131A (zh) | 2015-06-24 |
Family
ID=49759566
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380055413.3A Pending CN104736131A (zh) | 2012-11-21 | 2013-11-21 | 包含双峰乳液的化妆品组合物 |
CN201380057524.8A Pending CN104769092A (zh) | 2012-11-21 | 2013-11-21 | 包含乳液的织物护理组合物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201380057524.8A Pending CN104769092A (zh) | 2012-11-21 | 2013-11-21 | 包含乳液的织物护理组合物 |
Country Status (6)
Country | Link |
---|---|
US (2) | US20170260479A1 (zh) |
EP (2) | EP2922524A1 (zh) |
JP (2) | JP2016502611A (zh) |
KR (2) | KR20150087251A (zh) |
CN (2) | CN104736131A (zh) |
WO (2) | WO2014081939A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117598931A (zh) * | 2023-12-07 | 2024-02-27 | 古新(中山)新材料科技有限公司 | 一种基于硅油混合物的高效修护调理剂及其制备方法 |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016089720A1 (en) * | 2014-12-03 | 2016-06-09 | Dow Corning Corporation | Bi-modal emulsions |
KR102564239B1 (ko) | 2014-12-03 | 2023-08-09 | 마리 케이 인코포레이티드 | 화장료 조성물 및 이를 이용하는 방법 |
WO2017055943A1 (en) * | 2015-07-15 | 2017-04-06 | Bakel Srl | Cosmetic composition |
FR3040879B1 (fr) * | 2015-09-10 | 2017-10-13 | Oreal | Composition filtrante anhydre comprenant une phase grasse siliconee |
DE102015221058A1 (de) * | 2015-10-28 | 2017-05-04 | Henkel Ag & Co. Kgaa | "Schweißhemmende O/W-Emulsionen mit vernetzten Silikonpolymeren" |
US10206868B2 (en) | 2015-12-30 | 2019-02-19 | Mary Kay Inc. | Topical compositions |
JP6938677B2 (ja) * | 2017-05-27 | 2021-09-22 | ワッカー ケミー アクチエンゲゼルシャフトWacker Chemie AG | 水中油型マイクロエマルションおよびその製造 |
EP3687491A4 (en) * | 2017-09-25 | 2021-07-07 | Innospec Limited | HAIR CARE COMPOSITIONS AND METHODS |
KR102067094B1 (ko) | 2018-04-17 | 2020-01-15 | 김철환 | 비(非)계면활성제형 오일-물(o/w) 분산 조성물, 비(非)계면활성제형 물-오일(w/o) 분산 조성물 및 이들의 제조방법 |
CA3098801C (en) | 2018-05-04 | 2024-04-09 | Johnson & Johnson Consumer Inc. | Cleansing composition comprising stearic esters |
CN108786759B (zh) * | 2018-06-15 | 2020-10-16 | 山东交通学院 | 一种具有防污杀菌和染料吸附功能的油水分离材料及其制备方法 |
JP2021528443A (ja) | 2018-06-29 | 2021-10-21 | ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company | 二相製品 |
EP3813767A1 (en) | 2018-06-29 | 2021-05-05 | The Procter & Gamble Company | Dual phase products |
EP3814021A2 (en) | 2018-06-29 | 2021-05-05 | The Procter & Gamble Company | Dual phase products dispenser |
CN108893892B (zh) * | 2018-08-22 | 2020-05-12 | 贵州凯里经济开发区鑫田民族服饰工艺品发展有限公司 | 一种刺绣布料及其制作方法 |
DE102018222141A1 (de) * | 2018-12-18 | 2020-06-18 | Henkel Ag & Co. Kgaa | Zweikomponenten-Haarpflegemittel zur Herstellung einer Emulsion zur Pflege von Humanhaaren |
RU2702626C1 (ru) * | 2019-02-28 | 2019-10-09 | Общество с ограниченной ответственностью "АрБиПи" | Бальнеологическая концентратная композиция, содержащая нефть нафталанскую рафинированную |
RU2702629C1 (ru) * | 2019-03-05 | 2019-10-09 | Общество с ограниченной ответственностью "АрБиПи" | Бальнеологическая концентратная композиция, содержащая нефть нафталанскую рафинированную |
RU2702628C1 (ru) * | 2019-03-05 | 2019-10-09 | Общество с ограниченной ответственностью "АрБиПи" | Бальнеологическая концентратная композиция, содержащая нефть нафталанскую рафинированную |
RU2702627C1 (ru) * | 2019-03-05 | 2019-10-09 | Общество с ограниченной ответственностью "АрБиПи" | Бальнеологическая концентратная композиция, содержащая нефть нафталанскую рафинированную |
CN111518626A (zh) * | 2020-04-17 | 2020-08-11 | 周萍 | 一种基于5g移动洗衣站无水洗衣溶剂 |
CN113736360A (zh) * | 2020-05-27 | 2021-12-03 | 惠州市绿志岛工业材料有限公司 | 一种防水防油的喷雾剂 |
EP3967291A1 (en) * | 2020-09-15 | 2022-03-16 | Unilever Global IP Ltd | Hair composition |
KR102500988B1 (ko) * | 2020-11-23 | 2023-02-21 | 주식회사 메가코스 | 반응성 실리콘을 포함하는 화장료 조성물 |
CN112877149A (zh) * | 2021-02-05 | 2021-06-01 | 杭州诗茵服饰有限公司 | 一种适用于白色系牛仔布料的清洗剂及其制备方法 |
CN113150879A (zh) * | 2021-03-23 | 2021-07-23 | 广州市爱家有方日用品有限公司 | 一种洗涤泡腾片用的增稠组合物、洗涤泡腾片 |
US20230227755A1 (en) * | 2022-01-19 | 2023-07-20 | Ecolab Usa Inc. | Non-fluorocarbon laundry treatment providing enhanced fluid repellency |
WO2023152092A1 (en) * | 2022-02-14 | 2023-08-17 | Unilever Ip Holdings B.V. | A concentrated liquid composition premix |
WO2024013172A1 (en) * | 2022-07-12 | 2024-01-18 | Unilever Ip Holdings B.V. | Laundry composition |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030211069A1 (en) * | 2002-05-09 | 2003-11-13 | The Procter & Gamble Company | Rinsable skin conditioning compositions |
US20080299157A1 (en) * | 2007-06-01 | 2008-12-04 | L'oreal | Skin care compositions having unique texture properties |
CN102458345A (zh) * | 2009-06-19 | 2012-05-16 | 花王株式会社 | 双层分离型毛发化妆品 |
WO2012119062A2 (en) * | 2011-03-03 | 2012-09-07 | Dow Corning Corporation | Bi-modal emulsions |
Family Cites Families (62)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2891920A (en) | 1955-01-26 | 1959-06-23 | Dow Corning | Polymerization of organopolysiloxanes in aqueous emulsion |
BE553159A (zh) | 1955-12-05 | |||
GB1024024A (en) | 1963-04-08 | 1966-03-30 | Dow Corning | Improvements in or relating to polymerising or co-polymerising organosilicon compounds |
NL131800C (zh) | 1965-05-17 | |||
US3814730A (en) | 1970-08-06 | 1974-06-04 | Gen Electric | Platinum complexes of unsaturated siloxanes and platinum containing organopolysiloxanes |
US3715334A (en) | 1970-11-27 | 1973-02-06 | Gen Electric | Platinum-vinylsiloxanes |
US3923705A (en) | 1974-10-30 | 1975-12-02 | Dow Corning | Method of preparing fire retardant siloxane foams and foams prepared therefrom |
US4874547A (en) * | 1985-04-02 | 1989-10-17 | Dow Corning Corporation | Bi-modal silicone emulsions, silicone emulsification process and emulsions therefrom |
US4618645A (en) | 1985-05-24 | 1986-10-21 | Dow Corning Corporation | Method of producing aqueous latex of crosslinked polydiorganosiloxane |
CA1328139C (en) | 1985-12-12 | 1994-03-29 | Daniel Graiver | Methods for making polydiorganosiloxane microemulsions |
US4824877A (en) * | 1988-02-02 | 1989-04-25 | Dow Corning Corporation | High polymer content silicone emulsions |
CA2041599A1 (en) | 1990-06-01 | 1991-12-02 | Michael Gee | Method for making polysiloxane emulsions |
US5071573A (en) * | 1990-07-23 | 1991-12-10 | The Procter & Gamble Company | Microemulsified silicones in liquid fabric care compositions containing dye |
GB9103191D0 (en) | 1991-02-14 | 1991-04-03 | Dow Corning | Platinum complexes and use thereof |
JP2631772B2 (ja) | 1991-02-27 | 1997-07-16 | 信越化学工業株式会社 | 新規なシリコーン重合体及びそれを用いた水分散能を有するペースト状シリコーン組成物 |
US5254269A (en) * | 1991-11-26 | 1993-10-19 | Lever Brothers Company, Division Of Conopco, Inc. | Fabric conditioning composition containing an emulsified silicone mixture |
US5389364A (en) | 1993-08-06 | 1995-02-14 | Dow Corning Corporation | Conditioning hair with aminosilane reaction products with lactones or carbonates |
US5419627A (en) | 1993-09-07 | 1995-05-30 | Dow Corning Corporation | Illuminated cabinet for sensory evaluations |
US5409695A (en) | 1994-02-22 | 1995-04-25 | Dow Corning Corporation | Method of increasing deposition of silicone conditioner to hair |
US5504149A (en) | 1994-08-25 | 1996-04-02 | Dow Corning Corporation | Method of emulsion polymerization |
US5486566A (en) | 1994-09-23 | 1996-01-23 | Dow Corning Corporation | Siloxane gels |
FR2729853A1 (fr) | 1995-01-27 | 1996-08-02 | Oreal | Composition cosmetique a base de gomme de guar et de silicone oxyalkylenee |
US5661215A (en) | 1995-07-26 | 1997-08-26 | Dow Corning Corporation | Microemulsions of gel-free polymers |
GB9523167D0 (en) * | 1995-11-13 | 1996-01-17 | Unilever Plc | Cosmetic composition |
JPH09171154A (ja) | 1995-12-19 | 1997-06-30 | Nippon Sheet Glass Co Ltd | 画像入力光学系及びこの光学系を用いた画像入力装置 |
US5760116A (en) | 1996-09-05 | 1998-06-02 | General Electric Company | Elastomer gels containing volatile, low molecular weight silicones |
AU5156698A (en) | 1996-10-29 | 1998-05-22 | Grant Industries, Inc. | Grafted rubber-like silicone gel with enhanced oil compatibility and its synthetic process |
US5811487A (en) | 1996-12-16 | 1998-09-22 | Dow Corning Corporation | Thickening silicones with elastomeric silicone polyethers |
US5880210A (en) | 1997-04-01 | 1999-03-09 | Dow Corning Corporation | Silicone fluids and solvents thickened with silicone elastomers |
US6051216A (en) | 1997-08-01 | 2000-04-18 | Colgate-Palmolive Company | Cosmetic composition containing siloxane based polyamides as thickening agents |
US6280748B1 (en) | 1998-06-12 | 2001-08-28 | Dow Corning Toray Silicone, Ltd. | Cosmetic raw material cosmetic product and method for manufacturing cosmetic products |
GB9826394D0 (en) | 1998-12-02 | 1999-01-27 | Dow Corning Sa | Method of making silicone-in-water emulsions |
US6262170B1 (en) | 1998-12-15 | 2001-07-17 | General Electric Company | Silicone elastomer |
US6200581B1 (en) | 1999-04-28 | 2001-03-13 | Dow Corning Corporation | Elastomeric silicone terpolymer |
GB9911840D0 (en) | 1999-05-21 | 1999-07-21 | Dow Corning Sa | Siloxane emulsions |
EP1081272B1 (en) | 1999-09-02 | 2004-10-13 | Dow Corning Corporation | Fiber treatment composition containing amine, polyol, amide-functional siloxanes |
US6136215A (en) | 1999-09-02 | 2000-10-24 | Dow Corning Corporation | Fiber treatment composition containing amine-, polyol-, amide-functional siloxanes |
US6171515B1 (en) | 1999-09-02 | 2001-01-09 | Dow Corning Corporation | Fiber treatment composition containing amine-, polyol-, functional siloxanes |
US6768124B2 (en) | 1999-10-19 | 2004-07-27 | Nikon Corporation | Reticle-focus detector, and charged-particle-beam microlithography apparatus and methods comprising same |
US6365670B1 (en) | 2000-03-10 | 2002-04-02 | Wacker Silicones Corporation | Organopolysiloxane gels for use in cosmetics |
US6531540B1 (en) | 2001-05-16 | 2003-03-11 | General Electric Company | Polyether siloxane copolymer network compositions |
US6482969B1 (en) | 2001-10-24 | 2002-11-19 | Dow Corning Corporation | Silicon based quaternary ammonium functional compositions and methods for making them |
US6607717B1 (en) | 2001-10-24 | 2003-08-19 | Dow Corning Corporation | Silicon based quaternary ammonium functional compositions and their applications |
US6737444B1 (en) * | 2003-01-16 | 2004-05-18 | Dow Corning Corporation | Method of making silicone resin emulsions |
WO2004103326A1 (en) | 2003-05-16 | 2004-12-02 | Dow Corning Corporation | Personal care applications of emulsions containing elastomeric silanes and siloxanes with nitrogen atoms |
KR101094086B1 (ko) | 2003-05-16 | 2011-12-15 | 다우 코닝 코포레이션 | 4급 암모늄 그룹을 갖는 탄성중합체성 실란 및 실록산을함유하는 에멀전의 제조방법 |
JP4235061B2 (ja) * | 2003-08-21 | 2009-03-04 | 花王株式会社 | 毛髪化粧料 |
EP1678371A1 (en) * | 2003-10-31 | 2006-07-12 | The Procter & Gamble Company | Fabric care compositions comprising aminosilicone |
EP1711551B1 (en) | 2004-02-02 | 2007-08-29 | Dow Corning Corporation | Mq-t propyl siloxane resins |
ATE371691T1 (de) | 2004-04-12 | 2007-09-15 | Dow Corning | Silsesquioxanharzwachs |
JP5053859B2 (ja) | 2004-12-01 | 2012-10-24 | ダウ・コーニング・コーポレイション | シリコーンポリエーテル−アミドブロック共重合体 |
WO2006127883A2 (en) | 2005-05-23 | 2006-11-30 | Dow Corning Corporation | Personal care compositions comprising saccharide-siloxane copolymers |
JP2009540138A (ja) * | 2006-06-07 | 2009-11-19 | ダウ・コーニング・コーポレイション | シリコーンポリエーテル−アミドブロックコポリマーを用いる布地の処理 |
GB0611217D0 (en) | 2006-06-08 | 2006-07-19 | Dow Corning | Amino-acid functional siloxanes,methods of preparation and applications |
EP2115065B1 (en) | 2007-02-20 | 2016-05-11 | Dow Corning Corporation | Filler treating agents based on hydrogen bonding polyorganosiloxanes |
US20080299156A1 (en) * | 2007-06-01 | 2008-12-04 | L'oreal | Skin care compositions containing a high internal phase emulsion |
US8840911B2 (en) * | 2008-03-07 | 2014-09-23 | Kimberly-Clark Worldwide, Inc. | Moisturizing hand sanitizer |
EP2291435B1 (en) * | 2008-06-03 | 2016-08-17 | Dow Global Technologies LLC | A composite dispersion, method of producing the same, and articles made therefrom |
EP2385099A1 (en) * | 2010-05-06 | 2011-11-09 | The Procter & Gamble Company | Process of making liquid fabric softening compositions |
CN103154093B (zh) | 2010-08-23 | 2015-08-26 | 道康宁公司 | 糖硅氧烷共聚物及其制备和使用方法 |
WO2012027073A1 (en) | 2010-08-23 | 2012-03-01 | Dow Corning Corporation | Saccharide siloxanes stable in aqueous environments and methods for the preparation and use of such saccharide siloxanes |
BR112013022302A2 (pt) * | 2011-03-03 | 2016-12-06 | Dow Corning | emulsões bimodais |
-
2013
- 2013-11-21 US US15/522,589 patent/US20170260479A1/en not_active Abandoned
- 2013-11-21 KR KR1020157014091A patent/KR20150087251A/ko not_active Application Discontinuation
- 2013-11-21 WO PCT/US2013/071252 patent/WO2014081939A1/en active Application Filing
- 2013-11-21 EP EP13803354.3A patent/EP2922524A1/en not_active Withdrawn
- 2013-11-21 WO PCT/US2013/071278 patent/WO2014081950A2/en active Application Filing
- 2013-11-21 KR KR1020157014094A patent/KR20150086284A/ko not_active Application Discontinuation
- 2013-11-21 EP EP13803356.8A patent/EP2922939A2/en not_active Withdrawn
- 2013-11-21 CN CN201380055413.3A patent/CN104736131A/zh active Pending
- 2013-11-21 US US14/442,263 patent/US20160271023A1/en not_active Abandoned
- 2013-11-21 JP JP2015543157A patent/JP2016502611A/ja active Pending
- 2013-11-21 JP JP2015543155A patent/JP2016500078A/ja active Pending
- 2013-11-21 CN CN201380057524.8A patent/CN104769092A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030211069A1 (en) * | 2002-05-09 | 2003-11-13 | The Procter & Gamble Company | Rinsable skin conditioning compositions |
US20080299157A1 (en) * | 2007-06-01 | 2008-12-04 | L'oreal | Skin care compositions having unique texture properties |
CN102458345A (zh) * | 2009-06-19 | 2012-05-16 | 花王株式会社 | 双层分离型毛发化妆品 |
WO2012119062A2 (en) * | 2011-03-03 | 2012-09-07 | Dow Corning Corporation | Bi-modal emulsions |
Non-Patent Citations (7)
Title |
---|
R. GREENWOOD等: "Minimising the viscosity of concentrated dispersions hy using bimodal particle size distributions", 《COLLOIDS AND SURFACE A: PHYSICOCHEMICAL AND ENGINEERING ASPECTS》 * |
中华人民共和国卫生部: "《化妆品卫生规范》", 31 January 2007 * |
孟庆轩主编: "《生活中的健康隐患》", 31 July 2012, 金盾出版社 * |
王运赣等: "《功能器件自由成形》", 31 August 2012, 机械工业出版社 * |
章苏宁主编: "《化妆品工艺学》", 30 September 2007, 中国轻工业出版社 * |
赵陈超: "《有机硅乳液及其应用》", 30 September 2008, 化学工业出版社 * |
韩长日等主编: "《精细有机化工产品生产技术手册 下卷》", 30 June 2010, 中国石化出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117598931A (zh) * | 2023-12-07 | 2024-02-27 | 古新(中山)新材料科技有限公司 | 一种基于硅油混合物的高效修护调理剂及其制备方法 |
CN117598931B (zh) * | 2023-12-07 | 2024-05-14 | 古新(中山)新材料科技有限公司 | 一种基于硅油混合物的高效修护调理剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
EP2922939A2 (en) | 2015-09-30 |
KR20150086284A (ko) | 2015-07-27 |
WO2014081939A1 (en) | 2014-05-30 |
EP2922524A1 (en) | 2015-09-30 |
WO2014081950A2 (en) | 2014-05-30 |
KR20150087251A (ko) | 2015-07-29 |
US20160271023A1 (en) | 2016-09-22 |
WO2014081950A3 (en) | 2014-07-24 |
CN104769092A (zh) | 2015-07-08 |
US20170260479A1 (en) | 2017-09-14 |
JP2016500078A (ja) | 2016-01-07 |
JP2016502611A (ja) | 2016-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104736131A (zh) | 包含双峰乳液的化妆品组合物 | |
CN105636576B (zh) | 包含羧基官能化弹性体的化妆品组合物 | |
KR101902167B1 (ko) | 가교결합된 조성물 및 이를 포함하는 화장 조성물 | |
US11090253B2 (en) | Cosmetic composition comprising silicone materials | |
EP2914241B1 (en) | Cosmetic composition comprising hydrophilic organosilanes | |
CN104800102A (zh) | 包含弹性体的化妆品组合物 | |
WO2014143757A1 (en) | Cosmetic compositions containing silicone resin emulsions | |
CN103547316A (zh) | 个人护理和保健组合物 | |
CN111432885B (zh) | 包含有机硅材料的化妆品组合物 | |
US9913795B2 (en) | Cosmetic compositions containing silicones | |
CN108350273A (zh) | 水包油乳液和方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150624 |
|
RJ01 | Rejection of invention patent application after publication |